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The mouse embryonic oesophagus is initially lined with simple columnar 
epithelium which changes during the course of development to stratified 
squamous tissue. In the present study, an in vitro model based on oesophageal 
explants isolated from E11.5d mouse embryos was developed. The columnar 
epithelial markers keratins 8 and 18 (K8, 18) were expressed at the beginning of 
the culture period and decreased in the basal epithelial layer at around day 5, but 
persisted in the suprabasal layers of the stratified epithelium for several more 
days. In contrast, the stratified squamous epithelial marker keratin 14 (K14) was 
absent at the beginning but progressively appeared in cells within the basal layer 
from 5 days of culture. The time course of the cell type transition seen in culture is 
similar to that in vivo. The two possible mechanisms for the change are either (1) a 
direct conversion of columnar cells to the basal layer cells of the squamous 
epithelium; or (2) an overgrowth of columnar by squamous cells. To investigate, 
first I demonstrated that some epithelial cells express both K8 and K14 by 
co-staining for both markers during the transition period in vivo and in vitro. 
Second, after electroporation of a construct containing the K14 promoter driving 
nuclear GFP into the epithelium of E15.5 oesophagus, some cells expressed both 
K8 and GFP. Third, there is no preferential loss of the columnar cells by apoptosis. 
Final, inhibitors of apoptosis and cell division do not affect the process. The results 
suggest that in normal development, the squamous epithelium arises from the 
columnar epithelium by a direct conversion process. In terms of the molecular 
mechanism, inhibitor studies suggest that de novo DNA methylation is required for 
the loss of the K8 expression but not for the acquisition of the K14 expression. 
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1.1 Metaplasia and transdifferentiation, definitions and importance in 
development and disease
1.1.1 What is transdifferentiation?
The conversion from one cellular phenotype to another is termed metaplasia, 
and can include conversions between stem cells of different tissue types (Tosh 
and Slack, 2002). Transdifferentiation is a subclass of metaplasia and by 
definition it is an irreversible switch of one already differentiated cell to another 
type of differentiated cell (Eguchi and Kodama, 1993). Some pathologists use 
the term “metaplasia” to describe cell-type replacement from an overgrowth of 
one population by another, when it is the result of cell migration and outgrowth. 
According to Eguchi and Kodama, two important experimental criteria need to 
be established for a process to be defined as transdifferentiation. Firstly, the 
two different phenotypes (i.e. the cells that are present before and following the 
transdifferentiation event) should be clearly defined. Both morphological 
appearances and molecular or biochemical evidence is usually required. 
Secondly, the cell lineage (ancestor-descendent) relationship between the two 
cell types needs to be established. Other questions of interest involving 
metaplasia and transdifferentiation are whether (1) cell division is involved and 
(2) the transition is between closely related developmental hierarchy pathways 
or from distant cell lineages (Slack and Tosh, 2001).
1.1.2 Master reguiatory genes
Transdifferentiation is normally found to occur in cells that have the same 
embryonic origin (e.g. pancreas and liver are both derived from the endoderm)
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(Slack, 1985; Slack and Tosh, 2001; Tosh and Slack, 2002). It is possible that 
there is just one or a few important regulatory gene(s) known as master switch 
genes that are important in deciding the fate of a cell. When master switch 
genes are mutated or misexpressed either ectopically or as a result of a 
disease process, transdifferentiation can occur (Fig 1.1).
A number of genes that exist exemplify the definition of the master switch gene. 
These include MyoD for myogenesis, peroxisome proliferating activating 
receptor-gamma (PPARy) and CCAAT-enhancer binding proteins (C/EBPs) for 
adipogenesis, NeuroD for neurogenesis and PHA-4/FoxA for pharyngeal 
organogenesis in C. elegans.
The muscular master switch gene MyoD was found by a unique experimental 
approach. A mouse fibroblastic progenitor cell line-10T1/2 derived from C3H 
mouse embryonic cells (Reznikoff et al., 1973), was found to produce three 
different mesenchymal cell lineages when treated with the hypo-methylating 
agent-5-azacytidine (Taylor and Jones, 1979; Konieczny and Emerson, 1984). 
The three lineages were striated muscle cells, lipid-storing adipocytes and 
cartilage-producing chondrocytes. The phenotypes persisted after withdrawal 
of 5-azacytidine, suggesting a stable switch had occurred. To try and identify 
which genes were responsible for the switch in phenotype, a genomic DNA 
library was isolated from 5-azacytidine-treated 10T1/2 and screened by 
transfection into the untreated fibroblast (Davis et al., 1987), only 1 in 15,000 
transfected colonies was found to result in myogenic conversion, indicating the 
a single or only a few loci in the genome is sufficient for this conversion. Later, 
myoblastic-specific subtracted cDNA probes generated from the proliferating 
myoblasts were used for screening and one gene -  MyoD was found to be
2
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Fig 1.1 Model for a master switch gene in metaplasia.
A metaplasia model involving the master switch gene, (a) At some point during 
embryonic development, neighbouring tissue differs in expression of just one 
master switch gene X. The expression of gene X  may be controlled by a 
certain threshold of a morphogen gradient. Gene X subsequently controls the 
identity (expression profile of tissue specific genes) of the two neighbouring 
tissues, (b) In postnatal life, somatic mutation, change in environmental stimuli 
or loss of epigenetic regulation in one or some (progenitor) cells may cause 
gene X to be turned off in a gene X expressing tissue (Loss of function model), 
or gene X to be turned on in a tissue originally not expressing gene X (Gain of 
function model). This will cause a focus of metaplastic to occur. (Figure 
adapted from Tosh and Slack, 2001; Shen et al., 2003).
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responsible for the change of 10T1/2 cells to the muscle phenotype ( Lassar et 
al., 1986; Davis et al., 1987). It is now known that there are at least four 
myogenic regulatory transcription factors (MRFs) that are important for skeletal 
muscle commitment and myotube formation - Myf5, MyoD, myogenin and 
MRF4, and they are all basic helix-loop-helix nuclear proteins (Parker et al.,
2003). The DNA-binding domain of MyoD is similar to the proto-oncogene, 
c-myc (Miner and Wold, 1991) and MyoD has been postulated to compete for 
c-myc binding sites to suppress cell division and induce muscle progenitor 
cells to differentiate. This was the first found example of a master regulatory 
gene, which is able to transdifferentiate cells such as fibroblasts that are 
originally not muscular to adopt a muscle phenotype (myotube formation and 
fusion) and express specific muscle cellular markers, e.g. myosin heavy chain 
(MHC) and myosin light chain (MLC2) (Weintraub et al., 1989). What is more 
spectacular is when MyoD is introduced into some other cell lines, such as 
primary fibroblasts, adipocytes, smooth muscle cells, hepatocytes, baby 
hamster kidney cells, melanoma cells or neuroblastoma cells, the cells start to 
express a muscle phenotype. Remarkably, this conversion crosses the germ 
layer boundaries. Muscle, fibroblasts, adipocytes, smooth muscle and kidney 
cells are mesoderm in origin, but hepatocytes are endodermal, and melanoma 
and neuroblastoma are ectodermal. However, not all cells forced to express 
MyoD could turn on the muscle differentiation programme. Expression of 
MyoD in CV1 (an African green monkey kidney-derived cell), HeLa (human 
cervical carcinoma), and a human hepatoma cell line-HepG2 failed to activate 
differentiated muscle markers, such as desmin or MHC. In these experiments, 
the authors found co-expression of the parental neural or melanocyte markers 
with the muscle markers, but did not find the co-expression of adipocyte
5
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markers with the muscle markers in the transdifferentiated myocytes. The 
explanation is possibly because myogenesis might be exclusively inhibiting 
other differentiation pathways that are very close to the muscle lineage, but not 
those that are further away from the developmental pathway. The 
understanding of transdifferentiation therefore provides insights to the normal 
embryonic development.
Myocytes can also be induced to transdifferentiate into adipocytes. Normally, 
G8 myoblasts do not express the adipocyte specific transcription factor: 
Peroxisome proliferator activated receptor-gamma (PPARy) and CCAAT 
enhancer binding proteins (C/EBPs). When PPARy and C/EBPa are 
ectopically expressed in G8 cells, the myogenesis programme is inhibited 
under normal myogenic-promoting culture conditions (Hu et al., 1995), and 
expression of MyoD, Myf-5, myogenin and MRF-4 are markedly reduced. On 
the other hand, markers specific for adipocytes, such as aP-2, adipsin, LPL 
and PEPCK appeared only in G8 myoblast line co-expressing both PPARy and 
C/EBPa, and most of the cells become Oil red O-stained positive, which marks 
lipid storage within the cells. It was also found that C/EBPP and C/EBP5 
stimulates adipogenesis in fibroblasts (Yeh et al., 1995), which probably occurs 
through up-regulation of PPARy expression (Wu et al., 1995). However, the 
normal activation of the PPARy nuclear receptor in adipogenesis still requires 
ligand binding (Wu et al., 1996). There are also cases where over-expression 
of C/EBPa in 8 different lines of fibroblastic cells (such as NIH3T3, BALB/C-3T3) 
promotes adipogenesis (Freytag et al., 1994), but this only occurs when large 
quantities of C/EBPa is expressed. Normally, C/EBPa is expressed later than 
PPARy in preadipocyte differentiation, and physiological amounts of C/EBPa 
can synergize with PPARy in promoting adipogenesis in fibroblasts (Tontonoz
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et al., 1994). It is also found that the canonical Wnt signalling pathway is 
involved in inhibiting the pre-adipocyte differentiation into adipocytes (Ross et 
al., 2000). The inhibitory mechanism does not affect the expression of C/EBPp 
and C/EBP6, but controls the expression of PPARy, C/EBPa and the further 
activation of adipogenesis; therefore, Wnt signalling is thought to suppress the 
differentiation of pre-adipocytes by acting downstream of C/EBPs. 
Cross-regulation of C/EBPs and PPARy is important in maintaining the 
adipocyte differentiated state and the presence of both transcription factors is 
powerful enough to change the muscle cell lineage into fat cell lineage (Rosen 
et al., 2000). A simplified diagram of transcription factors important in 
adipogenesis is shown in Fig 1.2.
ligands
C/EBP|3 PPARy C/EBPa ~ ► adipogenesis
I_____________________________________*
Fig 1.2 A simplified diagram below shows the transcriptional regulatory 
hierarchy in the process of adipogenesis (arrows indicate activation or 
up-regulation).
A well understood “master switch” transcription factor controls the identity of 
C.elegans pharynx. PHA-4 is a C.elegans homologue of the mammalian 
forkhead transcription factor FoxA/HNF3 gene (Mango et al., 1994; Kalb et al.,
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1998). Nearly all of the pharyngeal-specific genes necessary for the foregut to 
develop into the pharynx contain binding sites for PHA-4/FoxA. It is the copy 
number of the PHA-4/FoxA binding element in the enhancer region that 
controls the timing and location of pharyngeal gene expression (Gaudet and 
Mango, 2002; Ao et al., 2004). PHA-4 also interacts with different genes such 
as DAF-12/NHR to further finetune which pharyngeal genes are to be 
appropriately expressed (Gaudet and Mango, 2002). However, there is no 
evidence at present to suggest that ectopic expression of PHA-4/FoxA will lead 
other cell types to transdifferentiation into pharyngeal cells.
1.1.3 Transdifferentiation of pancreas and liver
In our lab, we have worked extensively on the transdifferentiation of the 
pancreas and liver.
(1) The rat pancreatic cell line, AR42J-B13, upon treatment with the synthetic 
glucocorticoid - dexamethasone, will lose the expression of the pancreatic 
markers, e.g. amylase, and begin to express liver markers such as 
glucose-6-phosphatase, albumin, transferrin, glucokinase, CYP3A1, 
CYP2B1/2, Uridine diphosphate glucuronosyltransferase (UDPGT) and 
aryl-sulfotransferase (Shen et al., 2000; Tosh et al., 2002). When C/EBPP, 
a transcription factor not usually found in pancreas, is ectopically 
expressed in AR42J-B13 cell line, the cells transdifferentiates and express 
C/EBPa and perform liver-specific functions such as the production of 
acute phase proteins (APP) (Kurash et al., 2004). This ability to induce 
transdifferentiation of pancreatic cells to hepatocytes indicates the master 
regulatory function of C/EBPP in the transdifferentiation of AR42J-B13 into 
liver cells. Primary culture of hepatocytes usually results in loss of the
8
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hepatocyte differentiated properties. One possible role for the B13 
transdifferentiated hepatocyte model is as an alternative to rodent 
hepatocytes for studying of liver function in vitro. The B13 cells were also 
found stably expressing differentiated markers of the hepatocytes after 
long term dexamethasome treatment.
(2) In the reverse situation, a Xenopus liver can be converted into exocrine 
(amylase-expressing cells) and endocrine pancreatic tissue (such as 
insulin-secreting cells). When a modified Xenopus version of the 
pancreatic gene Pdx1 fused in frame with VP16 (the co-activator domain 
derived from Herpes simplex virus) was introduced into the embryonic 
liver by transgenesis, ectopic pancreas could be found in hepatic regions 
of the tadpoles (Horb et al., 2003). There is also evidence that the same 
construct can transdifferentiate the human liver cell line HepG2 into 
amylase or insulin expressing cells (Li et al., 2005).
1.1.4 Conceptual categorisation of metaplasia
The examples given above and the numerous homeotic transformations 
caused by mutations are clearly examples of metaplasia. However, I want to 
further clarify some terms usually found in the literature concerning metaplasia 
and transdifferentiation. Important concepts in understanding the switch of 
different cellular lineages are transdetermination, cell fusion and 
dedifferentiation.
1.1.4.1 Transdetermination
Transdetermination is defined as the switch of a specific precursor/stem cell 
lineage to another lineage (Tosh and Slack, 2002). The result is a change of
9
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the original progenitor /stem cell fate that gives rise to descendants of the 
second lineage instead. This belongs to our other category of metaplasia but is 
not transdifferentiation. For example, imaginal discs transplanted between 
Drosophila larvae and adult female fly after many generations will sometimes 
change cell fate (Gehring, 1998). Imaginal discs which normally form legs will 
sometimes be transformed to become wings. There are even cases when 
bristles (small hair of the Drosophila) from a leg identity changes to one of an 
eye. Intriguingly, this is not a clonal event, but a process that will occur in 
groups of cells. This implies that transdetermination of the imaginal disc cells is 
not just a process of somatic mutation of the master regulatory genes (such as 
the Hox family) controlling the cell fates of the imaginal discs, rather, the 
process correlates with environmental cues during metamorphosis and also 
the extent of cell proliferation (many generations of transplantation). Signals 
such as Wingless (wg, the Drosophila Wnt) interacting with Decapentaplegic 
(Dpp, a member of the TGFp family) in the leg disc, may account for the 
transdetermination of the dorsal leg cells to wing lineage (Maves and 
Schubiger, 1995; Maves and Schubiger, 1998).
1.1.4.2 Stem cells and metaplasia
The study of adult stem cells changing cell fates and give rise to descendants 
other than their own lineage is currently a very popular topic. Many scientists 
refer to this as transdifferentiation. However, considering our definition of 
transdifferentiation, which is conversion of cells from a differentiated state to 
another differentiated state, metaplasia concerning stem cells should be more 
appropriately considered as transdetermination (Fang et al., 2004). There are 
many examples of metaplastic cells where the source was considered to be
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from adult progenitor/stem cells. For instance, cells derived from murine 
skeletal muscle have the potential to form haematopoietic lineages (Jackson et 
al., 1999), also neural stem cells possess the ability to form tissues from all the 
three germ layers in chimeric mice (Clarke et al., 2000). There are cases of 
haematopoietic stem cells (HSC) giving rise to neural cells (Eglitis and Mezey, 
1997). Mesenchymal stem cells (MSC) and multipotent adult precursor cells 
can also form cell types of virtually all three layers (Krause et al., 2001; Jiang 
et al., 2002). HSC and MSC constitute what we know as bone marrow-derived 
cells (BMDC). It is proposed that highly plastic BMDCs have a role in 
maintenance and repairing of the non-hematopoietic tissue (Grove et al., 2004). 
The pluripotency of BMDC will be discussed in more detail in the next section.
1.1.4.3 Cell fusion
Bone marrow contains two populations of stem cells - (a) haematopoietic stem 
cell (HSC) which normally gives rise to all mature lineages of blood, and (b) 
mesenchymal stem cell (MSC) which can differentiate to bone, cartilage and 
fat. Bone marrow-derived cells (BMDC) are also capable of undergoing 
metaplasia (Pomerantz and Blau, 2004). Although recently, there are some 
incidences where direct conversion of BMDC to cells other than descendants 
of HSC and MSC lineages can occur (e.g. pancreatic endocrine cells derived 
from bone marrow without evidence of cell fusion (lanus et al., 2003) and 
haematopoietic stem cells convert into liver cells without fusion (Jang et al., 
2004)), most BMDC metaplasia appeared to be due to cell fusion. From the 
many examples of metaplasia involving BMDC changing phenotype to 
non-haematopoietic organs, there is now a growing body of evidence showing 
the ability of BMDC to form fusion heterokaryons with the target cells to rescue
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the phenotype (Pomerantz and Blau, 2004). BMDC are known to be 
pluripotent and can directly switch to non-haematopoietic cell types. It is now 
recognised that BMDC possess the ability of cell-cell fusion with other cell 
types in the target tissues. Ultimately BMDC can repair the organ, albeit this 
happens very rarely. So far, examples of BMDC fused with liver, skeletal 
muscle, cardiac muscle and neurons have been found (Pomerantz and Blau,
2004). While there is evidence of metaplasia of BMDC changing into satellite 
cells in irradiated or exercise-induced muscle damage (transdetermination) 
(LaBarge and Blau, 2002), there is also evidence that formation of the new 
functional myofibres are fused mature myeloid cells with the injured muscle 
fibres (Corbel et al., 2003). However, one disadvantage of using muscle as a 
model of metaplasia is the difficulty of distinguishing between the mature 
multi-nucleated muscle fibre and the incorporated nuclei during the fusion 
process. A simple diagram of how BMDC may contribute in regenerative 
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Fig 1.3 Examples of cell fusion and direct transdifferentiation of BMDC in many 
tissue types.
Bone marrow-derived cells may represent a new avenue for regenerative 
medicine or repairing damaged tissue. There are now examples that BMDC 
could either incorporates (cell fusion) or direct conversion into the target 
tissues, found mostly after transplantation of BMDC into animals. Some 
examples are shown here, BMDC could be found fused to neurons, liver and 
(skeletal and cardiac) muscle cells, while there is also evidence showing direct 
conversion of BMDC to become pancreas, hepatocytes and muscle stem cells.
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1.1.4.4 Cell lineage tracing
In order to look further into this subject, it is necessary to be able to trace the 
specific cell lineage of interest. Cre/lox recombinase is now one of the methods 
of choice for tracing cell lineages in vivo (Branda and Dymecki, 2004). For 
example, one can produce a bigenic animal by mating a transgenic mouse 
carrying a cell type-specific gene promoter driving Cre recombinase with 
another line carrying a LacZ reporter gene flanked by the loxP and stop codon 
that can be excised out when Cre recombinase is present (such as the R26R 
line). Following the excision event, any cell that has ever activated a specific 
promoter of interest will continue to express LacZ even after the cell stops 
using that specific promoter in question. This is a powerful method for tracing 
cell lineages as it is now possible to mark specific cell types which only 
transiently activates a specific promoter. Other cell lineage tracing methods 
utilise cytogenetic markers (such as tracing Y chromosome, when grafting 
male donor cells into female recipients) or simply lipophilic dyes (e.g. Dil) to 
label the cells of interest.
Using the Cre/lox system to detect cell fusion events, Alvarez-Dolado et al 
found evidence of BMDC fused with hepatocytes and cardiomyocytes in vivo, 
which raises the possibility of cell fusion as a mechanism for development and 
maintenance of tissue (Alvarez-Dolado et al., 2003). Also there is the case of 
BMDC incorporated into the fully differentiated, non-proliferative Purkinje 
neurons in both human (Weimann et al., 2003a) and mouse (Alvarez-Dolado 
et al., 2003; Weimann et al., 2003b). Neural stem cells were also found 
adopting embryonic stem cell characteristics after fusing with the co-cultured 
embryonic stem cell (Ying et al., 2002).
Evidence that transplanting HSC into fumarylacetoacetate hydroxylase
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deficient (Fah'7') mice could rescue the liver function indicates that HSC have 
the potential of changing differentiation status and give rise to functioning 
hepatocytes (Lagasse et al., 2000). Further evidence indicates that the Fah+/+ 
mice HSC that reconstitute the Fah'7' liver actually fuse to the existing 
hepatocytes (Wang et al., 2003; Vassilopoulos et al., 2003). Using a cell 
lineage tracing approach, the authors found that most of the Fah expressing 
cells still contain the recipient Y chromosome. The question is which cell type 
constituted the fused hepatocytes in the Fah deficient mouse model? They first 
ruled out the possibility that hepatocytes of Fah+/+ mouse were fused with the 
Fah'7" hepatocytes by analyzing the phenotype and sex chromosome of the 
reconstituted hepatocytes from serial transplantation of Fah+/+ female 
hepatocyte into male Fah'7' liver (Willenbring et al., 2004). Furthermore, using 
the same method, they established the cell types in the donor’s HSC that is 
responsible for the fusion. When a specific subgroup of the HSC derivatives -  
the granulocyte macrophage progenitors (GMP, the colony forming units of 
progenitors for ganulocytes, macrophages and dendritic cells) and one of the 
further differentiated myelomonocytic lineage -  macrophages are used to graft 
into the recipients, they fuse with the recipient hepatocytes and confer the 
long-term regenerative potential of the serial transplanted liver.
It is now important to investigate whether a metaplastic event is due to cell 
fusion rather than a direct switch from one cell type to another. To distinguish 
these possibilities, the chromosome numbers in the ‘metaplastic’ cells should 
be checked to see if it is a product of fused cells; and if possible, the cell 
lineage of the two cell types should be traced. Although tissue damage is 
thought to be an inducer for BMDC to fuse with the target cells, the precise 
inducing signals and the reason why only some tissue types could be fused
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and others could not are still not clear (Alvarez-Dolado et al., 2003). Examples 
of signals to look for include IL-3 (which is necessary for fusion of the BMDC 
with embryonic stem cell in vitro (Terada et al., 2002)), or prostaglandin F2A 
and IL-4 (which induce myoblasts fusion with the existing myofibres (Horsley et 
al., 2003)).
There is evidence that fused cells can become mononucleated again either by 
nuclear fusion or supernumerary nucleus elimination (Alvarez-Dolado et al., 
2003; Wang et al., 2003). Whether the fusion product, the stable 
heterokaryons, could also re-activate post-mitotic, terminally differentiated cell 
types to undergo cell division is currently in doubt but awaits intensive 
investigation. The fused BMDC-Fah'7" hepatocytes must undergo proliferation 
to produce a new functional liver and rescue the otherwise lethal condition. 
Despite the limitation of the low rate of cell fusion, these results show that cell 
fusion can possibly be considered as an alternative route for tissue repair, and 
the quest to have control over the process, i.e. induce its happening in specific 
cell types, and increase the possibilities, continues.
1.1.4.5 Dedilferentiaiton
During transdifferentiation, one important question to be addressed during the 
conversion of cellular phenotype from one to another is whether the cells 
undergo dedifferentiation. Dedifferentiation describes the process where by a 
differentiated cell first reverts to a common stem or progenitor cell type which 
then re-differentiates into another cell type. Understand the process of 
dedifferentiaiton will help us gain more knowledge about the normal 
differentiation process, as detailed understanding will be needed to establish 
the relationship between differentiated tissue and de-differentiated tissue.
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During newt limb regeneration, the muscle and cartilage under the wound 
epithelium of the amputated limb dedifferentiates and re-enters the cell cycle, 
followed by regeneration of cells along several lineages including cartilage, 
muscle and interstitial fibroblast (Brockes, 1997; Tsonis, 2000; Brockes and 
Kumar, 2002; Nye et al., 2003). However, transdifferentiation does not 
necessary occur in all examples of amphibian regeneration (Gargioli and Slack, 
2004).
It is interesting to note that in examples of BMDC conversion to muscle cells or 
hepatocytes, there are cases where the progenitor cells of skeletal muscle 
(satellite cells) and liver (oval cells) are found in the target organs originating 
from the myeloid origin (Petersen et al., 1999; LaBarge and Blau, 2002). These 
observations provide evidence of re-differentiation along the new tissue 
lineages when metaplasia occurs (Petersen et al., 1999).
1.1.5 Importance of understanding metaplasia
Metaplasia and transdifferentiation are important to study for several reasons.
(1) It is likely that between organs that undergo transdifferentiation, a single 
gene that acts as a differential switch during the course of development to 
form the otherwise different organ, and when that gene is activated, 
transdifferentiation occurs (see diagram in Fig 1.1). The study of 
transdifferentiation thus helps us understand more about the 
developmental relationship of the two organs that undergoes metaplasia or 
transdifferentiation (the two organs or cell types may be interrelated). In 
order to underpin the mechanism for metaplasia / transdifferentiation, we 
may also gain the serendipitous (or the must have) knowledge to reveal 




(2) Metaplasia found in human is often accompanied by dysplasia and 
neoplasia, this is of clinical importance and the treatment of such tumours 
often has a bad prognosis. Understanding metaplasia will help us find 
methods to stop the frequently occurring abnormalities.
(3) Metaplasia acts as a mechanism for regenerative medicine, e.g. the 
application of adult transdifferentiated (stem) cell as a source for other 
tissue specific organs in need. Understanding the mechanism of 
transdifferentiation may help us apply the same technique in inducing 
(embryonic) stem cells to differentiate to the cell or tissue types we need.
We are also aware that there is a general distaste for the term 
“transdifferentiation” arising from the controversy over stem cell potency and 
careful usage of the term is necessary (Raff, 2003; Wells, 2002).
1.1.6 Metaplasia in the oesophagus
The oesophagus is an interesting organ for studying metaplasia and 
transdifferentiation. The reason is that three types of cell-type conversions 
occur in the oesophagus:
First, during embryonic development of the oesophagus, the epithelium of the 
mammalian oesophagus changes from simple columnar to the mature 
stratified squamous. It is currently not known whether there is a direct change 
in the epithelial cell type or whether there is an outgrowth of a specific 
progenitor cell either already present in the oesophagus or migrates from 
outside the tissue. The change in the oesophagus epithelium will be the main 
focus of the present study.
Second, the muscle layers of the oesophagus change from submucosal
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mesenchymal cell type to more specified muscular cell type. More importantly, 
the appearance of a skeletal muscle phenotype that was found after the 
appearance of the smooth muscle cells indicates there is a change from 
smooth to skeletal muscle in at least some region of the oesophagus.
The third example relates to the clinical disorder - Barrett’s metaplasia. 
Barrett’s metaplasia (or sometimes referred to as Barrett’s oesophagus) is an 
abnormality of the oesophageal epithelium tissue characterised by a change of 
the epithelium near the gastroesophageal junction from stratified squamous to 
intestinal columnar cell type (including Goblet cells). The change is thought to 
be due to repeated gastric reflux which presumably gives the symptom of 
heartburn. Understanding Barrett’s metaplasia is important as it often 
predisposes to severe malignant adenocarcinoma. The prognosis of 
oesophageal adenocarcinoma is poor and the incidence is increasing in the 
Western world (Paulson and Reid, 2004). However, the molecular mechanism 
for Barrett’s metaplasia to occur is still largely unknown.
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1.2 Development of the mammalian oesophagus
1.2.1 Anatomical and cellular composition of the oesophagus
1.2.1.1 Basic anatomical description of the oesophagus development
In this thesis, the zoological convention is followed whereby “anterior” refers to 
the head end and “posterior” to the tail end. The oesophagus is derived from 
the anterior foregut endoderm. Just anterior to the oesophagus is a short 
segment of pharynx derived from the endoderm. More anterior than the 
pharynx is the oral cavity, which is derived partly from the endoderm and partly 
from the ectoderm (Waterman and Balian, 1980; Grapin-Botton and Melton, 
2000). Along the anterior-posterior axis, at the ventral side of the oesophagus, 
are the endodermally-derived organs - trachea, bronchus, and lung. The 
thymus appendages and endocrine glands such as thyroid, and parathyroid 
also arise ventrally or laterally. Along the anterior-posterior axis, the 
oesophagus is followed by the gastroesophageal junction which connects to 
the stomach, there is then the liver / gallbladder and the pancreas, which is 
followed by small intestine, caecum, large intestine and anus (which is also 
partly endoderm and partly ectoderm) (Fig 1.4 Diagram of the human gut and a 
cross section of an oesophagus). The oesophagus functions mainly as a 
passage to allow masticated food to enter the gut for further digestion. Four 
distinct structural layers are designated to the whole adult gastrointestinal tract: 
mucosa, submucosa, muscularis propria and adventitia (serosa), in the order 
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Fig 1.4 Diagram of the human gut and cross section of an oesophagus.
A diagram showing the location and the anatomy of adult human oesophagus. 
The oesophagus is the tube-like structure linked from the pharynx to stomach. 
Mucosal epithelium is showed in dark pink on the right, submucosa 
mesenchyme in light pink, two muscle layers in yellow and adventitia in blue 
(Adapted from Young and Heath, 2001).
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1.2.1.2 Initiation of the foregut endoderm
Much of the work on endoderm formation has been carried out in the chick. 
The definitive endoderm in chick is formed during gastrulation which emerged 
from the primitive streak (Slack, 2005). The gut tube itself is formed by the 
folding of the body away from the blastoderm, which can be thought of as a 
sort of evagination of all three germ layers (Fig 1.5). The head fold is formed by 
cells lifted off the blastoderm, the endoderm in this region is called foregut at 
this period. Later, a similar fold is formed at the posterior end forming the 
hindgut. Anterior intestinal portal (AIP) is the junction between the foregut and 
midgut, where the posterior intestinal portal (PIP) is the junction between the 
hindgut and the midgut. The AIP and PIP extend and meet at the midgut, 
where they close to form the gut tube, with a duct connecting the gut to the yolk 
sac. Non-endodermal tissue in the gut is derived from the splanchnic 
mesoderm and will be introduced later (section 1.2.1.4). Similarly, the mouse 
foregut is a single canal that forms after the AIP has folded into a tube-like 
structure. This folding occurs at the same time as somitogenesis begins 
(Lawson et al., 1986). At about E10, the foregut bifurcates into the trachea / 
lung buds and the oesophagus (Motoyama et al., 1998).
Signals like Sonic hedgehog (Shh) (see introduction of Shh signalling in 
section 1.2.4) and its downstream transcription factors G//2, G//3, are 
necessary for the formation of the oesophagus and in particular for bifurcation 
of the foregut (Motoyama et al., 1998). Another transcription factor Nkx2.1, is 
also important in the process of the separation of the foregut into the 
oesophagus and the trachea (Minoo et al., 1999). The phenotype of the 
Nkx2.1 knockout mutant has the characteristic of the human newborn
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Fig 1.5 Diagram of the embryonic gut formation in the amniotes from a sagittal 
view (from Slack, 2005; with the permission of Slack J.M.W.).
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abnormality - tracheoesophageal fistula (a fistula is an abnormal opening or 
passage between the trachea and oesophagus). In the forebrain 
(telencephalon), there is evidence that Shh signals to activate the transcription 
factors Gli1 and induces Nkx2.1 expression (Ruiz i Albata, 1998; Rallu et al., 
2002). However, the role of Shh in activating Nkx2.1 is yet to be confirmed in 
the developing foregut.
1.2.1.3 Epithelium in the oesophagus - Columnar and stratified squamous cells 
The structure and organisation of stratified squamous tissue has been well 
studied mostly in the epidermis. Fuchs and colleagues have shown that 
cytokeratin 14, an acidic intermediate filament cytoskeleton protein is a specific 
marker for the basal layer of the stratified squamous tissue, and is expressed 
in epidermis, cornea, vaginal epithelium and the oesophagus (Fuchs, 1988). 
Defects in this gene cause a human blistering skin disease called 
Epidermolysis Bullosa Simplex (EBS) (Coulombe and Fuchs, 1993). The 
formation and maintenance of stratified squamous tissue lies in the ability of 
cells to proliferate at the basal layer. Watt et al. described the stem cell and 
transit amplifying cell compartments in the adult epidermis (Jensen et al., 1999) 
and more recently, in the similar structure of the human oesophagus (Seery 
and Watt, 2000). Stem cells are presumed to reside in the inter-papillary region 
of the convoluted stratified squamous basal cell layer (Seery and Watt, 2000). 
Suprabasal cells of a stratified squamous tissue are found not to be 
proliferative. Differentiation of the suprabasal layers of stratified squamous 
tissue confer its capacity to withstand the environmental pressure it is 
subjected to and protect the organism from harm.
Previous studies in oesophageal development have shown that in the foetal
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and neonatal mouse, the epithelial layers were 2-3 cells thick at E15.5 and a 
stratum corneum is found after birth (Raymond et al., 1991). Labelling of the 
proliferative cells in the epithelium of E18.5 mice showed localisation in the 
germinal layer (basal layer). There is a specific type of ciliated cell found in 
human, chick and mouse oesophagus during late embryonic development. 
This has protruding cilia and microvilli on the apical surface of the oesophageal 
epithelium that are visible under scanning electron microscope (S.E.M.), but 
these gradually disappear after birth. In human foetal oesophagus, at about 4 
months of gestation, the columnar cells grow downward into the lamina propria, 
proliferate and then differentiate into the cardiac-type glands of the 
oesophagus (Johns, 1952). It has been speculated that the glandular tissue 
might be the source of Barrett’s metaplasia (Jankowski et al., 1999). 
Cytoskeletal proteins, involucrin, loricrin, filagrin and members of the small 
proline-rich protein family such as SPRR1 are expressed in keratinocytes of 
the cornified layers, but these are markers of many different differentiated 
stratified squamous tissues and are not restricted to the oesophagus (Steven 
and Steinert, 1994; Cabral et al., 2001). However, esophagin, one member of 
the SPRR family, is detected with an enhanced expression in the oesophagus 
(Smolinski et al., 2002). Esophagin is regulated by transcription factors such 
as C/EBPp, Oct1 and Oct3, and may also be used as an oesophageal 
differentiation specific marker. Other intermediate filament markers that can be 
used to identify oesophagus include cytokeratin 4 and cytokeratin 13. These 
cytokeratins are expressed in the buccal, nasal, oesophageal, cornea 
epithelium, but usually not in the epidermis, trachea or lung (Pang et al., 1993; 
Waseem et al., 1998).
The main difference between a simple columnar and stratified squamous
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epithelium is the multilayers of the stratified squamous epithelium. A columnar 
epithelial cell or basal cells in the stratified sqamous epithelium contains 
hemidesmosome (the cell junction between the basal lamina and basal cells), 
whereas cells in the stratified squamous suprabasal layers do not (Fuchs and 
Raghavan, 2002). Apart from the cytoskeletal proteins, the surface markers 
such as basal cell-specific, basal surface membrane marker (34-integrin, and 
polarity genes such as the apical PKC5 may also be used as specific markers 
to distiguish between the basal progenitor columnar and suprabasal layer 
stratified squamous cells (Lechler and Fuchs, 2005).
1.2.1 A Non-epithelial cell types in the oesophagus: muscular and submucosal 
tissue
The outer coat of the gut is comprised of smooth muscle, connective tissue 
and blood vessel. This mesenchymal region of the gut is derived from the 
splanchnic mesoderm, the inner subdivision of the lateral plate following the 
opening of the coelomic cavity (Fig 1.6 (a)-(c))(Slack, 2005). The combination 
of the splanchnic mesoderm and the endoderm is called splanchnopleure.
The relationship between the prospective regions in the endoderm and those 
in the splanchnic mesoderm in the chick has been determined using cell 
labelling techniques (Matsushita S. et al., 2002). The prospective regions in 
the mesoderm tend to be arranged longitudinally and are arranged quite 
differently in comparison to the endoderm (Fig 1.6 (d)). For example, the 
oesophageal epithelial cells arises from endodermal cells dorsal to the 1st and 
2nd somite, while the mesenchymal tissue which later surrounds the 
oesophagus tube comes from the splanchnic mesoderm that is lateral and 
positioned between the 1st and 7th somite. This shows that there is a
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considerable relative movement of the two germ layers during the process of 
closure of the gut and closure of the ventral body wall. The fate map study 
shows that a particular region of endoderm experiences contact with different 
regions of the mesoderm as the gut tube formation process takes place, and 
the inductive interactions between mesoderm and endoderm constantly 
changes throughout gut development. The state of specification of the 











Fig 1.6 Endodermal and mesodermal cell origins in embryonic gut formation.
(a)-(c) Cross-section views of the gut enclosure and ventral closure of the body 
in the chick embryo and (d) mismatch between the fates of endoderm and 
splanchnic mesoderm depicted at 1.5 days chick (from Slack, 2005; with the 
permission of Slack J.M.W.).
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One form of metaplasia found in the oesophagus is the transdifferentiation of 
the muscle layers of the muscularis propria from smooth muscle to skeletal 
muscle. Samarasinghe showed that striated muscle is found at the rostral end 
of the mouse oesophagus, extending caudally with a mixture of both smooth 
and skeletal muscle, with smooth muscle alone being observed near the 
stomach (Samarasinghe, 1972). Patapoutian and colleagues demonstrated 
this is an example of transdifferentiation by showing skeletal and smooth 
muscle specific markers in the same muscle cell of an oesophageal tissue 
section (Patapoutian et al., 1995), although this interpretation is not universally 
accepted (Rishniw et al., 2003). It is unclear whether the smooth-to-skeletal 
transition is cell autonomous or occurs in response to external signals. But 
from the results of Mammalian achaete-scute homolog 1 (MashT/_) knockout 
mice, where no innervation of the enteric neurons from the neural crest can 
occur, the transdifferentiation of the muscle in oesophagus still continues, this 
suggests at least enteric neuron stimulation is not necessary for the muscle 
transdifferentiation (Sang et al., 1999).
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1.2.2 The role of mesenchymal signals in endoderm development 
Reciprocal signals between the endoderm and mesenchyme are known to be 
important for the specification of the whole gut (Grapin-Botton and Melton, 
2000). Below are four examples of the signalling crosstalk between the 
endoderm and the mesenchyme in the gastrointestinal tract during embryonic 
development:
(a) Shh is ubiquitously expressed in the gut endoderm with the exception of 
the pancreatic region (Hebrok, 2003). Shh controls the bifurcation of the 
oesophagus and the trachea in the foregut region (Motoyama et al., 1998). 
A compound knockout mouse absent for the downstream transcription 
factors of Shh, which are G//2 and G//3, lacks trachea, oesophagus and 
lungs. Also, repressive signals such as activinpB and fibroblast growth 
factor 2 (FGF2) from the neighbouring notochord control the 
non-expression of Shh in the region of endoderm that will form pancreas 
(Kim et al., 1997; Hebrok et al., 1998; Kim and Hebrok, 2001). When Shh 
is ectopically expressed (by the Pdx1 promoter) in the endodermal region 
of the pancreas (Apelqvist et al., 1997), the underlying mesenchyme will 
change to intestine-like smooth muscle and interstitial cells of Cajal of the 
intestine. Shh has been shown to induce Hox expression in the hindgut, 
but not in the foregut, for review see (Roberts, 2000). How the same 
signal - Shh induces different mesenchymal identity and organogenesis 
programmes along the forming gut is not clear.
(b) After hepatic specification at around E8-E8.5, the liver-specific genes 
albumin and alpha-fetoprotein are induced in the hepatic cells located in 
the foregut endoderm. Prior to morphological changes and establishment 
of other hepatic functions, the few liver marker-positive cells undergo cell
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proliferation before morphogenetic movements towards a budding liver 
(Zaret, 1998). Hlx, a homeobox transcription factor, expressed in the 
mesenchyme of the septum transversum, is thought to be responsible for 
the secretion of the scatter factor / hepatocyte growth factor (HGF) 
(Hentsch et al., 1996). c-Met, receptor tyrosine kinase for HGF, is located 
on the epithelial hepatocyte membrane. When HGF binds to its receptor, 
c-Met is activated and stimulates the downstream activity of JNK (c-Jun 
N-terminal kinase) pathway. JNK in turn phosphorylates c-jun - one of the 
components of the transcription factor complex AP-1. The signal from the 
mesenchyme eventually leads to proliferation of the specified hepatocytes 
before budding morphogenesis occurs (Rodrigues et al., 1997; Auer et al., 
1998). Hence there is a similar hypoplastic liver phenotype of mice 
homozygous mutated for Hlx, HGF, c-met and c-jun molecules, because 
the effect is probably on the same pathway (Hilberg et al., 1993; Schmidt 
et al., 1995; Bladt et al., 1995; Hentsch et al., 1996).
(c) The rat intestinal endodermal epithelium can be reprogrammed, to some 
extent, to a different tissue type by recombining with mesenchyme from 
another tissue (Duluc et al., 1994). However the reprogramming is 
restricted to particular cell types. E14 rat colonic epithelium re-combined 
with the small intestine mesenchyme was grafted under the skin of nude 
mice for 5 weeks to allow further differentiation. The reprogrammed 
epithelium formed small intestine-specific crypt-villi morphological 
structure and expressesed sucrase-isomaltase (SI) and lactase phlorizin 
hydrolase (LPH) - enzymes that are normally only expressed in the 
absorptive epithelium of the small intestine. However, using stomach or 
lung epithelium recombined with small intestine mesenchyme will not
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change its original epithelial identity. In the case of the colon-to-small 
intestine epithelial conversion, the expression of caudal (posterior) related 
Hox genes shifted to the more cranial (anterior) expression pattern of the 
endoderm (Duluc et al., 1997).
(d) The chick non-glandular stomach (later to become gizzard) still retains a 
degree of plasticity as late as E9 and can be influenced by signals 
emanating from the mesenchyme, although cyto-differentiation has 
already begun. If the non-glandular endodermal epithelium is associated 
with glandular stomach mesenchyme, it can give rise to pepsinogen 
expressing glands (glandular stomach epithelium). If the stomach 
epithelium is combined with small intestine mesenchyme, it can even give 
rise to intestinal-type endocrine cells (Andrew and Rawdon, 1990; Mizuno 
and Yasugi, 1990).
Much is still not known regarding the signals that specify the oesophagus in 
the region of the foregut. In the current study, I focused on two important 
signalling pathways - the Wnt and Shh pathways. The function of Wnt and Shh 
in the gut and their relevance to the study is introduced below.
1.2.2.1 Wnt signalling in the gut
Wnt signalling is important in cell fate determination and cell proliferation 
(Logan and Nusse, 2004). A number of different Wnt isoforms are expressed in 
the developing gut (Lickert et al., 2001; Wang et al., 2001). At E12.5 and E16.5, 
Wnt5b and Wnt6 are expressed in the epithelium of the mouse oesophagus. 
Wnt4 is expressed weakly in the oesophagus. Wnt11 is expressed strongly at 
the gastroesophageal junction, but is in epithelial cells of the oesophagus and 
mesenchymal cells of the stomach. It is possible that Wnt signalling functions
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in the development of the oesophagus. In mice that lack the frizzled-4 Wnt 
receptor, the oesophagus is distended and is dysfunctional, but the defect is 
probably due to failure of the oesophageal skeletal muscle formation (Wang et 
al., 2001). Lack of frizzled-4 is thought to affect the Wnt/Ca2+ pathway rather 
than the canonical pathway.
P-catenin is a pivotal gene in canonical Wnt signalling and serves as a 
multifunctional adaptor protein and a transcriptional cofactor (Nelson and 
Nusse, 2004). p-catenin can servie as a structural protein that forms a complex 
with a-catenin and p120 (or y-catenin), linking actin to the cadherin family on 
the cell membrane (e.g. E-Cadherin in the epithelial cells). Normally, turnover 
of the p-catenin molecule is via a cytoplasmic degradation complex that 
contains axin, Adenomatous Polyposis Coli (APC), glycogen synthase 
kinase-3p (GSK-3P), and casein kinase 1 (CK1) which will phosphorylate 
p-catenin. Subsequently, phosphorylated p-catenin will be ubiquitinated and 
degraded in the proteasome. However, when cells are in contact with secreted 
Wnt, the Wnt receptor-frizzled and lipoprotein receptor-related protein 5 and 6 
(LRP5/6) are activated. These receptors transduce a signal to several 
intracellular proteins that include Disheveled (Dsh), GSK-3P, Axin, APC, and 
the transcriptional regulator - p-catenin. Phosphorylation and degradation of 
p-catenin is then inhibited. P-catenin accumulates in the cytoplasm and 
eventually translocates to the nucleus, where it binds to the transcription 
factor-LEF/TCF family leading to activation of many target genes, e.g. cyclin 
D1 (Shtutman et al., 1999) and c-myc (He et al., 1998).
1.2.2.2 Shh signalling in the gut
As mentioned earlier (sections 1.2.1.2 and 1.2.2), Shh signalling is important in
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the bifurcation of the oesophagus and the trachea (Litingtung et al., 1998). In 
GliZ^GliZ* knockout mice, the oesophagus and trachea form a single 
shortened tube and have a serious lung malformation (Motoyama et al., 1998). 
The role of hedgehog is not totally understood but it is known to be important in 
many processes of developmental patterning and maintenance of many adult 
tissues (Ingham and McMahon, 2001; Bijlsma et al., 2004). Hh signalling 
requires an autocatalytic cleavage process to becomes active, producing 
N-terminal (Hh-N) and C-terminal (Hh-C) products (Bijlsma et al., 2004). The 
active ligand is the Hh-N attached to lipophilic moieties. A cholesterol moiety is 
covalently attached to the C-terminal of Hh-N, which is so far the only known 
case of protein sterolation. Another modification is the covalent palmitoylation 
of the N-terminal of Hh-N, it is also the only known secreted protein to be 
palmitoylated. The sterolation is thought to affect the spatial distribution of Hh 
signalling, and palmitoylation is considered to enhance the ligand’s potency. 
The Hedgehog receptor (Patched) negatively regulates another membrane 
protein - Smoothened. In the absence of Hedgehog, the downstream signal 
mediated by Smoothened is inhibited by an unknown inhibitory small molecule 
probably pumped out of the membrane from Patched. When Hedgehog is 
present and binds to Patched, Smoothened is relieved from the inhibition. 
When hedgehog signalling is active, the zinc finger transcription factor-Cubitus 
interruptus (Ci) in Drosophila (Gli family proteins in mammals) will then be 
released from the microtubule complex which includes the kinase Fused (Fu), 
kinesin motor protein Costal 2 (Cos2) and Suppressor of Fused (SUFU). The 
activated (intact) form of Ci (CH55) /  Gli will translocate into the nucleus and 
activate the downstream targets, such as HNF3P, Hox genes, Bmps, etc 
(Ingham and McMahon, 2001). Shh was found to be expressed in the mouse
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oesophageal epithelium until at least E15.5 (Litingtung et al., 1998).
1.2.3 The Hox clusters
An important process for anterior-posterior (AP) patterning in the animal 
kingdom is the function of homeobox genes -  the HOM-C family of Drosophila 
or the Hox clusters in vertebrates (Kawazoe et al., 2002). The feature of Hox 
gene clusters is that there is a spatial and temporal colinearity expression 
pattern from the 3 to 5 along the chromosome which also corresponds to axial 
anterior-posterior positional information. The Hox clusters patterns the paraxial 
mesoderm (which later forms the vertebrae), neural tube, neural crest, 
hindbrain segments (the nervous system), branchial arches, and most likely, 
the gastrointestinal tract. This means that the sites and timing of expression of 
Hox genes along the anterior-posterior axis reflects its relative order of the 
genes on the chromosome. There are 4 clusters of the Hox genes in mouse -  
Hoxa, Hoxb, Hoxc, Hoxd- with each clusters containing 13 potential Hox gene 
sites, while none of the clusters contains all 13 genes (see Figure 1.5). Hox 
genes are expressed in both the endodermal and mesodermal region of the 
gut. Several studies have tried to demarcate the expression profile of the Hox 
clusters in the gut, and the results are summarised in Table 1.1. It may be 
possible that, with the combination of the expressing Hox code, we could 
specify each organ’s identity along the AP axis of the gastrointestinal gut. We 
could also utilise the Hox gene expression pattern as markers to identify each 
specific endoderm organ.
One example of the importance of the Hox genes in oesophagus development 
is provided by HoxC4. The homozygous mutant of HoxC4 in mice showed a 
partial or complete blockage of the oesophageal lumen in addition to the
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vertebral defect which is from the second to the eleventh of the thoracic 
vertebra (t2 to t11), and an over-proliferation of the oesophageal epithelium 
(Boulet and Capecchi, 1996). The major reason for lumen obstruction is 
probably due to the disorganization of the esophageal musculature, which may 
cause the lack of the structural support to maintain the space for the lumen. It 
is not clear whether HoxC4 targets directly to the oesophageal muscle, or 
HoxC4 acts indirectly through patterning proper myoenteric neuron formation, 
so that lack of HoxC4 causes reduced myoenteric neuron stimulation to the 
muscle layers to function. Although Hox genes are also found in the foreguts of 
other animal models (such as Quox-1 in quail (Xue et al., 1991)), and many 
genes of the Hox families are found spatially and temporarily regulated in the 
differentiated epidermis and hair follicle (Stelnicki et al., 1998; Reid and Gaunt, 
2002), so far there is no evidence that any Hox gene is directly required for the 
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Fig 1.7 The phylogeny homology between the Drosophila HOM-C family and 
the four mouse Hox paralogous group, (adapted from Beck, 2002)
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Table 1.1 Transcription Factors Expressed in Specific Organs (mostly 
Homeobox genes)




HoxA2(1’2), HoxA3°'2), HoxA5<3), HoxB4°'2), HoxB5<3>, 
HoxC5<1), HNF3y(4), Six2(1), Sox2(1)
Stomach
mesenchyme
Bapx1(1), Nkx2.5(1), HoxA4(3>, HoxB4(3), HoxA5(3), HoxB5<3), 
HoxC5<3), HoxA6<3), HoxB6<3), HoxA7<3), HoxB7<3), HoxB8(3)
Intestine
epithelium
Pdx1 (duodenum)®, HoxA2°'2), HoxC8<3), HoxA11<3), 
HoxD11(3), HoxA13 (colon)0'2®, HoxD13 (colon)0'2®, 




HoxA4<3), HoxA5<3), HoxB6(3>, HoxC6(3), HoxA7(3), 
HoxC8°®, HoxD8(3), HoxA9<3), HoxC9°®, HoxD9(3), 
HoxA10°®, HoxD10°,3), HoxA11 (colon)0®, HoxD11 
(colon)0'®, HoxD12 (colon)0 ®, HoxA13 (colon)0), HoxD13 
(colon)01, Bapxl (hindgut)01
*: The expression profile of transcription factors in the gut of mice and chick was adapted and 
combined from several reviews.
(1) Roberts DJ. Molecular mechanisms of the development of the gastrointestinal tract. 2000. 
Developmental Dynamics, Vol 210, pp109-120.
(2) Grapin-Botton A and Melton DA. Endoderm development-from patterning to organogenesis. 
2000. Trends in Genetics, Vol 16, pp124-130.
(3) Beck F, Tata F and Chawengsaksophak K. Homeobox genes and gut development. 2000. 
BioEssays, Vol 22, pp431-441.
(4) Kaestner K, Hiemisch H and Schutz G. Targeted disruption of the gene encoding 
hepatocyte nuclear factor 3 gamma results in reduced transcription of hepatocyte-specific 
genes. 1998. Mol. Cell Biol. Vol 18, pp4245-4251.
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1.3 Development of the intestine
1.3.1 The anatomical structure, morphology and function of the small and large 
intestine
In the embryo, the small and large intestine originate from the hindgut. From 
anterior to posterior, the small intestine starts from the pyloric end of the 
stomach, including the duodenum, jejunum, and ileum. The caecum marks the 
separation of the small intestine and colon. The rectum is at the end of the 
gastrointestinal tract. In mouse intestine, cyto-differentiation starts from around 
E14 and is completed at 20 days after weaning. Roughly, intestinal 
development can be categorised into 3 phases.
(a) Villi formation at foetal stages - the differentiation along the crypt-villus axis 
is first seen between E17-18, when the endoderm is converted from a 
pseudo-stratified epithelium to an epithelial monolayer overlying nascent villi 
(Mathan et al., 1976).
(b) Crypt formation perinatally - crypts develop during the early postnatal 
period (days 1 - 5 )  from the flat inter-villus epithelium and mitotic cells 
segregate into these intervillus regions (Marshman et al., 2002).
(c) Maturation for digestive function after weaning. Differentiation of the 
epithelium also occurs along the anterior-posterior axis. The stem cells of the 
intestine are situated in the crypts, and can produce two daughter cells when 
undergoing cell division, one is a stem cell and one transit amplifying (TA) cell, 
the TA cells eventually differentiate into the four functional cell types of the 
intestine and will be introduced later in the section 1.3.4. The differentiated 
cells are situated above the stem cell position toward the tip of the villi except 
for the Paneth cell (see section 1.3.4). The most differentiated cells at the tip 
were constantly being shed off into the lumen.
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Growth factors and hormones induce maturation of the intestine. These 
include glucocorticoids, which are important in maintaining intestine 
electro-neutral sodium absorption (Bastl et al., 1992), and are essential for 
intestinal cellular differentiation, such as the induction of the brush border 
enzymes -  alkaline phosphatase, trehelase, and sucrase isomaltase. 
Glucocorticoid also induces premature accumulation of the goblet cells along 
the villi in the intestine if added in the culture from E17 in vitro (Beaulieu and 
Calvert, 1985). The glucocorticoid receptor, mineralcorticoid receptor and other 
non-classical corticosteroid receptors are expressed in the gut mucosa, and 
the 11-beta-hydroxysteroid dehydrogenase (11-(3-HSD1 and 11-P-HSD2) 
enzymes are crucial for regulating and selecting between the ligands - 
glucocorticoid and aldosterone to function (Sheppard, 2002).
Another hormone stimulating the differentiation of the intestine is thyroid 
hormone. The circulating concentration of thyroid hormone is significantly 
increased during the second week after birth. Although there are 2 main 
subtypes of thyroid receptors (T3Ra and T3R(3), thyroid hormone mainly acts 
through the T3Ra receptor to induce the morphological maturation of intestinal 
features (the villi are shorter in T3Ra mutants). Thyroid hormone is also 
important for proliferation of the epithelial cells, the expression of digestive 
enzymes and intestinal transcriptional factors such as Cdx1 and Cdx2 
(Plateroti et al., 1999).
The function of the intestine is mainly digestion and absorption of food. After 
the initial physical breakdown of food from mastication, the salivary glands 
secrete amylase to digest carbohydrates; the food is swallowed and then 
enters the stomach through the oesophagus. In the stomach, the gastric 
glands process acidic hydrolysis of the food, a bolus is then formed and enters
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the intestine. Digestion is carried out by enzymes whose secretion is controlled 
by various hormones. The bile and digestive enzymes are produced from the 
liver and pancreas, respectively. Another important function is the assimilation / 
absorption of the nutrients (including water) after their digestion, which is 
mainly done at the posterior end of the intestine (from the ileum to colon). The 
five ceil types including the intestinal stem cells carrying out the functions of an 
adult intestine will be described in section 1.3.4.
1.3.2 Signalling pathways controlling the development of the intestine 
Wnt signalling is a well studied pathway in the intestine. In the intestinal crypt, 
Wnt signalling suppresses cell cycle inhibitors like p21 and confers proliferative 
activity to the intestinal progenitor epithelial cells (van de Wetering et al., 2002). 
In canonical Wnt signalling, activated p-catenin accumulates in the nucleus, 
transactivating the Tcf target genes such as c-Myc, cyclin D1, Tcf1, gastrin and 
PPAR6, etc (van Noort and Clevers, 2002). When the Tcf-p-catenin pathway 
is disrupted, the progenitor cells arrest at G1 phase and differentiate.
Indian hedgehog (Ihh) expression at the villi restricts the Wnt signalling to the 
crypt (van den Brink et al., 2004). Ihh also regulates the transition of the 
epithelial precursor cells in the crypt into their differentiated derivatives. Wnt 
and Hh signalling was found to be down regulating each other in colonic 
epithelial renewal.
The Bmp pathway is also involved in the intricate regulation of intestinal cell 
fate. A recent publication of the mouse BMP receptor-BMPRIa conditional 
knockout model further revealed the subtle fine tuning of the intestinal stem 
cell (ISC) sensing autonomous and mesenchymal signals. Noggin, the BMP 
inhibitor was found secreted from the ISC (He et al., 2004). He et al.
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established BMP as an inhibitory signal for proliferation of the intestinal stem 
cell. Bmp will block the Akt pathway by activating PTEN. When BMP signalling 
is inactivated by Noggin (secreted by the ISC), Akt signalling becomes 
activated and subsequently activates Wnt signalling. Accumulation of 
P-catenin in the nucleus in turn stimulates the proliferation of the stem cells in 
the crypt. Interestingly, Fkh6 (a transcription factor of the forkhead family 
containing the winged helix domain) is expressed in the mesenchyme adjacent 
to the intestinal epithelium and regulates Bmp2 and Bmp4 secretion in the 
intestine. The knockout phenotype shows that it is also a negative regulator of 
the crypt cell proliferation (Kaestner et al., 1997). Another transcription factor, 
Nkx2.3 is also expressed in the intestinal mesenchyme, the homozygote 
mutant mice produced the same phenotype, which is the expansion of the 
crypt cell compartment, and decreased expression of BMP2 and BMP4 (Pabst 
et al., 1999).
Ectopic expression of a secreted Wnt inhibitor - Dickkopfl (Dkk1) suppresses 
intestinal cell proliferation and subsequently causes loss of intestinal crypts 
(Pinto et al., 2003). However, the secretory cell lineages in the intestine are 
also largely absent in this inhibitorory Wnt signalling mutant mouse model, 
showing that the Wnt pathway is also involved in lineage determination.
In conclusion, signalling pathways such as Bmp and the canonical Wnt 
inhibitor-Dkk1 are negative signals secreted by neighbouring cells of the 
intestinal stem cell to supress ISC proliferation. Noggin, the suppresser of the 
Bmp pathway is secreted by ISC to counteract these negative signals. The 
different signalling pathways are found to act at different developmental stages 
for the maintenance of ISC and regulation of differentiation along the intestinal 
cell lineages. Whether these signalling pathways themselves regulate one
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another is worth pursuing.
1.3.3 Genes and Cell types
Transcription factors such as Tcf4, Cdx1, Fkh6, HNF3/HFH11 and Nkx2.3 are 
found localised at the crypt compartment and are important for maintaining the 
intestinal stem cell identity and function (Clatworthy and Subramanian, 2001). 
Activating the Wnt - (3-catenin complex will induce Cdx1 expression in mouse 
ES cells and rat embryonic endoderm, and so link the Wnt signalling pathway 
to Cdx1 function in the crypt (Lickert et al., 2000).
Mice in which one allele of the Cdx2 gene had been inactivated by 
homologous recombination, develop multiple intestinal polyp-like lesions that 
do not express Cdx2 but contain areas of metaplasia in the form of keratinizing 
stratified squamous epithelium - the hallmark of oesophagus epithelium (Beck 
et al., 1999). Cdx2+/' mice showed “intercalary regeneration”, in which small 
intestine, stomach and oesophagus tissue type cells form foci in the Cdx2+A 
mice proximal colon polyps. Metaplastic epithelium were found to “fill in” the 
polyps following the AP axis sequence of the gut (colonic -> small intestinal -> 
gastric -> oesophageal, from peripheral to centre of the polyp). The expression 
of Cdx2 was totally lost from both alleles in gastric and oesophageal 
regenerative tissues in the centre of the polyps of the heterozygous mice. 
Intercalary regeneration implicates Cdx2 as a candidate for determining the 
caudal (intestinal) patterning of the gut. Without the gene, intestine reverts to a 
default state of anterior tissue. This is a fine example of homeotic 
transformation in the mammalian gut. Cdx2 has also a role in regulating 




There is a functional difference in the intestine at different regions along the AP 
axis of the gut. Some genes may play a role in controlling the morphological 
and biochemical differences from the duodenum to the colon (Sweetser et al., 
1988). Genes such as different types of laminins, Cdx1 and Cdx2, have 
different expression levels along this anterior-posterior axis, showing 
expression gradients from the anterior to posterior of the small and large 
intestine. There might also be a correlation between the expression of different 
laminins (via induction of Cdx2) and the differentiation status in the intestine 
(Kedinger et al., 1998).
Another complementary gene expression pattern is in the crypt-villus axis. For 
example, integrin subunit a2 is expressed in the crypt and a3 subunit in the villi 
(Beaulieu, 1992). Cdx1 is located in the crypt region while Cdx2 is expressed 
in the more differentiated villous enterocytes (Clatworthy and Subramanian,
2001). This expression gradient pattern may provide a molecular basis for 
crypt-villus cellular differentiation.
1.3.4 Markers for different intestinal cell types
Intestinal cells types can at be divided into: common stem cell, absorptive 
enterocytes, mucin secretive cells, Paneth cells and enteroendocrine cells. 
Results deduced from cell kinetic studies show intestinal stem cells are located 
about four cells up from the bottom of the crypt (Potten and Morris, 1988). 
Markers for the intestinal stem cell include Musashi-1 (Msi1)y an RNA binding 
protein and a mammalian neural stem cell marker that can induce a 
transcription repressor - Hairy and Enhancer of Split homologue (Hes1) 
(Sakakibara et al., 1996; Potten et al., 2003). Hes-1 is essential for neural stem 
cell renewal and suppression of neural stem cell differentiation (Nakamura et
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al., 2000). Msi-1 and Hes-1 are found co-expressed in cells just above the 
Paneth cells (Kayahara et al., 2003), and can be used as intestinal stem cell 
markers.
The four differentiated cell types of adult intestine are:
1. Absorptive cells. These are the most abundant intestinal cell type. In the 
small intestine they are termed “enterocyte” and in the large intestine 
“colonocyte”. Absorptive cells are polarised cells specialised for absorption by 
the presence of microvilli at the apical membrane. Villin is an actin bundling 
protein expressed on the apical brush border of absorptive cells. Although it is 
expressed in every cells of the crypt-villi axis, there is a gradient of villin 
expression with more at the villi and less at the crypt (Madison et al., 2002). 
Markers such as intestinal specific alkaline phosphatase (which is expressed 
embryologically)(Alpers et al., 1994), lactase phlorizin hydrolase (LPH) and 
sucrase isomaltase (SI) (usually expressed after weaning)(Traber and Silberg, 
1996), are known as brush border enzymes. These enzymes are important for 
the digestive function of the absorptive cells. Cdx2, Pdx1, gut-enriched 
Kruppel-like factor, members of the HNF1 family and the GATA family as well 
as glucocorticoid and thyroid hormones are known to regulate the expression 
of the enzymes mentioned above. The cell fate of the absorptive intestinal 
epithelia is probably determined via some intestinal progenitor cells that start 
expressing Hes-1, a transcription factor downstream of Notch signalling 
(Jensen et al., 2000). Hes-1 in turn suppresses the expression of Math-1 in 
those cells. Mathl is a downstream transcription factor of Delta receptor and is 
important in determining secretive cell fate in the intestine (Yang et al., 2001). 
The sequential activation of another transcription factor E74-like factor 3 (Elf-3), 
combining Hes-1 or Math-1 eventually leads to different lineage determination
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in the intestine (Ng et al., 2002; Sancho et al., 2003).
2. Mucous-secretive (Goblet) cells are dispersed throughout the intestinal 
epithelium and secrete mucous to (a) lubricate the intestinal contents and (b) 
trap and expel unwanted micro-organisms. Glycoproteins -  the rich cellular 
content of a goblet cell allows several histochemical techniques to be applied 
to visualise the presence of this cell type. Periodic Acid Schiff (PAS) and acidic 
alcian blue (pH 2.5) both stain the intestinal mucopolysaccharides revealing 
conspicuously stained mucigen of Goblet cells and are reliable markers for 
showing the goblet phenotype and morphology. Muc2 is a gel-forming secreted 
mucin expressed only in Goblet cells of the small and large intestine, and could 
be used for an intestinal specific marker (Corfield et al., 2000). The 
Delta-Notch pathway is important in specifying intestinal lineage cell fate. 
Mathl, which is activated in the Delta ligand expressing cells (neighbouring 
cells of the Notch activated cells), is a transcription factor involved in 
committing cells to become the three secretory cell lineages - Goblet, Paneth, 
and enteroendocrine cells (Yang et al., 2001). A zinc finger transcription factor, 
gut-enriched Kruppel-like factor-4 (GKIf-4) is important in Goblet cell 
maturation. GKIf-4 knockout mice showed a dramatic reduction in the number 
of Goblet cells, and patchy expression of Muc2 along the crypt of the colon 
(Katz et al., 2002). The Goblet cell lineage determination is considered to be 
controlled by the sequential expression of transcription factors Math-1, Elf-3 
and Klf4 (Sancho et al., 2003).
3. Paneth cells are exclusively found at the crypt base of the small intestine 
and the ascending colon. The cells contain large apical secretory granules and 
express various proteins including lysozyme and anti-bacterial peptides called 
defensins or cryptdins. Metalloproteinase matrilysin (MMP-7)-dependent
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procryptdin activation in vivo provides mouse Paneth cells with functional 
peptides for apical secretion into the small intestine lumen (Wilson et al., 1999; 
Ayabe et al., 2002). Math 1 is important for the determination of the secretory 
cell lineages in the intestine including Paneth cells. It is worth noting that the 
nuclear form p-catenin is also found in the Paneth cells (van de Wetering et al.,
2002).
4. Enteroendocrine cells. There are at least 10 different enteroendocrine cell 
types (Schonhoff et al., 2004). Markers for enteroendocrine cells are such as 
chromagranin A, synaptophysin, cholecystokinin A. Some types of the 
enteroendocrine cells can also be found in stomach, pancreas and the pituitary 
gland. Enteroendocrine cells function not only in embryonic development, but 
also during the constant renewal of gut epithelia in the adult. They are believed 
to be formed by regulation of the Notch signalling pathway. Notch is inactive in 
endocrine precursor cells, allowing the expression of the proendocrine basic 
helix-loop-helix proteins Mathl and neurogenin3 (Ngn3). Mathl is the first 
transcription factor involved in endocrine specification, committing cells to 
become one of three secretory lineages - Goblet, Paneth, and enteroendocrine 
(Yang et al., 2001). Neurogenin3 appears to be a downstream target that is 
essential for endocrine cell differentiation (Lee et al., 2002). The transcription 
factors Pax4, Pax6, BETA2/NeuroD, and Pdx1 have all been implicated in 
enteroendocrine differentiation (Schonhoff et al., 2004). BETA2/NeuroD 
coordinates secretin gene expression in S-type enteroendocrine cells with cell 
cycle arrest as cells terminally differentiate. Peptide hormones such as GLP-1, 
GLP-2 are secreted from the enteroendocrine cells in response to nutrient 
ingestion (Baggio and Drucker, 2004). GLP-1 enhances glucose-stimulated 
insulin secretion and inhibits glucagon secretion, gastric emptying and feeding.
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GLP-1 also has proliferative, neogenic and anti-apoptotic effects on pancreatic 
beta-cells (Baggio and Drucker, 2004). GLP-2 is an intestinal trophic peptide 
that stimulates cell proliferation and inhibits apoptosis in the intestinal crypt 
compartment. GLP-2 also regulates intestinal glucose transport, food intake, 
gastric acid secretion and stomach emptying, and can improve the intestinal 





In the adult, the epithelia lining the gut are columnar except in the oesophagus 
where it is stratified squamous. A pathological change in oesophageal epithelia 
is observed in Barrett’s metaplasia (BM). BM is characterised by a 
mucin-secreting simple columnar epithelium that forms glandular invaginations 
in the oesophageal mucosa, localising near the gastro-oesophageal junction 
(Fig 1.8). This is known as intestinal metaplasia of the oesophagus. Nowadays, 
the criteria for diagnosis of Barrett’s metaplasia include the appearance of 
intestinal mucous secreting Goblet cells in the tissue biopsies (reviewed in 
Jankowski et al., 2000).
The main cause of Barrett’s metaplasia is thought to be the reflux of bile acids 
and digestive enzymes from the stomach and intestine to the oesophageal 
mucosa and is often referred to as gastro-oesophageal reflux disease (GORD) 
(Jankowski et al., 2000). This is now very common in Western countries, 
where many patients complained about heartburn, a clinical symptom of BM 
(see section 1.1.6). 10% of adults screened by gastroenterologists have 
endoscopic evidence of oesophagitis due to GORD, and 10% of these people 
will progress to Barrett’s metaplasia (Cameron et al., 1990). Oesophageal 
metaplasia is thought to be a strong prognostic indicator of adenocarcinoma of 
the oesophagus (the prevalence of oesophageal adenocarcinoma is 
increasing by 0.2-2% each year over the last decade)(Cameron et al., 1990). 
Once oesophageal adenocarcinoma is diagnosed, despite chemotherapy and 
surgery, patients have a median survival time of less than 1 year, and fewer 
than 10% of patients survive for more than 5 years (Cameron et al., 1990).
The current favoured theory of how Barrett’s metaplasia arises is that over 
many years, repeated damage to stem cells located in the oesophageal
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epithelia causes some of the renewing epithelial cells to change to 
intestinal-like epithelial cells (see diagram below for an explanation of the 
epithelial changes). It is still not clear whether it is the stem cell of the 
squamous tissue, or the oesophageal gland that undergoes metaplasia 
(Jankowski et al., 1999).
The epithelial changes of the oesophagus:
Stratified squamous /
Columnar Epithelium ___ .  ^ Columnar Epithelium
w keratinsed epitheliumlium w
(Embryonic development) (Barrett’s metaplasia)
By using animal models and by monitoring the human oesophageal pH and 
bilirubin level, many investigators have tried to understand the role of acid and 
duodenal-gastric reflux in oesophageal mucosal injury. Bilirubin is a 
reddish-yellow bile pigment that is an intermediate product of the breakdown of 
haemoglobin in liver (Vaezi et al., 1995). There are two phases of the effects of 
bile and acid. At pH 2, HCI with gastric digestive enzyme pepsin and 
conjugated bile taurocholate, taurodeoxycholate and lysolecithin cause 
oesophageal mucous damage, while at neutral pH, unconjugated bile acid 
cholic acid with the digestive enzyme trypsin cause increased mucosal 
disruption (Vaezi et al., 1995). These results suggest synergistic damaging 






Fig 1.8 Two clinical samples of Barrett’s oesophagus.
Haematoxylin and eosin staining of two Barrett’s metaplasia biopsy 
samples from the oesophagus of patients is shown. Note that the 
metaplastic glandular tissue is found on the epithelium layer near the 
lumen and also underneath the submucosal region of the stratified 
squamous epithelium. The images were 400x in A and 200x in B 
(Courtesy of Dr. Leigh Biddlestone, RUH, Bath).
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1.5 Objectives of the current work
My main goal is to determine the mechanism for the development of the 
oesophageal epithelium, i.e. after the septation between the oesophagus and 
the trachea/lung buds, what makes the oesophagus develop from a simple 
columnar sheet of epithelium to a fully differentiated, cornified stratified 
squamous epithelium?
I start by describing the oesophageal muscular and epithelial morphology 
during mouse embryonic development and the production of a mouse in vitro 
culture system that mimics the normal development. The advantage of using 
mouse as an animal model is because it is genetically well defined (the 
genomic sequence of Mus musculas is completed), and the physiology and the 
genetics are evolutionary closer to human than other well studied model 
systems such as the Drosophila and Xenopus.
Next, I will demonstrate the cellular basis of the epithelial switch and answer 
the question of whether the columnar-to-stratified squamous is a direct 
conversion, or is an outgrowth of the stratified squamous progenitor cells. I will 
also try to answer whether cell death and cell proliferation is necessary during 
this phenotype switch.
I will then focus on the molecular mechanisms that control this event and 
consider whther the transcription factors controlling the initiation of the 
stratified squamous tissue in the oesophagus are similar to those in the 
epidermis. I also described perturbation of several signalling pathways to see if 
the process is regulated by these signals.
The last objective is to understand the molecular mechanisms of how the fully 
differentiated stratified squamous tissue will convert to a columnar intestinal 
phenotype, ectopically found in the Barrett’s oesophagus. Our findings on how
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stratified squamous epithelia formed from simple columnar cells in the 
oesophagus may be applicable to patients with Barrett’s oesophagus and help 
to reverse its progress.
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Chapter 2 Materials and Methods
2.1 Isolation and culture of embryonic oesophagus, trachea, lung buds, 
stomach and intestine
Female CD1 outbred albino mice (from Charles River) were mated overnight 
and the following morning was designated E0.5 if the presence of vaginal 
plugs was observed. Pregnant animals were killed by cervical dislocation and 
the uteri dissected out in ice-cold sterile phosphate buffered saline A (PBSA). 
E11.5, E13.5, E15.5 or E17.5 embryos were removed from the deciduas, 
transferred to ice-cold Minimum Essential Medium (MEM) with Hank’s salts, 
10% FBS and 50 pg/ml gentamycin and the gut (from pharynx to the intestine) 
was dissected free using a microscapel and fine forceps under a Leica 
dissecting microscope with indirect light source. The oesophagus was 
removed from its position rostral to the stomach and was separated from the 
trachea. Oesophagi were collected in ice-cold MEM / Hank’s medium.
For organ culture, the oesophagus was placed on a coverslip subbed and 
coated with fibronectin. To sub, the coverslips were immersed sequentially in 
hot soapy water, reverse osmosis (RO) water and 95% ethanol / 0.1% acetic 
acid. The coverslips were allowed to air dry and then dipped for 10 minutes in 
2% 3-aminopropyltriethoxysilane (APTES, Sigma) in the fume cupboard. 
Afterwards, the rack was dipped in two separate containers of acetone before 
washing in RO water. The coverslips were then dried at 37°C or heat sterilised 
overnight at 180 C. To coat with fibronectin, individual coverslips were placed 
in sterile 35 mm plastic dishes and then 40 pi of 50 pg/ml bovine fibronectin 
(dissolved in water (Life Technologies) was placed in the centre of the 
coverslip. Initially, a plastic ring of 5 mm internal diameter was placed over the
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fibronectin-coated area and media (Basal Medium Eagle (BME) medium with 
Earle’s salts, 10% foetal bovine serum, 2 mM glutamine (all from Life 
Technologies) and 50 pg/ml gentamycin (Gibco/lnvitrogen) was pipetted 
dropwise into the cloning ring and thereafter into the rest of the dish up to 2.5 
ml. The oesophagus bud was then dropped onto the centre. 24 hrs later, the 
cloning ring was removed and the media decanted and replaced with 2 ml. The 
cultures were grown in 37°C, 95% air/ 5% CO2  humidified incubator for up to 
20 days. The medium was changed every 2 days. Trachea, lung buds, 










Fig 2.1 Diagram of the dissected E11.5 embryonic oesophagus.
A schematic diagram shown in A is the gut region of an E11.5 mouse, the 
oesophagus is marked in red (A). Note the oesophagus is at the ventral side to 
the trachea and lung bud. A simplified diagram showed in B is the 
electroporation technique used for delivering genes into the epithelium of the 
oesophagus, the approach can be used to deliver genes into other organs 
such as the stomach, intestine, trachea and lung buds. The views shown in C 
is a diagram of how the horizontal confocal pictures of an oesophagus culture 
looks. Mesenchyme is on the outside then the epithelial basal layer then 





Fig 2.2 Stepwise illustration of the dissection of the mouse E11.5 oesophagus 
(and trachea, lung, stomach, intestine).
Photos of the lateral (A), dorsal (B) and ventral (C) views of an E11.5 embryo 
are shown. Head of the embryo has been removed. A ventral view of the 
internal organs after further removal of the integument and the outer part of the 
body is shown in D. The view of the gut region is blocked by heart and liver 
located ventrally (D). The oesophagus, trachea and lung buds, stomach and 
small intestine are shown in E after removal of heart and liver. The 
oesophagus, stomach and small intestine are shown in F after removal of the 




2.2 Cell lines, transfection and culture conditions
All cell lines were purchased from European Collection of Cell Cultures 
(ECACC, Porton Down, U.K.) The culturing conditions of each cell line are as 
follows. KYSE30 was cultured in 50% RPMI-1640 and 50% F-12 HAM Nutrient 
medium (Sigma) supplemented with 2% FBS, 2 mM L-Glutamine, 0.5 U/ml of 
penicillin and 500 ng/ml of streptomycin (Life Technologies). OE33 was 
cultured in RPMI-1640 medium supplemented with 10% FBS, L-Glu and 
penicillin/streptomycin. Caco-2 was cultured in MEM medium (Sigma) 
supplemented with 10% FBS, 1% Non-essential amino acids (Life 
Technologies), L-Glu and penicillin/streptomycin. NIH3T3 4.2 was cultured in 
DMEM medium (Sigma) supplemented with 10% FBS, L-Glu and penicillin 
streptomycin. HepG2 was cultured in DMEM medium (Sigma) supplemented 
with 10% FBS, 1% Non-essential amino acids (Life Technologies), L-Glu and 
penicillin/streptomycin. Cells were cultured in 37°C, 95% air / 5% CO2  
humidified incubator and the medium was changed every 2 days; until 90% 
confluent (usually between 4 ~ 6 days) and subcultured at a 1:8 ~ 1:12 ratio. 
For transient transfection, generally, 1 pg of DNA was mixed with 3 pi of 
GeneJuice (Novagen) for 15 min in room temperature in 100 pi of serum free 
RPMI medium, and added to ~50% confluent cells for 24 hrs.
5-azacytidine (5-AzaC) 1 - 2 pM (Sigma) or 5-aza-2 deoxycytidine (5-Aza2C) 1 
- 2 pM (Sigma) were added to the culture for 6 days or 12 days, starting from 1 
day of culture or 8 day of culture to examine the effect of DNA methylation on 
the basal and suprabasal cell layers, respectively.
z-VAD-fmk (Calbiochem), a general caspase inhibitor was dissolved in DMSO 
to be added to a final concentration of 40 pM.
Mitomycin C (Sigma) was prepared in PBS and added in a final concentration
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of 10 pg/ml, 5 |jg/ml or 1 |jg/ml and added to the culture medium for 24 hrs. 
Keratinocyte serum-free medium (KSFM) culture was supplemented with 25 
pg/ml of bovine pituitary gland extract (BPE) and 2.5 pg/ml of recombinant 
epidermal growth factor (EGF) according to the manufacturer’s instruction. 
E11.5 oesophageal explants were cultured in the KSFM medium right after 
isolation from the embryo for 7 days.
Cyclopamine (Toronto Research Chemicals) was prepared in DMSO and 
stored in - 20°C as a 250 pM stock, and added in the culture medium to a final 
concentration of 1 pM from day 1 of culture for 6 days.
20 mM LiCI (Sigma) was added to the culture medium from a 5M stock 
(dissolved in H2 O). 20 mM NaCI (Sigma) was used as control.
2.3 Histology, immunohistochemistry and immunofluorescence 
detection
Oesophageal cultures (1-20 days) were fixed for 5 min in acetone / methanol 
(1:1 ratio) (for immunostaining of cytoskeleton proteins) at room temperature 
or 30 min in MEM FA (10% formalin, 01% MOPS, pH 7.4, 2mM EGTA, 1mM 
MgS0 4 ) (for membrane, cytosolic and nuclear proteins) at room temperature. 
Cultures were then washed three times in PBSAand stored in PBSAat 4°C for 
several days.
Cultures were permeabilised by adding 1% TritonX-100 in PBSA for 30 min 
prior to immunostaining. Antigen retrieval was performed if necessary by 
adding citrate buffer (pH 6) (LAB VISION) for 1 hr at 37°C. The cultures were 
washed three times for 10 minutes in PBSA. Non-specific binding sites were 
blocked for at least 1h in 2% Blocking Buffer, which was made up according to 
the manufacturer’s instruction. 5x stock of Roche Blocking Reagent was made
67
Wei-Yuan Yu
by dissolving with shaking and heating the Blocking Reagent (Roche, 1096176) 
in maleic acid buffer to a final concentration of 10% (w/v). The stock solution is 
autoclaved and stored at -20°C before diluting to 2% with PBSA. Primary 
antibodies were applied overnight at 4°C and the following day the samples 
were washed three times in PBS for 10 min each. The fluorescent secondary 
antibody was applied for 3 hrs in the dark at room temperature and the 
coverslips were rewashed and then mounted in Gelvatol medium. Gelvatol is 
prepared by dissolving 20 g of polyvinyl alcohol in 80 ml of 10 mM Tris, pH 8.6, 
and adding 0.2% NaN3 . This is mixed with 50 ml glycerol containing 3 g of 
n-propyl gallate. Any lumps were removed by centrifugation and the gelvatol 
was stored in the dark at 4°C.
When more than one primary antibody was used, the second round of staining 
began after the first round of 2° antibody incubation had been finished. 
Samples were washed 3 times in PBS before applying the second 1° antibody 
overnight at 4°C. Samples were washed 3 times the next day and the second 
2° antibody then added for 3 hrs at room temperature and the coverslips were 
washed and mounted in Gelvatol. 0.1 pg/ml of 4',6 -diamidino-2-phenylindole 
(DAPI) was applied 15 min to stain cell nucleus when appropriate.
For analysis of in vivo changes in expression, tissue was fixed at different 
stages of development from embryonic E11.5 up to 3 days postnatal and the 
adult tissue (~2 months old). For staining of transcription factors, tissue was 
fixed in MEMFA, and for keratin staining, tissue was fixed in acetone/methanol 
(vol. 1:1). In both cases, the length of fixation varied depending on the size of 
the sample. For tissue from E11.5 and E13.5 embryos, 2 hrs was sufficient. We 
used 24 hrs fixation for E15.5, E17.5 and E18.5 embryos and 48 hours for P1, 
P3 and adult tissues. All fixations were performed at 4°C. After fixation,
68
Wei-Yuan Yu
samples were washed three times in PBSA. The tissue was then placed in a 
tissue processor, the typical program was serial immersion in 70%, 90%, 95%, 
100% EtOH twice followed by Histoclear (National Diagnostics) twice. Tissues 
were then embedded in paraffin. All conditions were carried out for 2 hrs. The 
wax-embedded samples were then positioned in trays and covered with wax, 
which were allowed to set. Subsequently, transverse sections were cut 7 pm 
on a Leica 2155 microtome.
For haematoxylin and eosin (H & E) staining of sections, histoclear was used 
to dissolve the paraffin, and sections were gradually hydrated in 100% EtOH 
twice, and in 95% EtOH, 90% EtOH, 75% EtOH, 50% EtOH and RO water 
once, each for 1 min. Haematoxylin was added for 5 minutes followed by 15 
seconds of 0.1% HCI treatment to sharpen the contrast then 30 seconds of 
0.1% NaOH to neutralise the pH. Eosin treatment was for 30 seconds and 
slides were then washed, dehydrated in graded alcohol in the reverse 
sequence of the EtOH used in hydration process and mounted in DePeX 
(BDH). 3,3-Diaminobenzidine (DAB) staining was carried out by first 
permeabilising the re-hydrated slides (as done in H&E) with 1% Triton X-100 in 
PBSA for 30 minutes at room temperature, and then incubated the slides with 
0.6% H2 O2  in 80% methanol, and blocked in the 2% Roche blocking buffer. 
Slides were then stained with the primary antibody overnight at 4°C. The 
following morning, the slides were washed with PBSA and the appropriate 
biotinylated secondary antibody was added for 1 hr. The DAKO ABC detection 
kit was used for development with the chromogen DAB. One DAB tablet was 
dissolved in 0.1 M Tris, pH 7.5 to a final concentration of 6.67 mg/ml to which 
H202was added to a final concentration of 0.1%. To stop the staining reaction, 
the slides were washed with PBSA and counterstained with haematoxylin.
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Prior to mounting in DePeX, the sections were dehydrated in graded alcohols 
as in H & E staining and immersed in Histoclear twice.
For dual immuno-histochemical staining, the first round of staining was the 
same as the single staining procedure, followed by a short microwave (45 
seconds on 800 W) and slowly cooling down for 15 min. Sections were then 
incubated with the second primary antibody overnight. Staining procedure is 
the same on the next day as single DAB staining using ABC kit from DAKO 
with an additional round of H2 O2  quenching and lastly developed in a DAB 
solution added with NiS0 4 . (DAB 0.6 mg/ml, 320 mM NiS04, 0.1% TritonX-100 
in a pH 7.2 acetate buffer containing 10 mM imidazole), mounted in DePeX 
without counterstaining.
The primary antibodies used with sources were as follows, the concentration 
used was 1/100 unless otherwise stated: mouse anti-GFP, Clontech (8362-1); 
rabbit anti-GFP, Abeam (ab290); mouse anti-keratin 14, NeoMarkers (MS-115); 
rabbit anti-K14, Covance (PRB-155P); mouse anti-keratin 18 (LE61) (neat), 
Prof. E Birgitte Lane, University of Dundee, UK; Rat anti-keratin 8 (TROMA I), 
Devlopmental Studies Hybridoma Bank (DSHB); mouse anti-pan p63, Santa 
Cruz (4A4); mouse anti-AP-2a, DSHB (3B5); rabbit anti-C/EBPa, Santa Cruz 
(sc-61); mouse anti-C/EBPp, Santa Cruz (sc-7962); mouse anti-Desmin, 
DAKO (D33); mouse anti-smooth muscle myosin kinase, Sigma (K36); mouse 
anti-a-smooth muscle actin, Sigma (1A4); mouse anti-skeletal myosin (Fast), 
Sigma (MY-32); rabbit anti-human Myoglobin, DAKO (A0324); mouse anti-K10, 
DAKO (DE-K10); mouse anti-lnvolucrin, Neomarkers (SY5); mouse anti-K4, 
Sigma (6B10); mouse anti-K13, Sigma (KS-1A3); rabbit anti-loricrin, Covance 
(PRB145P); rabbit anti-filagrin, Covance (PRB-417P); mouse anti-Ki67, BD 
Pharmingen (556003); mouse anti-beta-catenin, Transduction Laboratory
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(610153); mouse anti-E-cadherin, Transduction Laboratory (C20820).
Various species specific secondary antibodies were used, at 1/100 
concentration: Fluorescein Isothiocyanate (FITC) anti-mouse IgG, Vector 
(FI-2000); FITC anti-rat IgG, Vector (FI-4000); FITC anti-rabbit IgG, Vector 
(F-0382); Texas Red anti-Rat IgG, Vector (TI-9400); Tetramethylrhodamine 
Isothiocyanate (TRITC) swine anti-rabbit IgG, DAKO (R0156).
Normally, the secondary antibodies of the same species were applied to 
specimens as negative controls before trying any primary antibody first time; 
experiments were usually done for more than twice unless stated otherwise. 
Specimens were either examined under a DMRB compound microscope 
(Leica) and images collected using a SPOT camera with Image Solution 
software; or collected using a Zeiss LSM 510 confocal microscope (Carl Zeiss, 
Welwyn Garden City, UK). The same image collecting conditions were applied 
for cytokeratins expression for the time course results. For determining the 
area of the mitomycin C treated cultures, the outline of the epithelium region 
are measured by the peripheral lining function of the confocal imaging 
program -  LSM 5 Image browser. Final images were processed with 
Photoshop (Adobe System).
2.4 Dil lineage tracing
The E13.5 oesophagi were dissected out, and microinjected with 100 pM of 
1 .T-dioctadecyl-S.S.S'.S'-tetramethylindocarbocyanine perchlorate (Vybrant 
Dil solution) (1mM stock from Molecular Probe, V-22885). Final concentration 
of Dil was prepared by diluting the stock in 90% DMSO and 10% EtOH solvent. 
Centrifugation may be needed to remove the undissolved crystal. Dil was 
pipetted into thin wall borosilicate glass capillaries; the parameters for the
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capillaries are the same as for electroporation (section 2.9). Oesophagi were 
then cultured until wanted for live image under confocal microscopy, or to 
follow up the lineage tracing by immunostaining with markers. Confocal 
images were taken for the immunostaining; the secondary Ab is conjugated for 
FITC and combined with Dil, the red fluorescence. The oesophagus cultures 
were fixed with 30 minutes of MEMFA, and lightly fixed with acetone/methanol 
for 1 minutes in 4°C before the immunostaining procedure.
2.5 Dead cell assay
Ethidium Homodimer (Molecular Probes) is used a marker for cell death 
because it will penetrate the cell membrane of dead and dying cells and stain 
fragmented DNA (Decherchi P. et al., 1997). To stain for dead and dying cells, 
the medium was removed at different time points and replaced with 2 ml of 
Hank’s Balanced Salt Solution (HBSS without phenol red). Add a final 
concentration of 1.6 pM Ethidium homodimer to the HBSS. Incubate at 37°C 
for 20-40 min. Wash with PBS three times, then fix in MEMFA and 
immunostain with antibodies as designed.
2.6 Fluorescence activated cell sorting
To prepare single cell suspensions of the embryonic organ cultures, I took 
between 15 and 20 oesophageal buds from each time point. The buds were 
washed once with PBS, trypsinized for 10 min in the 37°C incubator and then 
pipetting trituration was performed for 10-15 min. The cells were passed 
through a 20G needle or a 40 pm cell strainer (Falcon) to ensure single cell 
suspension. Cells were counted on a haemocytometer and the number 
adjusted to -  105 cells/tube with staining buffer (2% FCS, 0.1% NaN3 in PBS).
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The cell suspension was permeablised and fixed by incubation for 15 min with 
Cytofix / Cytoperm solution (4% PFA, 0.5% Triton X-100, 2% FBS and 0.1% 
NaN3  in PBS). The cells were then washed in Perm/Wash buffer (0.5% Triton 
X-100, 2% FBS and 0.1% NaN3 in PBS) to maintain the permeability of the 
cells. Primary antibodies were added at a dilution of 1:200 and were incubated 
for 30 min in room temperature prior to washing and incubating for 30 minutes 
with FITC-conjugated secondary antibodies (1:200). Propidium iodide with 
RNaseA (BD Pharmingen #550825) was added to designated tubes 15 
minutes before analyzing on the FACS machine (BD Coulter flow cytometer). 
Before determining the DNA content of K14+ and K18+ cells, cell samples that 
had been incubated with secondary antibodies alone and single colour staining 
were used to establish background signal and the compensation parameters.
2.7 RT-PCR analysis
Total RNA was extracted using the TRI reagent (Sigma). Briefly, embryonic 
tissues were dissected as described previously at different time points, and 
collected into 1 ml of TRI reagent and stored at -80°C before further RNA 
extraction. Embryonic tissue in TRI reagent were homogenised on ice by using 
a glass dounce homogeniser. After homogenization, the lysate was collected, 
and then 0.2 ml of chloroform per millilitre of TRI reagent was added to the 
tube. The tubes were shaken vigorously for 15 seconds, allowed to stand for 
10 minutes at room temperature and then centrifuged at 12,000 x g for 15 
minutes at 4°C. The aqueous phase was transferred to a fresh tube, and 0.5 
ml of isopropanol was added and mixed. The sample was allowed to stand for 
5-10 minutes at room temperature, and then centrifuged at 12,000 x g for 10 
minutes at 4°C. The supernatant was removed and the RNA pellet was
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washed with 75% ethanol. The RNA pellet was dried for 5-10 minutes, 
dissolved in water, and then stored in -80°C.
Before carrying out the cDNA synthesis, the RNA samples were digested with 
RQ-1 DNase (Promega) to remove any contaminating genomic DNA. First 
strand complementary DNA was synthesized using Murine Maloney 
Leukaemia Virus (MMLV) reverse transcriptase (Invitrogen).
The PCR reactions were processed in a DNA thermal cycler under the 
following conditions: denaturation at 94°C for 1 min, annealing at 55°C for 1 
min, and extension at 72°C for 1 min. The primer sequences and the number 
of cycles are as follow,
MoTF-AP-2a-F544 TATCTACCCCCAGTCGCAAG 351 bp 35x
MoTF-AP-2a-R894 GACACGGGGCCTTTCTTAAT
m63TA.F# TCGCAGAGCACCCAGACA 610 bp 35x
m63dN.F# TTGTACCTGGAAAACAATG 447 bp 35x
m63-2R# GCATCGTTTCACAACCTCG
mp63TA*-F TTTGAAACTTCACGGTGTGC 117 bp 35x
mp63TA*-R GGC AG AT CT GTAATAACTTT CTTT CC
Mo C/EBPa-F GTTCCAGATCGCGCACTGCG 449 bp 35x
Mo & Rat C/EBPa-R T GACCAAGGAGCTCTCAGGC
Mo & Rat C/EBPP-F ACAAGCT GAGCGACGAGTAC 159 bp 35x
Mo & Rat C/EBPP-R ACAGCTGCTCCACCTTCTTC
Mo & Hu K14-F GT G ACC AT GC AGAACCT C AA 404 bp 28x
Mo & Hu K14-R TTCTTCAGGTAGGCCAGCTC
Mo K18-F GTGGAATCCAGACCGAGAAA 496 bp 28x
Mo K18-R GC AT CC ACTTCC AC AGT C AA
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Mo HoxC4-F GCACTTCTGAAGACCACTCC 331 bp 35x
MoHoxC4-R CCATGCTAAGACAACACCAC
(#): primer sequence from (Koster et al., 2004).
2.8 Preparation of plasmids
Cloning of plasmids was carried out by standard molecular biology protocols. 
To generate the pK14-nucGFP plasmid, nucGFP was excised from 
pcDNA3-nuclearGFP (Tosh et al., 2002) with BamHI andXbal and cloned into 
the same sites of the K14 expression cassette (Vasioukhin et al., 1999) 
generously provided by Professor Elaine Fuchs, Howard Hughes Medical 
Institute, Rockerfeller University, New York. The K14 expression cassette 
contains a 2100 bp of the keratin 14 promoter/enhancer, a rabbit P-Globin 5 
untranslated region (UTR), together with an intronic sequence upstream of the 
BamHI, Xbal sites, and the K14 3 UTR, followed by a polyadenylation site 3 
downstream of the BamHI /Xbal site. Similarly, pK14-LucE was generated by 
excising the K14 promoter/enhancer region from the K14-cassette with BamHI, 
Sad and cloned into the Bgll, Sad sites of the pGL3-Enhancer vector 
(Promega) containing the firefly luciferase protein. pK18mTELucE was 
generated by excising the luciferase from the pGL3-Enhancer with BamHI, 
Ncol and cloned into the same sites of the pK18mTELacZ (Chow et al., 2000) 
(a plasmid kindly provided by J Hu, Lung Biology Research Programme, 
Research Institute Hospital of Sick Children, Toronto, Canada). The 
K18mTELacZ plasmid contains a 3.3 kb of the keratin 18 promoter/enhancer 
region, including the 1st intron of K18 where the splicing site was deleted and a 
translation enhancer was added (Chow et al., 2000). pGL2-Enhancer is 
obtained from Promega and used initially as a positive control for Luciferase
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assay. pAP-2at was obtained from MRC geneservice, UK, vector backbone is 
pCMV-SPORT6. Rat pC/EBPa and mouse pC/EBPp plasmids were gifts from 
S. McKnight, University of Texas Southwestern Medical Center, and subcloned 
in the pcDNA3 multiple cloning site by using Hindlll and BamHI restriction 
enzymes. Human p63 isoforms pTAp63a, pANp63a and pTA*p63awerein the 
pcDNA3.1/mycHis plasmid backbone, they are gifts generously provided from 
K. Engeland, Max-Burger-Forschungszentrum, University of Leipzig. pcDNA3 
was obtained from Invitrogen.
2.9 Electroporation of plasmids into embryonic organ cultures
Briefly, 0.1% Fast Green was added to 1 pg/pl of plasmid DNA for easy 
visualisation and this was pipetted into thin wall borosilicate glass capillaries. 
The parameters for pulling the capillaries on a Micropipette Puller (Sutter, P-97) 
were: Heat 300, Pull 40, Velocity 220, Time 150. The capillaries had the 
following dimensions: outer diameter, 1.0 mm, inner diameter, 0.58 mm (Clark 
Electromedical Instrument, GC100-15). The electrode gap width was 5mm. 
For electroporation, I used the Electrosquareporator (BTX, ECM830), with the 
voltage set at 50V, the pulse length 50 ms, continuous electroporation for 3 
times in a unipolar direction, interval was 200ms. DNA was injected into the 
lumen of the oesophagus, stomach, trachea-lung buds and small intestine that 
had been dissected free in PBSA. Tissues were then immunoassayed after 
24h (oesophagus) or 48h (stomach, trachea-lung buds and intestine) of 
embryonic explant culture.
2.10 Assay of luciferase activity
The purpose of luciferase assay is to determine whether transcription factors
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will activate or suppress the expression of a reporter gene linked under the 
control of a piece of genomic DNA containing the promoter/enhancer region of 
interest. Briefly, KYSE30, OE33, CaC02 and NIH3T3 4.2 cell lines were 
seeded at -  40 - 50% confluency into 6-well plates 24 hours before 
transfection. Cells were then transiently transfected by using 6 pi GeneJuice 
with 1 pg of a promoter drive firefly luciferase reporter plasmid (pK18mTELucE, 
pK14-LucE, pTTR-Luc), 2 pg of transcription factor(s) including pcDNA3 with 
pAP-2a, pC/EBPa, pC/EBPp, pTAp63a, pTA*p63a, pANp63a or different 
combinations of two p63 isoform plasmids, and 1 pg of (3-Gal plasmid 
(pCMV-nucLacZ) to normalise for variations in transfection efficiency. Initially, a 
constitutive luciferase expressing plasmid, pGL2-Enhancer (Promega) was 
used as a positive control for the assay system (data not shown). After 48 
hours of incubation, cells were harvested for measurement of luciferase 
activities by using the Luciferase Assay Reagent (Promega). Light emissions 
were integrated for the initial 10 seconds of emission detected by Microplate 
Luminometer (Berthold LB96V) and operated by Winglow software. p-Gal 
activity and protein quantity were assayed by a Microplate Colorimeter (Anthos 
AN2001) and Stingray v1.5 software. I used 
2-nitrophenyl-p-D-galactopyranoside (ONPG) (Sigma N1127) as the substrate 
in the P-Gal assay; Biorad Protein Reagent (500-0006) and BSA standards 
were used for protein assay. For the p-gal assay, 140 pi of 0.1 M P04 buffer 
with 10 mM of KCI, 1mM of MgSC> 4 and 50 mM 2-mercaptoethanol were added 
to a 20 pi of sample and 25 pi of 4 mg/ml ONPG in the 96 well plates, 
incubated at 37 °C overnight before p-Gal measurements were done on the 
Microplate Colorimeter using the absorbance 405 nm filter. For the protein 
quantification, 190 pi of five times diluted Biorad protein reagent (in H2 O) were
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added to 10 pi of sample, waited for 30 minutes in room temperature and the 
protein measurement was done by the Microplate Colorimeter reading at the 
absorbance of 590 nm. (3-gal assay and protein assay were done in duplicates. 
The luciferase specific activity was determined by subtracting background 
signal and normalizing to the (3-Gal activity and protein quantity of each sample. 
A standard curve of Luciferase standard ranging from 1 ng -  lO’4 ng was used 
to determine the definitive luciferase quantity and to compare values between 
each different experiments. Fold induction (or inhibition) was calculated by 
dividing the values obtained for the transcription factor(s) by the values of 
control plasmid (pcDNA3). Samples were run in quadruplicate, and all 
experiments were performed on at least three separate occasions.
2.11 Statistical Analysis
Statistical differences were analyzed with a 2-way Student-t test. All tests were 
assessed at the 0.05 level of significance.
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Chapter 3 In vivo and in vitro development of the oesophagus
3.1 Introduction
3.1.1 Overview
To date, study on the development of the oesophagus is scarce. The reason 
for this is partly due to a lack of suitable model system. Except for some 
oesophageal cell lines (e.g. OE33, KYSE30) that do not fully reflect the 
characteristics of the organ, there is no proper in vitro model for the study of 
the oesophagus. Here, the development of the oesophagus in vivo and the 
establishment of an in vitro culture system will be described. Some in vitro 
culture systems commonly used for mammalian organ explant are briefly 
introduced.
3.1.2 In vitro culture systems
3.1.2.1 The need for an in vitro culture system of the oesophagus 
The aim of this chapter is to describe the establishment of an in vitro culture 
system for the oesophagus. A culture model system may facilitate the 
understanding of oesophagus development which might not be achieved from 
in vivo models. The development of such a model will help us gain more 
understanding of oesophageal development. Information such as (a) the 
mechanism underlying formation of the endodermal stratified squamous 
epithelium, (b) the maturation of the mesenchymal and musclar tissue, (c) the 
interactions between the mesodermal and endodermal tissues could be 
achieved by a suitable culture system. An additional benefit of an in vitro 
system is that it can also be manipulated, e.g. addition of extracellular factors
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and ectopic expression of genes. The frequently used methods for in vitro 
culture are described below.
3.1.2.2 Features of different in vitro culture systems
Commonly used culture systems include (a) culture of a single cell suspension, 
(b) hanging drop culture of cells or organs and (c) whole-mount organ culture 
on extracellular matrix coated cover-slip. It is known that cell-cell contact, cell 
adhesion to the extracellular matrix in the basal lamina, and aggregation, 
sorting and migration of different cell types in the embryo are important factors 
involved in the social context of individual cells during morphogenesis and 
organogenesis. These factors regulate the survival, proliferative and 
differentiating signals of cells, and are involved in how organs take shapes and 
function. Different culture methods will influence the aspects of these important 
factors.
The culture of cells following mechanical or enzymatical digestion is a method 
advantageous for gene delivery (e.g. easy for transfection) and is straight 
forward for immunostaining steps of the samples. However, the disadvantage 
is that the normal relationship of the different cell types in a tissue is usually 
lost. However, many detail information of molecules and mechanisms that 
regulate cellular differentiation was found using single cell culture methods. 
Such models are also useful in verifying gene function. For instance, 
clonal-derived lens epithelial cells isolated from newly hatched chicks show 
differentiation when cultured in conditioned medium (Okada et al., 1973). 
There is also the study of cadherin gene function in cell-cell adhesion and cell 
sorting using L cells, a line of cultured mouse fibroblasts which do not normally 
express the classical cadherins. When L cells were transfected with
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E-cadherin, they start to adhere to one another in a Ca2+-dependent manner 
(Nagafuchi et al., 1987). When L cells transfected with N-cadherin were mixed 
with cells transfected with E-cadherin, the N-cadherin cells would be sorted out 
from the E-cadherin positive cells. The single cell culture method is the 
simplest way to understand how individual cell types would behave 
autologously. Various cell lines now used in laboratories were found using this 
approach.
Another frequently used method is to culture cells or a piece of tissue in a drop 
of medium suspended on an inverted solid support (the “hanging drop” method) 
(Gilbert, 2000). The surface tension of the drop of medium keeps the small 
tissue from free falling. Although there are usually no dramatic changes in the 
size of the culture, the tissue (or cell spheroid) formed will usually differentiate. 
The hanging drop method was originally developed by Ross Harrison to study 
the identity and formation of neuronal axon (Gilbert, 2000). He cultured the 
neural tube of a frog tadpole in a drop of frog lymph on a transparent inverted 
coverslip and observed the development of axon outgrowth at a speed of 56 
pm/hr from the neuroblast in the cultured neural tube. The hanging drop 
method is now widely used for the study of culturing embryonic stem cells to a 
spheroid differentiated structure, the embryoid body (Yamada et al., 2002). 
The advantage of using hanging drop culture is in the maintenance of the 3D 
structure of the tissue or embryonic organ. Physiological intercellular 
interactions and cellular organization can be readily studied by hanging drop 
model, such as understanding the vascularizion of a microtissue (Kelm et al., 
2004). However, long-distance migration of cells during development is not 
easily studied by this method.
The whole-mount organ culture on different extracellular matrices on a solid
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coverslips has been adopted in our lab to investigate the development of 
pancreas (Percival and Slack, 1999). The characterise of this method is that 
morphologically, the tissue or organ in culture is intact, but gradually it 
becomes stretched and flattened while lying on the surface of the coverslip. 
The spatial organisation of cells in the culture is mainly the same as in vivo 
although the direction of the mechanical stress applied on the culture might be 
different. The cell layers in direct contact to the extracellular matrix pre-coated 
on the coverslip also encounters an articial environment initially but later these 
cells will secrete their own extracellular proteins. However, the epithelial cells 
in the pancreas culture model and the oesophagus model shown here do 
express the differentiated phentotype.
In the current study, the method generally adopted to investigate the 
development of the oesophagus is the whole-mount culture on the extracellular 
matrix coated coverslips. Next, previous work on the oesophageal 
development is reviewed.
3.1.3 Development of the oesophageal epithelium
In humans, pseudostratified columnar epithelial cells initially line the embryonic 
oesophagus (DeNardi and Riddell, 1991). At 8 weeks of gestation, ciliated cells 
can be found in the middle third of the oesophagus and extending rostrally and 
caudally. At 10 weeks, a single layer of columnar cells populates both the 
proximal (near the stomach) and distal ends of the oesophagus. Around 4 
months of gestation, the columnar cells grow downward into the lamina propria, 
proliferate and then differentiate into the cardiac-type glands of the 
oesophagus. At approximately 5 months gestation, stratified squamous 
epithelium initially appears in the middle third of the oesophagus and extends
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towards the rostral and caudal ends, replacing the ciliated epithelium (Johns, 
1952). The process of in vivo epithelial differentiation has not been studied 
further, but development of human foetal oesophageal explants from ~12-16 
weeks gestation have been investigated in vitro, and an accelerated rate of 
formation of stratified squamous epithelium were found after 15 days in organ 
culture (Menard and Arsenault, 1987).
3.1.4 Cytoskeletal proteins: intermediate filaments and cytokeratins 
Intermediate filaments are cytoskeletal polymers that provide structural 
support to the cytoplasm and nucleus of higher eukaryotes; they also function 
to sustain the cells for mechanical and non-mechanical stresses (Coulombe 
and Wong, 2004). Intermediate filaments such as keratin or desmin connects 
to desmosomes in cell-cell anchoring junctions via cytoplasmic plaques 
composed of intracellular dense anchor proteins - desmoplakin and 
plakoglobin (y-catenin) (Jamora and Fuchs, 2002). A desmosome is the 
anchoring cell-cell junction found between two epithelial cells, and consists of 
the transmembrane proteins desmoglein and desmocolin of the cadherin 
family. In cells anchoring to the extracellular matrix, intermediate filaments 
connect to the hemidesmosome via anchor protein -  plectin, which binds to 
integrin in the cell membrane hemidesmosome. Integrin binds to basement 
membrane extracellular matrix such as laminin and facilitates the anchoring of 
cells in the cell-matrix adhesion.
Actin is also a major cytoskeletal protein which facilitates the intracellular 
cytoskeletal support to the cell-cell adherin junctions and the cell-matrix focal 
adhesions. The adherin junction proteins-cadherins, such as E-cadherin 
expressed in the epithelial cells, facilitates the calcium-dependent binding of
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two neighbouring cells. Actin filaments are connected to the membrane 
cadherins by associating with anchor proteins vinculin, a-actinin and a, (3 and 
y-catenin or p120. In the focal adhesion complex, actin connects to integrins 
via anchor proteins such as talin, vinculin, a-actinin and filamin.
Structural components such as keratin filaments, anchoring prepteins and 
desmosomes form a three-dimensional array within the cytoplasm of epithelial 
cells. Recent findings showed that keratins interact with non-structural proteins 
that influence cell growth and cell death (Coulombe and Wong, 2004). The 
intermediate filaments belong to a large family of structural proteins and are 
expressed according to the differentiated state of the cell (Lazarides, 1980). 
For example, keratin 18 (K18, a type I acidic cytokeratin intermediate filament 
protein), normally heterodimerizes with another simple columnar intermediate 
filament (the type II cytokeratin 8 (K8)) in simple columnar cells (Owens and 
Lane, 2003).
3.1.5 What are the markers of an oesophageal stratified squamous 
epithelium?
In stratified squamous tissue, structural proteins maintain the integrity of 
epithelial tissues and function as a protective barrier. As part of the normal 
growth of stratified squamous tissues, terminally differentiated cells are 
continuously sloughed off the cornified layer and are replaced from cells of the 
basal layer. Cytokeratin 14 (K14) and cytokeratin 5 (K5) are markers for the 
basal layer of stratified squamous tissue. Mutations in keratins K5 or K14 are 
found in epidermolysis bullosa simplex (EBS), the abnormal keratin filament 
aggregates in the basal cells and disrupts the keratin filament cytoskeleton 
complex, resulting in cells that are less resilient and cause blistering when
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subjected to even mild physical trauma (Smith, 2003). K1 and K10 are specific 
markers for the suprabasal layers. Bullous congenital ichthyosiform 
erythroderma is caused by mutations in keratins 1 and/or 10. These patients 
are born as bright red babies with large blisters and erosions. Other tissue 
specific cytokeratin markers are such as K4 and K13 for the oesophagus, 
cornea and buccal epithelium and function-specific cytokeratins such as K6 
and K16 for wound healing of epithelia cells (Moll et al., 1982). The cornified 
cell envelope is an extremely tough protein / lipid polymer structure formed just 
below the cytoplasmic membrane and subsequently resides on the exterior of 
the dead cornified cells. Loricrin, a terminal differentiation marker of the 
stratified squamous, is the major protein of the cornified cell envelope, a 
structure that replaces the plasma membrane during keratinocyte terminal 
differentiation (Nemes and Steinert, 1999; Presland and Dale, 2000). Loricrin 
and involucrin are proteins cross-linked into the cornified layers by the 
transglutaminase enzyme. Filaggrin is also a terminal differentiation marker, 
and is expressed in the corneum stratum of stratified squamous tissue such as 
epidermis and oral cavity. A defect in pro-filaggrin causes ichthyosis vulgaris, 
which shows fine white flaky scales of the extensor surfaces, trunk, flank, lower 
legs but spares the folds and wet areas (Presland et al., 2000). Autoimmune 
antibodies reactive to filaggrin is a marker for rheumatoid arthritis and could be 
involved in the pathogenesis of this disease (Francis, 1994; Serre, 2001). 
Using a combination of the cytokeratin markers described above should 
provide detailed information on the development of the oesophageal 




Table 3-1 Cytokeratin markers and expression profile used in this study:
Markers Expression profile
K8, 18 Columnar (glandular) epithelium
K5, K14 Basal layer of stratified squamous epithelium
K4, K13 Oesophagus, buccal and cornea specific epithelium
K1, K10 Early differentiated marker of the suprabasal stratified squamous 
epithelium.
Involucrin Earliest differentiation marker located in the suprabasal stratified 
squamous epithelium.
Loricrin Late / terminal differentiation marker located in the spinal to cornified 
layers of the oesophageal stratified squamous epithelium.
Filaggrin Late / terminal differentiation marker located in the granular to 
corneum layers of the oesophageal stratified squamous epithelium.
*:after Moll, R„ et al. (1982). Cell 31, pp11-24.
K4. I10.S 
Involi crin
Figure 3.1 A diagram showing the relative location of distinct types of 
cytokeratin-expressing cells in each layer of stratified squamous epithelium 
(adapted from Young and Heath, 2001).
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3.1.6 Development of the oesophageal muscle
As stated previously (Chapter 1, section 1.2.3), the adult mouse oesophagus 
contains both smooth muscle and skeletal muscle cell types (Patapoutian et al., 
1995; Kablar et al., 2000). Skeletal muscle is found predominantly in the upper 
two-thirds and smooth muscle in the lower third of the mammalian oesophagus. 
It was shown that prior to E15, the myogenic regulatory factors (MRFs) of 
skeletal muscle are not expressed in the mouse oesophagus (Kablar et al., 
2000). This raises the question of where the skeletal muscle cells come from? 
The origin of the skeletal muscle was thought to come from smooth muscle 
cells and that the conversion was classified as transdifferentiation. However, 
there are some contradictory findings. By immunohistochemistry and electron 
microscopy, Zhao and Dhoot suggested that there are individual smooth and 
skeletal precursors located in the foetal oesophagus that follow different 
differentiation pathways and the conversion is not transdifferentiation (Zhao 
and Dhoot, 2000). There is also a report using lineage tracing in mouse 
expressing two proteins driven by the smooth muscle specific promoter 
(smooth muscle heavy chain myosin (smMHC)) (Rishniw et al., 2003). One 
encodes enhanced green fluorescence protein (eGFP) for real time monitoring 
of smooth muscle expression, and the other is the Cre recombinase 
expression for tracing cells that have ever activated the smooth muscle gene. 
This line is mated with the reporter line R26R, which is a mouse line containing 
a CMV promoter driving a (3-galactosidase gene with a loxP-stop-loxP site at 
its 5 region. The CMV promoter will only be able to drive LacZ expression 
when Cre recombinase reaches a certain level in the same cell. By this 
approach, the authors are able to differentiate between smooth muscle cells
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that are currently expressing smMHC, (GFP and LacZ positive) with those cells 
that have expressed the smMHC gene previously, but not any more (only LacZ 
positive) due to transdifferentiation. From the crossed smMHC-Cre:GFP x 
CMV-loxP-stop-loxP-LacZ mice, the authors found that the expression pattern 
of LacZ is exactly the same as the GFP in the oesophagus, indicating that the 
skeletal muscle in the oesophagus must not come from the smooth muscle but 
probably is an outgrowth from a different precursor cell (Rishniw et al., 2003). 
In this chapter, I will characterise the development of the oesophageal muscle 
both in vivo and in vitro, and address whether there is transdifferentiation 
occurring in the muscle cells.
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3.2 The in vitro culture system of the oesophagus
3.2.1 Development of an in vitro culture system for oesophagus
To address some questions of the development of the epithelial and muscle 
layers encircling the upper gastroenteral tract, oesophagi were dissected free 
from E11.5d mouse embryos and placed in culture on fibronectin-coated glass 
coverslips. The size of the dissected oesophagi ranged from 75 pm -  200 pm. 
After 24hr of culture, the oesophagus had attached to the substrate and the cut 
ends had healed. At this stage, the culture is composed of a tube of epithelium 
surrounded by mesenchyme composed of fibroblasts and probably some 
endothelial cells. During the first few days of culture, some of the 
mesenchymal cells spread away from the explants but they also continue to 
maintain a layer above and below the epithelium, which will often spread freely 
onto the surface of the coated extracellular surface or even straight onto the 
glass after some days of culture. Results are shown from confocal z-stack 
images of E-cadherin and smooth muscle actin stained culture summarised in 
a diagram, Fig 2.1 C. Later in the culture period, the mesenchymal cells 
resolve into an inner region composed of smooth muscle actin-positive cells 
and a peripheral region of fibroblast-like cells, resembling the situation in vivo 
(data not shown). The cultures remain viable and continue to grow for at least 
20 days although the growth is not as extensive as that found in vivo.
3.2.2 Optimizing the culture system using different extracellular matrices
The initial goal was to determine whether spatially and temporally, 
oesophageal explants differentiate as in vivo oesophagi. To find out the 
conditions for culturing explants, I tried culturing either on glass coverslips or 
on coverslips soaked with 40 pi of different extracellular matrices solution
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dissolved in sterile water (fibronectin, collagen I, collagen IV and laminin), each 
at a concentration of 50 |jg/ml. Most explants attach and epithelium and 
muscular differentiation occured on glass coverslips as well as on the different 
extracellular matrices I used (results tabulated in Table 3-2). Although there 
were some differences as to when the cytokeratin markers become expressed, 
they were quite small. I found explants usually attached more efficiently to 
fibronectin, and in this culture system, the muscular and epithelium 
differentiation rates were also comparable to in vivo results. In the present 
study, I mainly focused on the culture system using fibronectin as a substrate 
for the oesophageal explants.
Below are expression results of differentiation markers when cultured on 
different extracellular matrices summarised in a table.
Table 3-2 Epithelial markers expression profile of oesophagi cultured on
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3.3 Conversion of columnar to stratified squamous epithelium in the 
oesophagus
3.3.1 Morphology of the oesophageal epithelium
Histological sections of mouse oesophagus at different stages of development 
(from embryonic E11.5 - E17.5 days, perinatal stages and adult) were stained 
for haematoxylin and eosin (Fig 3.2). Just after the foregut separates into the 
oesophagus and trachea, the oesophagus is lined with simple columnar 
epithelial cells surrounded by undifferentiated mesenchyme (E11.5d, Fig 3.2 A). 
As the oesophagus develops (E13.5-E17.5, Fig 3.2 B, C, D), the epithelium 
remains columnar but gradually becomes composed of more layers, while the 
mesenchyme separates into zones corresponding to the later submucosa and 
smooth muscle layers. At E17.5, the cell layer closer to the lumen starts to 
show the squamous cell morphology (Fig 3.2 E). In the perinatal stages, a 
cornified layer of squamous tissue appears (Fig 3.2 F, G). Finally, in the adult, 
the basal layer is clearly distinct (dense layer of cells) and the suprabasal part 
is divided into the spinous, granulous and cornified layers of a fully 
differentiated and keratinised stratified squamous epithelium (Fig 3.2 H, I).
3.3.2 Immunohistochemical analysis of the oesophagus epithelium in vivo
To find out if the expression of the cytokeratins correlates with the morphology 
of the oesophagus, immunohistochemical analysis was performed to 
determine the temporal expression of the columnar marker (K8) and stratified 
squamous epithelium marker (K14) during oesophageal development. At 
E11.5, all the cells in the epithelium of the oesophagus are K8 positive and K14 
negative (Fig 3.3 A, I). K8 continues to be expressed as the epithelium 
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Fig. 3.2 Haematoxylin and eosin staining of the mouse embryonic and adult 
oesophagus.
Haematoxylin and eosin (H&E) staining of the mouse oesophagus during 
different stages of embryonic development and in the adult. (A) E11.5, (B) 
E13.5, (C) E15.5, (D, E) E17.5 (F, G) P1 and (H, I) adult (2 months old). The 
epithelium of the oesophagus at E11.5d is simple columnar and gradually 
becomes stratified during development. The four distinct layers, i.e. B, basal 
layer, Sp, spinous layers, Gr, granular layers and C, corneum stratum, features 
of a fully differentiated stratified squamous tissue are shown in the adult (I). 
The muscle layers of the oesophagus are found from E13.5, two layers of the 
muscle (inner longitudinal and outer circular) could be found in the 
oesophageal cross sections after E15.5, but striations could only be found 
from after E17.5. bm, basement membrane (a black line drawn in A,B), ep, 
epithelium, sm, submucosa m, muscle layers, In, inner longitudinal, and Out, 
outer circular muscle. Scale bars are 60 pm in (A, B, C, E, G, I), 190 pm in (D, 





Fig. 3.3 The oesophageal epithelium changes from columnar to stratified 
squamous in vivo.
Keratin 8 (A-H) and Keratin 14 (l-P) immunostaining on embryonic 
oesophageal cross sections. (A, I) E11.5, (B, J) E13.5, (C, D, K) E15.5, (E, L) 
E17.5, (F, M, N) E18.5, (O) postnatal day 1, (G) postnatal day 3, (H, P) Adult (3 
months). Keratin markers show a reciprocal expression in the columnar and 
the basal layer of stratified squamous during the development of the 
oesophagus epithelium. Arrows in (D-F) show the gradual disappearance of 
K8 expression in the basal layer, while the arrow in (L) shows the emerging 
K14 positive cells. Note that the suprabasal epithelium still expresses K8 until 
P3 but not in the adult. Scale bars are 50 pm in (A, B, D, E, F, I, J, N), 160 pm 
in (C, G, K, L, M, O) and 320 pm in (H, P).
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E17.5 (arrows in Fig 3.3 D, E). It is almost absent from the basal layer by E18.5 
(arrow in Fig 3.3 F). However, the suprabasal layer tissue continues to express 
K8 (Fig 3.3 F, G) until at least P3, only finally disappearing later (Fig 3.3 H, an 
example of a 2 month old mouse oesophagus). The expression pattern of the 
K14 stratified squamous marker is quite different. Basal cells expressing K14 
could be observed at around E17.5 (arrow in Fig 3.3 L). At P1, most cells of the 
basal layer express K14 (Fig 3.3 O) and in adult oesophagus, all cells of the 
basal layer clearly show K14 expression (Fig 3.3 P). The expression of K8 and 
K14 in the basal layer therefore correlates with the switch from columnar to 
squamous morphology. Other stratified squamous-specific keratin markers 
showed similar timing of expression in the appearance of a stratified 
squamous epithelium (Fig 3.5, Fig 3.6 and Table 3-3). Since K14 is not seen in 
the suprabasal layers, it presumably turns over fast enough to become 
degraded before cells move from basal to suprabasal levels. Conversely the 
fact that K8 does persist in the suprabasal levels of the foetal stages (Fig 3.3 
D-G) suggests that it is still expressed in these cells after being turned off in the 
basal layer.
3.3.3 Immunofluorescence analysis of the oesophagus epithelium in vitro 
The in vitro culture system was used to compare the time course of the 
process from simple columnar to stratified squamous cell type to the normal 
oesophageal development. 24-72 hours after the start of the culture, the entire 
epithelium was K8 positive (Fig 3.4 A, B). After 5 days of culture the basal layer 
showed a marked decrease in the number of K8 positive cells (Fig 3.4 C, D) 
while the K8 positive cells in the suprabasal layers disappeared more gradually, 
















Fig. 3.4 In vitro evidence for the E11.5 oesophageal culture converting from 
columnar to stratified squamous.
Oesophageal segments were isolated from E11.5 day embryos, cultured for 
different times and then immunostained for K14 (green) and K8 (red) or K18 (I, 
J). (A, I) 1 day, (B) 3 days, (C) 5 days, (D) 7 days, (E) 9 days, (F) 11 days, (G) 
15 days and (H, J) 20 days of culture. Scale bars indicate the magnification. 
The columnar marker K8 was expressed in the epithelium from the first day of 
culture, whereas the stratified squamous marker K14 only started to be 
expressed at the basal layer of the epithelium from around 3 to 5 days in 
culture. The K8 expression becomes less intense in the basal layers at about 
the same time as K14 cells appear. A second wave of the loss of K8 cells was 
observed in the suprabasal layers from around 11 days onwards. By 20 days 
of culture very few K8 positive cells remain. K18 immunostaining on 1d (I) and 
20d (J) show the same results as K8 staining. Scale bars are 50 pm in (A-H) 
and 200 pm in (I, J).
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that this result reflected a switch of cell type rather than just of two specific 
gene products, I also examined K18 expression. This showed a similar pattern 
and timing of expression as K8 with initial uniform expression but almost 
complete loss by 20 days (Fig 3.4 I, J). Conversely, the expression of the 
squamous marker K14 starts in the basal layer by day 5 of culture (Fig 3.4 C) 
and by 7 days, nearly all cells of the basal layer express K14, and continue to 
do so during the culture period (Fig 3.4 D-H). Comparing the suprabasal cells 
stained with K8 on day 1 (Fig 3.4 A), day 7 (Fig 3.4 D) and day 9 cultures (Fig
3.4 E), the suprabasal cells can be clearly seen to gradually change shape 
from a columnar to a flattened (squamous) morphology in the in vitro culture 
system. This indicates there is a correlation of the appearance of K14 marker 
and the stratified squamous morphology. Culturing the embryonic oesophagus 
on different extracellular matrix proteins (including glass) showed the same 
columnar to stratified squamous conversion (K8 to K14) (data not shown). The 
study of K8, K18 and K14 indicates that the epithelium of the in vitro cultures 
showed autonomously the same reciprocal expression of cytokeratins as it 
happens during development in vivo.
3.3.4 Other stratified squamous markers
To follow the progress of oesophageal epithelial differentiation, I examined the 
expression of different markers including involucrin, K10 (Fig 3.5), loricrin, 
filaggrin and K4 (Fig 3.6). The intermediate filament involucrin (Inv) is an early 
differentiation marker and cytokeratin 10 (K10) a later differentiation marker for 
stratified squamous tissue. The expression of K10 (Fig 3.5 A, B) and involucrin 
(Fig 3.5 G, H) in relation to K14 in the adult oesophagus is shown. K10 or 





Fig. 3.5 Expression of stratified squamous differentiation markers in adult 
oesophagus and oesophageal cultures.
K10, a suprabasal marker for the differentiated stratified squamous epithelium 
was co-stained with the basal layer marker K14. Low (x100) (A) and high (x400)
(B) magnification adult oesophageal sections or a 15 day oesophageal culture
(C) (K14, green, K10, red in A, B, C) are shown. Invoulcrin, also a suprabasal 
marker for the terminal differentiation stratified squamous, was co-stained with 
basal layer marker K14 on adult oesophageal sections and viewed at low 
(x100) (G) and high (x400) (H) magnification. E11.5 oesophagi cultured for 7 
days (D, I), 9 days (E, J) and 20 days (F, K) were stained with K10 (green) (D-F) 
or co-stained with involucrin (red) and K14 (green) (l-K). 4', 








Fig. 3.6 Late differentiation and oesophageal specific stratified squamous 
epithelium markers.
Cross-sections of adult mouse oesophagus (A, B, D, E, G, H) or cultured 
oesophagus from E11.5 (C, F, I) were immunostained for (A-C) loricrin (green); 
(D-F) filagrin (green); (G, H) K14 (green), K4 (red) and DAPI; and (I) K4 (green). 
The culture periods of the oesophageal cultures were (C) 11 days, (E) 15 days, 
(G) 7 days. K4 expression in vitro showed the cultures are oesophageal in 
character. The expression of loricrin and filaggrin showed terminal 
differentiation markers of a stratified squamous tissue and usually stained the 
corneum layers. The magnification of G is 100x and H 400x. Scale bars are 
100 pm in A, C, D, F, and 10 pm in B, E, I.
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the K14 positive green cells are at the basal layer. The cultured oesophageal 
explants co-ordinately express K10 (Fig 3.5 C) and involucrin (Fig 3.5 J, K) in 
the suprabasal layers, which is identical to the normal staining pattern on adult 
sections. K10 starts to be expressed around 7-9 days of culture but not earlier 
(Fig 3.5 D-F). Involucrin starts to express at similar time points with very few 
involucrin cells to be found before 7 days of culture (Fig 3.5 l-K). The K14 
positive cells express earlier than involucrin.
To examine whether the oesophageal culture could undergo terminal 
differentiation, filaggrin and loricrin, two stratified squamous markers located in 
the suprabasal region most distant to the basal layer (the corneum stratum) 
was used (Fig 3.6 A, B, D, E). These markers were found in the oesophageal 
explants after many days of culture (Fig 3.6 C 11 days, Fig 3.6 F 15 days), the 
time points of expression is later than other stratified squamous markers. 
Lastly, to prove that oesophagus (as opposed to other tissues e.g. stomach or 
lung) was cultured in vitro, K4, (a suprabasal marker for oesophagus and 
corneum epithelium), was immunostained (Fig 3.6 G-l). The expression of 
stratified squamous markers with the combination of K4 ensures what was 
cultured is oesophagus but not trachea (which is pseudostratified and will not 
express stratified squamous markers such as K14 and K10). These results tell 
us that the explants isolated at 11.5 days do have the potential to develop into 
mature oesophageal stratified squamous tissue.
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3.4 The oesophagus as a model for developing and transdifferentiating 
muscular tissue
3.4.1 Morphology of embryonic and adult oesophageal muscular structure 
The results of H & E staining of sections of the mouse oesophagus at different 
developmental stages also showed muscle development (Fig 3.2). The 
mesenchymal layers (outer layers from the basement membrane of the 
oesophagus), are only 3-4 layers of cells at E11.5 (Fig 3.2 A). At E13.5, the 
outer layers of the mesenchymal layers have differentiated and show myofibre 
morphology although no striations can be found at this stage of development 
(Fig 3.2 B). At E15.5, two layers in the muscle region are seen (Fig 3.2 C) and 
are more obvious at E17.5. At E17.5, postnatal day 1 and at adult stages (Fig
3.1 D-l), the two layers of muscle tissue are well developed, we can clearly see 
the striations in some parts of the muscle layers and in adult, the thickness 
(~500 pm in average) of the muscle layers are larger than the region of 
submucosa and epithelium combined (Fig 3.2 H). The endodermal cells 
(epithelium) actually occupied less space than the mesodermal cells 
(submucosal mesenchyme and muscle cells) in the oesophagus. The normal 
muscle layers of the oesophagus starts differentiation as seen in haematoxylin 
and eosin from E13.5-E15.5, and striated muscle are found from perinatal 
stages (Fig 3.2 G).
3.4.2 Muscle development
Initially, I determined the timing of muscle markers being expressed in 
mesenchymal cells in both in vivo and in vitro culture. Desmin is a marker for 
both smooth and skeletal muscle and is expressed in early myoblasts (Costa 
et al., 2004). Desmin expression was found in the myofibres of the adult
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oesophagus (Fig 3.7 A-C), but not in the epithelial region (cell layers above the 
black asterisk in Fig 3.7 B) (the light brown colour is residual non-specific 
staining). There is strong desmin expression in the outer circular and the inner 
longitudinal layers of the muscularis regions (muscularis externa) (red asterisk 
in Fig 3.7 B) of the oesophagus, and some expression of desmin in the 
submucosal region especially at the muscularis mucosa (black asterisk in Fig
3.7 B). The epithelium showed no expression of desmin (Fig 3.7 A, B).
In the in vitro culture system, there is no desmin expression from the first day. 
After 9 days of culture, desmin was found strongly expressed in the fibre-like 
cells of the outer layers (presumably the muscle cells) (Fig 3.7 E, F), but not in 
the inner epithelial part of the culture. The expression persists until at least 20 
days of culture. The change of expression of the desmin marker in the E11.5d 
in vitro model showed the submucosal region of the explant could differentiate 
and form the muscle layers.
In order to examine whether transdifferentiation of the muscularis region of the 
oesophagus occurs in vitro, markers of both smooth and skeletal muscle were 
used for immunostaining. A number of different culture periods were examined 
(1d, 7d and 15d) (Fig 3.8 E-N). On the glass coverslips culture (Fig 3.8 E-l) as 
well as on the fibronectin coverslips (Fig 3.8 J-N), no expression of either the 
smooth muscle (smooth muscle myosin kinase -  SmMyoK)) or the skeletal 
(and cardiac) muscle markers (myoglobin) on the first day of culture was found 
(Fig 3.8 E, J) (The green and red colour in Fig 3.8 E were non-specific staining 
which did not correspond to the muscle fibrous cellular shapes). The muscle 
layers of the cultures that grew on either glass or fibronectin coverslips, 
expresses both smooth (smooth muscle myosin kinase) and skeletal 







Fig. 3.7 The development of the oesophageal muscular layers in the 
embryonic culture system -  expression of desmin.
Adult mouse transverse section (A-C) was immunostained for desmin, from 
low to high magnification. Desmin was also stained on the 1 day (D), 9 day (E) 
and 20 day (F) culture of the E11.5 oesophagus. The expression of desmin, a 
cytoskeletal marker for both smooth and skeletal muscle (Kablar et al., 2000), 
is also a marker for early myoblasts. Desmin was found in the adult mouse 
oesophagus, both in the muscularis mucosa region (black asterisk in B) and 
the outer circular and inner longitudinal muscularis region (red asterisk in B). 
On the first day of culture, desmin was not expressed, but was positive at 9 
days and 20 days of culture. This change of expression of desmin showed the 
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Fig. 3.8 Development of the oesophageal smooth and skeletal muscle layers 
in the embryonic culture system.
Smooth muscle actin (SMA) (A, B), a marker for the smooth muscle and 
mesenchymal cells, and skeletal myosin (SkMyo) (C, D), a marker for the 
skeletal muscle, were immunostained on the adult oesophageal cross sections 
at low (A, C) and high magnification (B, D). In adult, the expression of the SMA 
was found both at the muscularis mucosa (black asterisk in A) and the outer 
circular and inner longitudinal muscularis region (red asterisk in B). The 
expression profile is the same as desmin (Fig 3.7 A-C). However, the skeletal 
muscle marker -  SkMyo, was only found at the outer circular and inner 
longitudinal muscularis region (red asterisk in C), but not at the muscularis 
mucosa (black asterisk in C). Double staining was done for smooth muscle 
marker (smooth muscle myosin kinase SmMyoK, (Green)) and skeletal and 
cardiac myocyte marker (myoglobin, (Red)) on the in vitro oesophageal 
cultures (E-N). Embryonic oesophagi were cultured on glass cover slips (E-l), 
or were cultured on fibronectin (FN) coated cover slips (J-N). Oesophagi were 
cultured for 1 day (E, J), 7 days (F, G, K, L) or 15 days (H, I, M, N). No 
expression of either smooth or skeletal muscle markers was found on 1 day of 
culture, but they were found on 15 days culture on both glass or fibronectin 
coated cover slips. The skeletal muscle marker was expressed earlier on the 
glass coverslip than on the fibronectin coated culture (compare F, G, K, L).
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expression of the skeletal muscle marker at day 7 cultures on glass (Fig 3.8 F, 
G) is earlier than on the fibronectin coverslips (Fig 3.8 K, L).
Examples of cells expressing only the SmMyoK (green) or Myoglobin (red) or 
both (yellow) could be found in both glass (Fig 3.8 I) and fibronectin (Fig 3.8 M) 
cultures. The coexpression of both smooth and skeletal markers indicates the 
process of muscle transdifferentiation. Both smooth and skeletal muscle 
markers are not expressed at day 1, but start to be expressed later during the 
culture period. This expression profile is the same as the appearance of 
desmin in vitro.
The adult section showed the expression of alpha-smooth muscle actin (SMA) 
(Fig 3.8 A, B) for smooth muscle and skeletal muscle myosin (FAST) (SkMyo) 
(Fig 3.8 C, D) for skeletal muscle. SMA expression was identical to the 
expression pattern of desmin (Fig 3.8 C, D compared with Fig 3.7 B, C), which 
was positive in both muscularis extema (red asterisk) and muscularis 
submuscosa (black asterisk), while skeletal myosin kinase was only positive in 
muscularis externa but not in muscularis submucosa. Both smooth (SMA) and 
skeletal markers (SkMyo) were absent in the epithelium region, although there 
were stronger background signal in the epithelial region for SMA staining (Fig
3.8 A).
In conclusion, I have used smooth muscle actin and smooth muscle myosin 
kinase as smooth muscle markers, skeletal muscle myosin and myoglobin for 
skeletal muscle markers and desmin as a general marker for both smooth and 
skeletal muscle. The adult oesophagus is used as a positive control for the 
markers. Interestingly, in the adult, the results from desmin, SMA and SkMyo 
indicate that the muscularis submucosa region contains smooth muscle but not 
skeletal muscle. I also compared fibronectin coated versus uncoated glass
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coverslips for culture and examined the time course for expression of smooth 
and skeletal muscle markers, in both conditions neither smooth muscle 
markers (SMA and desmin) nor skeletal muscle markers (SkMyo and desmin) 
appear on the first day of culture. Instead, skeletal muscular differentiation 




The aim of the research described in this chapter was to describe the 
development of the epithelium and muscle regions in the oesophagus. I 
needed evidence of changes in morphology and cell-specific markers to gain 
more understanding of the oesophageal development. I also established an in 
vitro embryonic oesophageal culture system to recapitulate the development of 
the oesophagus in vivo. Both aims were achieved.
Below is a table summarising the results of the epithelial and mesenchymal / 
muscular expression profile comparing in vivo and in vitro systems.
Table 3-3 Expression profile of differentiation markers of the oesophagus 
cultured on fibronectin.
Epithelial and Mesenchymal 
/ Muscular Markers
In vitro expression time 
points (isolated from E11.5)
In vivo expression time 
points
K8 (K18) day1-day15 E11.5--P5
K14 day5->day20 E15.5-adult
K10 day5-day20 E17.5-adult
K4 (K13) day1-day20 E11.5- adult
Involucrin day3-day20 E13.5-adult
Filagrin day7-day20 E17.5-adult
Desmin day3-day20 adult, not done in embryos
a-Smooth muscle actin day3-day20 adult, not done in embryos
Smooth muscle myosin 
kinase
not done adult, not done in embryos
myoglobin >day7->day15 adult, not done in embryos
Skeletal myosin Not done adult, not done in embryos
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3.5.1 Characteristics of the in vitro culture model system
The epithelium and muscle tissue develop in oesophagi isolated from mouse 
embryos when cultured on fibronectin-coated coverslips. However, the 
morphology of the in vitro oesophagus may differ to the oesophagus in vivo. 
First, the cultured oesophagus is no longer supported by other organs such as 
trachea and lung that normally develop around the oesophagus, and the shape 
of the oesophagus lying on the flat surface also changes to a flattened 
morphology with hardly any space remaining as lumen (Fig 2.1 C). However, 
the epithelial cell morphology and the differentiation markers still changes from 
columnar (red cells in Fig 3.4 A) to stratified (many layers) and squamous-like 
(flattened) (red cells in Fig 3.4 G).
Second, it is clear that there are mesenchymal cells spreading on the glass 
coverslip or the extracellular matrix-coated surface. For example, cells that 
spread around the oesophagus buds are shown in Fig 3.5 F, Fig 3.7 D and Fig
5.1 C. The origin of these fibroblastic-like mesenchymal cells remains elusive 
but one might postulate they come from serosa, the outer layer of the culture. 
This is because the epithelial and muscular cells form concentric layers in the 
cultured buds, in which their organization are usually intactly kept. This lack of 
coherence in some of the mesenchymal cells in culture is somehow different to 
the oesophageal development in vivo.
Third, the mechanical stress and tension force applied to the oesophagus is 
different between culture on the solid surface and the normal in vivo 
arrangement. It is known that mechanical forces are crucial to the regulation of 
cells and tissue morphology (Katsumi et. al., 2004). Extracellular matrix 
proteins can activate their receptor proteins-integrins to facilitate the focal
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adhesion of cells and mechanotransduction of force to the cells. Forces 
influences cytoskeletal organization, gene expression, and survival and 
proliferation signals to cells. It is now known that in addition to structural 
functions, many components of the adhesion apparatus also possess 
signalling capabilities (Jamora and Fuchs, 2002). The mechanical force and 
tension applied is apparently very different between oesophagus developed in 
vivo and the whole-mount culture attached on the flat solid surface. The 
different time points of skeletal muscle marker expression between oesophagi 
cultured on the glass coverslip and on the fibronectin-coated coverslip (Fig 3.8 
G vs L) might be due to specific effects of the different extracellular matrix 
proteins on the signalling to the focal adhesion complex and thus the rate of 
inducing cellular differentiation.
3.5.2 Oesophageal stratified squamous epithelium
The main focus of this study is on the differentiation of the oesophageal 
epithelium. The epithelium of the oesophagus is just simple columnar at E11.5 
day. It gradually becomes multilayered and became a fully differentiated 
stratified squamous tissue after birth (or ~ 15 days culture). The typical 
stratified squamous markers K10, involucrin, loricrin and filaggrin were found in 
our culture system accordingly. Simple columnar markers such as K8 and K18 
were expressed from E11.5 (1 day culture) but were lost from the basal layer at 
perinatal stages (~7-9 days culture) and totally disappeared from the 
epithelium in 2 months (or 20 days culture). On the contrary, K14 the basal 
layer marker of a stratified squamous tissue becomes expressed around 
E15.5-E17.5 (5-7 days culture), and gradually the whole epithelium is K14 
positive after birth (or after 9-11 days culture). Thus there is a change from
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simple columnar to stratified squamous tissue in the oesophageal epithelium 
during development.
3.5.3 Muscle development and changes in the oesophagus 
To study muscle development in the oesophagus, I determined the dramatic 
changes of morphology of mesenchymal region in the oesophagus during the 
time points of E11.5d -  2 months old mouse. Within the mesenchymal layer, 
the muscular region becomes distinct from other fibroblastic cells at about 
E13.5d, when the mesenchymal region could be seen to divide into the 
submucosal and muscularis region. The two layers of muscular tissue are 
seen from E15.5, and striation of the muscle is found from E17.5 in our 
oesophageal sections. Next, both markers of smooth muscle and skeletal 
muscle were shown to be expressed in the muscular region of adult oesophagi. 
Using a-smooth muscle actin and smooth muscle myosin kinase as markers 
for smooth muscle, myoglobin and skeletal muscle myosin (fast muscle) as 
markers for skeletal muscle, and desmin as a marker for both smooth and 
skeletal muscle, the spatial and temporal profile of the muscle specific markers 
was characterised.
From the results of the changes in expression of the skeletal muscle 
marker-myoglobin in the oesophagi cultured on glass coverslip (earlier) and 
fibronectin-coated surface (later) (Fig 3.8 G vs L), one might imagine that the 
change of extracellular matrix proteins provided near the muscle layers may 
influence the development of the muscle. The expression of stratified 
squamous epithelial markers, on the other hand, has less variation between 
oesophagi grown on different extracellular matrix-coated surfaces (Table 3-2 
and data not shown). This might be because the epithelial layers are
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influenced by immediate signals from the extracellular matrix proteins of the 
basal lamina and the submucosa mesenchymal cells, which are in contact with 
the epithelium of the cultured oesophagus no matter which coverslip coating.
3.5.4 Is there transdifferentiation of oesophageal muscle?
To prove that “transdifferentiation” occurs in cells is to trace the cell lineage 
before and after the phenotypic and molecular/biochemical change of the cells. 
In the present study, two conditions I examined, i.e. culturing embryonic 
oesophagus on glass or fibronectin coated coverslips, muscle cells either 
expressed markers of smooth muscle specific only, markers of skeletal muscle 
specific only or cells that contained both markers (undergoing 
transdifferentiation).
Zhao and Dhoot argue that a-smooth muscle actin (SMA), the smooth muscle 
marker they used is found in both smooth and skeletal muscles at the foetal 
stages (Zhao and Dhoot, 2000), and at later stage, SMA became a specific 
marker to the mesenchymal / smooth muscle but not skeletal muscle. In our 
system, SMA and smooth muscle myosin kinase were used as smooth muscle 
markers. It seems unlikely that two markers for smooth muscle are both 
non-specific at the early stage. With the finding of myoglobin and SmMyoK 
co-expressing cells (Fig 3.8 I, M) and myoglobin expressing only cells (Fig 3.8 I, 
N) in the 15 days cultured E11.5 oesophagus, the specificity of SmMyoK as a 
smooth muscle marker is established.
For the lineage tracing studies using smooth muscle promoter driven Cre and 
GFP (Rishniw et al., 2003), we might also argue that in their transgenic mice, 
the Cre protein driven by the smooth muscle myosin heavy chain promoter 
needs time to accumulate for the Cre recombinase to function, and LacZ will
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not express as early as the real smMHC. This might result in the Cre induced 
LacZ expressed at a later time than the normal expression hence missing the 
transdifferentiation event (cf. Fig 1a and 1b ED15 GFP and LacZ results in 
Rishniw et al., 2003). Our muscle marker staining results also showed 
comparable time points in the changes of the skeletal markers in the in vitro 
culture to another paper on this topic (Kablar et al., 2000).
The findings that some cells express both smooth and skeletal muscle markers 
in the oesophageal cultures, suggests that the origin of the skeletal muscle 
cells is very probably from the smooth muscle cells. This may constitue an 
example of transdifferentiation. However, there are also cases such as insulin 
and glucagon co-expressing cells found during embryogensis are actually not 
the precursors of these two cell types in the adult (Herrera, 2002), and we still 
cannot rule out the possibility that there are other types of skeletal muscle 
precursor cells that actually outgrow and replace some smooth muscle cells in 
parts of the oesophagus.
3.5.5 Conclusions and directions
In summary, the morphological change of the mouse oesophagus in the 
muscle and epithelium regions was shown from E11.5 to adult. Specific 
markers were used to confirm the changes of both columnar to stratified 
squamous epithelium and smooth to skeletal muscle during development of 
the oesophagus.
What is the mechanism of the change from simple columnar to stratified 
squamous epithelium? Is it specified before the foregut endoderm separates 
into trachea and oesophagus? If this is the case, there must be a difference in 
the ventral and dorsal patterning in the undivided foregut, but then we must go
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to an earlier time point (E9) to verify the differential gene expression or the 
signalling mechanisms. If the stratification process is specified after the 
oesophagus bifurcates from the foregut, then there must be a change in either 
signalling or gene expression during the time points we are studying. Also, 
what are the candidate genes involved in this process? Is there a correlation 
(in both genes and signals) between the changes from simple columnar to 
stratified squamous during development and the stratified squamous to simple 
columnar metaplasia? Maybe there is a universal mechanism in all types of 
stratified squamous metaplasia that happens in tissues like breast epithelium, 
cervix / vagina epithelium or bronchial regions of the lung.
To begin to answer these questions, I certainly would like to verify whether the 
epithelial switch is in fact a transdifferentiation event. In the next chapter, I will 
start by asking what is the source of the K14 cells arising from the basal layer.
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Chapter 4 Cell fate and origin of the developing oesophageal epithelium
4.1 Introduction
4.1.1 Is the conversion of columnar to stratified squamous epithelium an 
example of transdifferentiation?
In Chapter 3 ,1 demonstrated that the phenotype of the oesophageal epithelium 
changed from simple columnar to stratified squamous both in vivo and in vitro. 
The change of oesophagus morphology was shown (in vivo) in Fig 3.2, 
markers of columnar markers to stratified squamous markers were shown in 
Fig 3.3 (in vivo), and Fig 3.4 (in vitro) and terminal differentiation markers of a 
stratified squamous tissue were shown in Fig 3.5-3.6. The aim of the present 
chapter is to extend the results presented in Chapter 3 to investigate whether 
the normal development of the oesophagus could be attributed as a 
transdifferentiation event. According to Eguchi and Kodama, in order for a 
process to be considered as transdifferentiation, a number of criteria must be 
fulfilled (Eguchi and Kodama, 1993; Eguchi, 1995). The first is that the 
phenotype of the cells at the start and the end of the conversion must be 
clearly defined. The second is a clear demonstration of the 
ancestral-descendent relationship. Put simply; we wish to understand the 
cellular origin of the basal stratified squamous cells. To address this problem, I 
investigated three lines of evidence: (1) Whether there were co-expression of 
columnar and stratified squamous markers in the same cells (both in vivo and 
in vitro) during the time period when stratified squamous cells were appearing. 
For this purpose, representative markers of the two cell types were examined 
in the oesophagus. (2) Dil labelling was employed to trace the cell fate of the
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basal epithelial cells and (3) using the stratified squamous basal cell 
specific-K14 promoter driving a GFP reporter, the cell lineage was determined.
4.1.2 Dil cell lineage tracing
I.I'-dialkyl-S.S.^S'-tetramethylindocarbocyanine (CNcf/7) dyes (N = 12, 18, 
and 22) or Dil is a lipophilic cell tracer composed of a long-chain 
dialkylcarbocyanine, which emits at 565 nm, and gives an orange-red 
fluorescent colour (Packard and Wolf, 1985). Dil has been widely used for 
tracing live cells in tissues as it is readily absorbed in the cell membrane. Dil 
apparently does not affect the viability and developmental or physiological 
properties of cells that take it up. For example, motorneurons labelled with Dil 
can be traced for up to 4 weeks in vitro and up to a year in vivo (Honig and 
Hume, 1986; Honig and Hume, 1989). In addition to cell tracing, lipophilic 
carbocyanines have many other applications such as the detection of cell-cell 
fusion and adhesion, tracing cell migration during development and after 
transplantation, cytotoxicity assays and labelling of lipoproteins. In the present 
study, I used E13.5d oesophageal cultures for Dil cell labelling. This time point 
was chosen as the epithelial cells are still columnar. Assuming Dil can remain 
incorporated into the cells for a few days, I should be able to show the 
presence of Dil and K14 in the same cells. I will present evidence for Dll 
labelling of stratified squamous cells suggesting direct conversion from 
columnar cells.
4.1.3 Cell fate analysis in the developing oesophagus
I was also interested in the cell fate of the columnar and stratified squamous 
cells in the developing oesophagus. If the stratified squamous cells do not
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arise due to direct transdifferentiation, but via replacement of the columnar 
cells by the squamous lining of the oesophagus, I should then see an increase 
in the rate of cell death of columnar cells and an increase in the proliferation of 
stratified squamous cells. These results would tell us whether there is an 
overgrowth of the stratified squamous progenitor cell population.
4.1.4 Apoptosis and development
Programmed cell death, also known as apoptosis, can be generally 
categorised into two main pathways: the death-receptor pathway and the 
mitochondrial pathway (Hengartner, 2000). In both situations, the process of 
programmed cell death is through a cascade of proteolytic reactions in which 
caspases are the central executioners. Chemical caspase inhibitors, such as 
zVADfmk, normally inhibit apoptosis, although, new evidence shows there are 
examples of caspase-independent programmed cell death (Abraham and 
Shaham, 2004). Caspases have been found to work not only as an apoptosis 
executioner, but have other roles such as regulators of cell differentiation 
(Abraham and Shaham, 2004). Apoptosis is also important for the 
development of an organism (Meier et al., 2000), for example the degeneration 
of the temporary functioning pronephric kidney tubules in mammals and the 
regression of the tadpole tail during metamorphosis. Both these processes 
depend on programmed cell death to remove the parts that are no longer 
necessary for the developing animal. This could be a common theme for 
organisms to remove specific cells or tissue. I will address the question of 
whether the columnar cells were lost by apoptosis.
4.1.5 Studies of proliferating cells in the human oesophagus
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Studies in the mouse oesophagus have shown that the epithelial layer is 
initially composed of cuboidal ciliated cells which become replaced by 
squamous cells from about E17 (Raymond et al., 1991). By E17, 3HTdR 
labelling is confined to the basal layer and the suprabasal cells of the mouse 
squamous epithelium without the proliferating capacity became keratinised 8 
days after birth. Ki67, a proliferation marker for cells actively going through cell 
cycle (Endl and Gerdes, 2000), was used in the present study to find the 
location of the dividing cells in the oesophagus culture.
4.1.6 Metaplasia with intervening cell division
For most examples of metaplasia, we would imagine that the cells undergoing 
phenotypic changes must go through a number of cell divisions (Beresford, 
1990). The reason for this is because metaplasia in the adult is a rare event, 
and it is very difficult to imagine how “all” cells in a large area of a metaplastic 
focus will directly switch to the phenotype of another. Therefore, the more likely 
possibility is that a small population of cells in tissue A has changed phenotype 
to progenitor-like cells of tissue B, which then proliferate to populate the whole 
metaplastic area. Dedifferentiation may be a necessary intermediate in 
metaplasia before the direct switch and cell division begins, but this needs to 
be studied. However, metaplasia usually requires a long period of time to 
develop. It is technically awkward to address the question of cell division in 
vivo and an alternative is to utilise techniques employed by stem cell biologists. 
For example, proliferating cells can be visualised in a tissue by injection of 
BrdU to trace the cells that have incorporated the label (Tumbar et al., 2004). 
The long-retaining labelled cells that have been pulsed once for the BrdU and 
chased for a long period of time (e.g. 6 months) may be seen as a stem cell.
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An in vitro model system becomes more useful under these circumstances. If 
we can provide a reliable system in culture that represents a model of how 
metaplasia occurs, details of the cellular and molecular pathways that are 
involved in metaplasia / transdifferentiation can then be determined.
In this chapter, I will address (a) the cell lineage of the switch in epithelial 




4.2 Co-expression of columnar and stratified squamous markers
4.2.11n vivo and in vitro evidence
I employed a number of different approaches to determine if stratified 
squamous cells arise from columnar cells. First, I examined the K8 and K14 
expression in vivo and in vitro. From previous results (Chapter 3, Fig 3.5 K, L), 
we know that the stratified squamous basal layer marker appears around 
E17.5, and the columnar marker starts to disappear around E15.5. I used two 
colour DAB immunostaining for K8 and K14 on sections from E18.5 embryos in 
order to find whether the keratins are co-expressed at the time point when the 
markers are just switching from columnar to stratified squamous at the basal 
layer. The oesophagus (Fig 4.1 A-F), epidermis (Fig 4.1 G) and bronchial 
region (Fig 4.1 H) show sharply contrasting staining patterns with K8 and K14 
antibodies. The epidermal cells stain only for K14, presumably because the 
epidermis has turned into a stratified squamous tissue earlier than the 
oesophagus (Fig 4.1 G). On the contrary, the bronchial epithelium which is 
pseudo-stratified, stained only for K8 (Fig 4.1 H). In the oesophagus we see 
the expression of both K8 and K14 markers in two examples given here (Fig
4.1 A-C and D-F). While the K8 is predominantly found in suprabasal cells, 
some black granules may also be seen in basal cells that are expressing K14 
(arrows in Fig 4.1 B, C, E, F) (co-expressing cells were found in 3/3 cases. The 
number of coexpressing cells are 21, 28 and 16 on the 3 sections). Three 
consecutive sections of an E17.5 oesophagus were also stained for K14 (Fig
4.1 D) or K8 (Fig 4.1 E) alone and in combination (Fig 4.1 F). I found that K14 
stains the basal layer (Fig 4.1 D). Although K8 is predominantly found in 
suprabasal cells, there is also much weaker staining at the basal layers (Fig
4.1 E). This is masked in the dual-stained section (Fig 4.1 F), but when
125
Wei-Yuan Yu
adjacent sections are singly stained it is clear that some cells do express both 
K8 and K14. A transitional expression of both markers would be expected if 
stratified epithelium does indeed arise from the columnar cells by 
transdifferentiation.
From previous in vitro staining results (Fig 3.3 C), we know that K14 cells starts 
to express in the oesophagus culture from around day 5 (co-expressing cells 
were found in 4/5 of 5d cultures). The second proof of cell lineage is to find 
whether any cells simultaneously expressed both markers in the 5 day cultured 
E11.5 oesophagus. Again, this showed that the K14 cells start to appear in the 
basal layer while some K8 expression still persists in the basal layer. Some 
emerging cells were found to have both markers (arrows in Fig 4.1 I, this is an 





Fig 4.1 Expression of K8 and K14 in oesophageal and other epithelia.
Dual immunohistochemical staining for K14 (brown) and K8 (black) in E18.5 
oesophagus (A-C), E17.5 oesophagus (D-F), epidermis (G) and bronchial 
epithelium (H). (B) (1.3 x of (A)) and (C) (1.69 x of (A)) show higher 
magnification of the area in (A) where there is a co-stained cell (arrow). 
Example of single and dual staining for K14 (brown) and K8 (black) in 
consecutive sections of E17.5 oesophagus were shown in (D-F). K14 (D), K8 
(E) and K8 and K14 (F). Black arrows indicate cells expressing both 
cytokeratins. At the early stage of the conversion, some oesophageal cells 
express both K14 and K8, while the epidermis is only positive for K14 (G) and 
the bronchial epithelium is only positive for K8 (H). Confocal images of dual 
staining for K14 (green, FITC) and K8 (red, TR) in 5 day E11.5 oesophageal 
culture (I) (a further 10x enlargement of Fig 3.3 C). The arrow points to some 
cells starting to express K14 in the K8 positive cells. Scale bars are 80 pm in 
(D, E, F) and 200 pm in (A, G, H).
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4.3 Lineage analysis using Dil and perdurance of green fluorescence 
protein
4.3.1 Dil lineage tracing
To complement the results of the co-expression of the columnar and stratified 
squamous markers, I have examined the lineage using cell tracing techniques 
during the epithelium conversion period. Initially, a segment of epithelial cells 
lining the oesophageal lumen was labelled with a lipophilic acetylated red dye - 
Dil. Injecting Dil into the lumen of an E13.5 oesophagus will result in the dye 
being quickly incorporated into the cell membrane of the lining epithelium. In 
theory, with cell division, the concentration of Dil in each daughter cell will be 
diluted. When tracing the cell fate of the K8 positive cells lining the lumen, the 
earliest feasible time point for micro-injection of cell lineage tracing markers is 
at E13.5. Earlier than this time point, there is virtually no lumen in the 
oesophagus or the space of the lumen is just about one cell thick (see Fig 3.2 
A and 3.5 A). Presumably, this restriction is because the oesophagus has not 
yet undergone the vacuolization process, and there is still constriction of the 
lumen (DeNardi and Riddell, 1991).
From previous results (Fig 3.5 B, J), we know that all cells of E13.5 
oesophageal epithelium are K8 positive and K14 negative. Assuming cells in 
the E13.5d oesophageal epithelium incorporate Dil, then after the basal cells 
switch phenotype, there should be some cells that contain label and express 
K14. This would provide additional evidence that the K14 positive cells were 
formed from K8 positive cells of the E13.5 oesophagus. First, we show how the 
E13.5 oesophageal epithelial cells take up Dil. Fig 4.2 A shows a live image of 
an E13.5 oesophagus lumen cultured 24 hrs after injection with the red Dil. Dil 
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Fig 4.2 Dil cell lineage tracing of oesophageal epithelium.
Live image of an E13.5 oesophagus injected with Dil and cultured for 24 hrs (A) 
and an example of tracing an E13.5 oesophagus cultured for 9 days after Dil 
injection (B-D). Cells that take up Dil were K8 positive at the time of injection, 
and during the culture period, the epithelial cells that were red start to express 
the basal stratified squamous marker K14. K14 was stained after the Dil 
injected E13.5 oesophagus was cultured for 9 days. Yellow cells in the 
epithelium (C, D) showed the K14 cells (green, FITC) were originally from the 
cells that contained Dil (red).
131
Wei-Yuan Yu
injected an E13.5 d oesophagus and left it for 9 days in culture showed in Fig
4.2 B-D. This should be sufficient time to allow conversion from columnar to 
stratified squamous epithelium. After fixation, the culture was immunostained 
with K14 to examine whether the stratified squamous cells are Dil labelled. In 
Fig 4.2 C and D, we see cells that are labelled with Dil are stained with the K14 
antibody. In higher magnification, we can distinguish the region where Dil is 
less intense, the green (K14) and red (Dil) are found together in the basal layer. 
This suggests the K14 cells do come from Dil labelled cells, although in this 
case, we see that some layers of cells beneath the basal layer are also 
labelled faint red, which is probably due to diffusion of Dil into the 
mesenchymal layers from the lumen. Similar results were also found in E13.5 
day injected cultured for 5 days (not shown).
4.3.2 Activation of K14 promoter in K8 expressing cells
Although the Dil labelling experiment is suggestive of a columnar origin for the 
K14 positive cells, I could not be absolutely certain of the cell origin of the K14 
expressing cells from the Dil tracing experiment due to the fact that some 
non-epithelial cells may also be labelled with Dil. Another approach I used is to 
construct a reporter plasmid to perform cell lineage tracing. This reporter 
consists of the stratified squamous K14 promoter driving the expression of 
GFP with a nuclear localizing signal. The plasmid was introduced into the 
epithelium by electroporation at a time when the cells are just switching from 
the columnar phenotype to stratified squamous. Oesophageal segments from 
E15.5 embryos were dissected and then electroporated with the plasmid. The 
oesophagus was cultured for 24 hrs and then co-stained for GFP and the 
columnar K8 marker (diagram to explain shown in Fig 4.3 A). In those cells that
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Fig 4.3 Activation of K14 promoter in K8 expressing cells.
(A) Diagram showing the theoretical basis of the lineage experiment. A plasmid 
containing the stratified squamous K14 promoter driving GFP (with a nuclear 
localisation signal) expressed during the period when the columnar cells are 
converting to stratified squamous cells. Cells that are becoming stratified 
squamous should have an active K14 promoter and therefore possess a green 
nucleus. Assuming these are starting as columnar cells, the cells should 
co-express with K8 (shown here in red), and appear as yellow. Two examples 
are given. (B-D) and (E-G) show staining of the oesophagus 24 hrs after 
electroporation at stage E15.5. Some cells express both the K8 columnar 
marker and nuclear GFP (arrows in D,F,G), suggesting the origin of the 
stratified squamous tissue is from the columnar cells, while other GFP positive 
cells do not stain red suggesting they have already shut off K8 expression. 
Scale bars are 10 pm in (D, F, G), 100 pm in (B, C, E).
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start to express the K14 promoter (as judged by GFP expression), at least 
some cells still express the K8 columnar marker. In the five E15.5 oesophagi 
injected with the K14-GFP construct, four samples showed cells with green 
nuclei. The numbers of green nuclei were 17, 13, 12, 9 and 0 in the five 
samples examined, and the number of cells with green nuclei co-stained with 
K8 (red) were 2, 5, 1, 0 and 0, respectively. Two cultures are shown in Fig 4.3 
B-G; and in both, several basal cells express GFP and K8 in the same cell 
(arrows). There are also some GFP-positive cells that do not express K8, but 
this is not surprising because during this period cells are shutting off K8 and 
other genes responsible for the columnar phenotype, so it is likely that some of 
the cells acquiring and expressing the K14-GFP plasmid will already have 
done so.
In order to establish the fidelity of the expression of the K14 reporter construct, 
it was also electroporated into the epithelial cells of the stomach, small 
intestine and tracheal explants from E11.5 embryos and cultured under the 
same conditions as the oesophagus (Fig 4.4 A-D). These epithelia do not 
normally express K14 and indeed GFP was not expressed. Under the same 
conditions, GFP controlled by the CMV promoter was expressed (Fig 4.4 E-G), 
demonstrating the validity of the electroporation method. Experiments using 
the K14 promoter reporter construct transfected into various K14 positive and 
negative cell lines also provided additional proof of the specificity of the 
promoter (see Chapter 6, Fig 6.6).
In summary, from the three experiments: (a) some cells co-express K8 and 
K14 in the oesophageal basal layer both in vivo and in vitro, (b) Dil tracing of 
the basal layer K8 cells shows that they later express K14, and (c) the K14 
promoter is activated in some cells still expressing K8. The combination of
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results suggests that the basal cells of the squamous epithelium are derived 















Fig 4.4 Specificity of the K14 promoter.
The K14 reporter construct was electroporated into tissue that does not 
normally express the stratified squamous epithelium markers. The same 
culturing condition for examining the K14 promoter expression after 
electroporation in the oesophagus was used for these negative controls. 
Cultures of E11.5d stomach, small intestine and trachea do not express 




4.4 Cell death during development of the oesophagus
4.4.1 FACS analysis of single cell suspensions
Assuming the conversion of columnar to stratified squamous epithelium 
depended on a selective overgrowth of columnar by squamous cells; we 
should expect the rate of cell death to be greater among the columnar cells 
during the transition period. To investigate this possibility, I quantified the 
proportion of dead cells in the K8-positive and K14-positive cell populations 
during the course of the culture period. The oesophageal cultures were 
trypsinised, and the cells resuspended as a single cell suspension. They were 
stained with propidium iodide (PI) (staining DNA) and either K8 or 14 antibody 
and then analysed by flow cytometry. K14 or K8 positive cells are shown as 
upper-right and lower-right quadrant combined (Fig 4.5 A). Because of the 
apoptotic cell DNA being fragmented or the DNA fragments appeared in the 
necrotic cell debris, the Sub-Go cells (defined as Pl-low in (Fig 4.5 B)) were 
stained with less PI and were counted as dead cells. This is counted as the 
percentage of cells from the lower-left and lower-right quadrant combined (Fig
4.5 A) (raw data tabulated in Appendix A.2). The proportion of dead cells in 
K14 or K8 cells was from each keratin and PI double stained results and 
calculated as follows:
(percentage of lower-right quadrant) x (percentage of upper and lower-right quadrant combined) '1
The results show that the proportion of dead cells in the K8 population is about 
the same as in the K14 population at all three time points examined: 7 days, 11 
days and 15 days (Fig 4.5 C). The reason for examining these time points is 
because this is the period of time when we start to see loss of columnar cells in
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the basal then the suprabasal layers of the oesophagus. When expressed as a 
proportion of particles, the dead cells appear rather more numerous (-50%) 
than on the intensity profile, this might be because the fraction also includes 
small subcellular debris which might be caused by pipetting when making 
single cell suspension. From the FACS analysis, we find slightly more K14 
cells than K8 cells are dying using FACS analysis in all three time points (Fig
4.5 C) but the difference is not significant. This shows that the K8 positive cells 
do not die at a greater rate than the K14 cells.
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Fig 4.5 Determination of the dead cell proportion in the K8 and K14 cells during 
oesophagus development.
Intracellular staining of K14 / K8 and PI were carried out on a cell suspension 
as described in the Material and Methods (Section 2.8) and run through FACS 
to estimate the dead cell proportion of different cell types after 7 days, 11 days 
and 15 days of culture. A typical result from each of the time points is shown in 
(A). A histogram of PI single staining is shown in (B) and the Sub-GO cells 
(defined as PI-low in (B)) are counted as dead cells, which is the percentage of 
cells from the lower-left and lower-right quadrant combined in (A). The 
proportion of dead cells does not significantly differ from columnar and 
stratified squamous basal cells in three time points observed (C). Experiments 
were performed in quadruplicate and the error bar in (C) represents the 
standard error. Raw data were tabulated in the Appendix A.2.
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4.5 Effect of inhibition of apoptosis in the developing oesophageal 
culture
4.5.1 General caspase inhibitor -  zVADfmk
If the switch of cell phenotype were really due to preferential death of one 
population and resultant overgrowth by the other, then an inhibition of cell 
death should arrest or delay the process. For this purpose I utilised a general 
inhibitor of all caspases - zVADfmk. As DMSO was used for dissolving the 
zVADfmk, 0.1% DMSO was added to control cultures (Fig 4.6 A, B, E, F). To 
check the effect of zVADfmk on the oesophageal cultures, I added ethidium 
homodimer to stain the dead cells. The results showed a dramatic reduction in 
the number of dead cells stained with the red ethidium homodimer, especially 
in the epithelial region of the E11.5 explants cultured for 7 days (Fig 4.6 C vs A 
and Fig 4.6 G vs E). To examine the effect on the basal layer transition, I 
started treating cultures with 40 pM of zVADfmk after 24hrs of culture and 
continued until day 7. As shown in Fig 4.6 B and D, the disappearance of the 
K8 cells is similar in the DMSO control treatment and the zVADfmk treated 
cultures. In fact, comparing Fig 4.6 B and D, the level of K14 in the basal layer 
of the treated culture exceeds that in the untreated culture, which is the 
reverse of what would be expected if there is K14 cells outgrow to replace 
dead K8 cells. I also treated the cultures with zVADfmk from day 8 of culture 
until day 20, which is the period of loss of K8 cells from the suprabasal layers. 
In this case too, there was no difference in the rate of loss of K8 cells (Fig 4.6 F 
vs H).
Both the results of the flow cytometry analysis and the lack of effect of the 
caspase inhibitor show that progammed cell death is not a significant 
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Fig 4.6 Loss of columnar cells does not occur by programmed cell death.
To understand whether apoptosis has a role in the loss of K8 cells at the basal 
layer, E11.5 oesophagus organs were cultured for 7 days (A-D) and treated 
with 0.1% DMSO control (A, B) or with 40 pM zVADfmk (C, D) for 6 days. To 
examine if apoptosis is the mechanism for loss of K8 in the suprabasal layers, 
the organs were cultured for 20 days (E-H) and treated with 0.1% DMSO 
control (E, F) or with 40 pM zVADfmk (G, H) for 12 days. Afterwards, 
oesophageal cultures were incubated with ethidium homodimer for 30 min to 
label the dead cells with red fluorescence (A, C, E, G). K8 (red, TR) and K14 
(green, FITC) were used to stain the cultures after 7 days (B, D) or K8 (green, 
FITC) only staining cultures for 20 days (F, H). Many dead cells are clearly 
visible under control conditions (A, E) but very few in the cultures treated with 
the caspase inhibitor (C, G). The red fluorescence in (C) is auto-fluorescence, 
whereas true dead cells appear as rounded red spots, of which a few are 
visible in the mesenchyme. (B) and (D) show that preventing cell death does 
not affect the disappearance of K8 cells from the basal layer after 7 days of 




4.6 Cell proliferation in the developing oesophagus
4.6.1 Ki67 expression in cultured embryonic oesophagus 
If the switch in cell phenotype occurred by selective overgrowth of K14 positive 
cells, then it could not occur in the absence of cell division. Alternatively, if the 
mechanism depends on transdifferentiation with an obligatory cell division step, 
it could still not occur. To identify proliferating cells I immunostained for Ki67, a 
nuclear protein expressed in cells undergoing active phases of the cell cycle 
(Endl and Gerdes, 2000). The proliferative cells in mature stratified squamous 
tissues (e.g. skin) are located in the basal layer (Fuchs and Raghavan, 2002). 
In the early embryonic oesophagus, the epithelium showed high proliferative 
capacity throughout (Fig 4.7 A, B). When the culture differentiates into multiple 
layers, the Ki67 positive cells are, as expected, localised exclusively to the 
basal layer of the epithelium (Fig 4.7 J-L) as well as in some of the 
mesenchymal cells of the culture, but not in the K8 positive cells any longer 
(Fig 4.7 C-F). Interestingly, we find the proportion of K14 cells that are Ki67 
negative at the time when K14 starts to appear - day 5 culture (9 out of 18 - 
results were obtained from Fig 4.7 H, I, high magnification images from both 
ends of the oesophageal culture of Fig 4.7 G), is slightly higher than day 7 
culture (15 out of 43) (from Fig 4.7 K) and day 11 culture (14 out of 35) (from 
Fig 4.7 L), when Ki67 is restricted to just K14-expressing cells. The fact that 
there are less proliferating K14 cells when they just appear suggests the 
transition may not require cell division at the start, but the basal cells after the 
switch became highly proliferative. This hypothesis could be tested if I can 
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Fig 4.7 Location of proliferating cells in the oesophageal culture.
Oesophageal bud cultures were stained for K8 (green, FITC) and Ki67 (red, 
TR) in (A-F); or K14 (green, FITC) and Ki67 (red, TR) in (G-L). 1 day culture 
result is shown in (A, B), 5 days in (G, H, I), 7 days in (C, D, J, K) and 11 days 
in (L) and 15 days in (E, F). At the beginning of the culture, many of the 
epithelial cells in the columnar marker K8 positive layer of oesophageal 
cultures expressed the Ki67 proliferation marker. At 5 days of culture, when 
K14 positive cells start to appear, some of the stratified squamous cells are 
Ki67 positive. After 7 days of culture, only the basal layer K14 positive cells but 
not the suprabasal K8 positive cells showed proliferative capacity (compare C, 
D with J, K and F with L). Many of the mesenchymal cells at different stages 
show Ki67 positive cells.
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4.7 Effect of a proliferation inhibitor on the developing oesophageal 
culture
4.7.1 Mitomycin C does not affect the switch of the epithelium in the 
oesophagus
To examine the requirement for cell division, I added mitomycin C, a DNA 
cross linking reagent that blocks cells from entering the cell cycle (Kubilus et 
al., 1981), to the E11.5d oesophageal cultures. At day 4, the cultures were 
treated with 1, 5 or 10 pg/ml mitomycin C for 24 hours and then cultured for a 
further 5 days (without mitomycin C) until day 9. During the 5-9 day culture 
period, the basal epithelial layer normally completes the change from columnar 
to stratified squamous. We find the mitomycin C-treated cultures much smaller 
than the controls. The epithelial area of the 5 pg/ml mitomycin C treated culture 
was 0.22-x of the PBSA control, and the area of 10 pg/ml mitomycin C treated 
culture was 0.1-x of the control (Fig 4.8 A, D, G, J). In addition to the 
differences in area, Ki67 expression is rarely found in the 5 pg/ml treatment 
and is completely absent in the 10 pg/ml treated cultures (Fig 4.8 I, L). 
However, a complete basal layer of K14 positive cells continues to appear in 
the epithelium treated with mitomycin C. This indicates that the switch from 




Fig 4.8 Conversion of columnar to stratified squamous epithelium does not 
require cell proliferation.
To determine whether inhibition of proliferation had an effect on the emergence 
of stratified squamous cells, 0 pg/ml (PBS control)(A-C), 1 yjg/ml (D-F), 5 pg/ml 
(G-l), 10 pg/ml (J-L) of mitomycin C were added to the oesophagus at day 4 of 
culture for 24 hr. After treatment, the cultures were then switched back to 
normal culture medium until day 9 and stained for K14 (green, FITC) and Ki67 
(red, TR). PBS controls expressed many Ki67 positive cells on day 9 of culture. 
Many Ki67 expressing cells were found in the 1 pg/ml mitomycin C treated 
cultures (E, F) and a few in the 5 pg/ml treatment (H, I), but none were found in 
the 10 pg/ml cultures (K, L). Despite the inhibition of proliferation, K14 is still 
expressed in the epithelium treated with the mitomycin C. Again, (C, L) are 
grazing sections through the basal layer. Setting the area of the PBS control as 
1, the relative area for 1 M9/m|. 5 pg/ml and 10 pg/ml mitomycin C treated 





In this chapter, I examined the cellular origin of the stratified squamous 
epithelium in the developing mouse oesophagus. The organization of stratified 
squamous tissues such as the epidermis has been intensively studied in 
recent years and is quite well understood (Watt et al., 1989; Byrne et al., 1994; 
Jensen et al., 1999). But in the oesophagus, the embryonic origin of the 
stratified squamous basal layer has not been resolved. Although it has been 
proposed that it derives from the original columnar tissue (Thorey et al., 1993), 
direct evidence for this has so far been lacking.
In terms of the mechanism of the switch, I have shown that the basal layer 
cells do indeed derive directly from the former columnar cells. This was done 
by three methods, first by showing the co-expression of keratin 8 and 14 in 
some cells (both in vivo and in vitro)] second by performing Dil labelling of 
columnar cells, which later show co-expression with K14, and third by showing 
the activation of the K14 promoter in some basal cells expressing K8. I have 
examined the possibility of an overgrowth of one cell type by the other by 
examining both the cell death and the cell division. Cell death does occur but in 
both populations to about the same extent. Moreover if cell death is inhibited, 
the change in phenotype still takes place as normal. Similarly I show that cell 
division is not necessary for the change, although under normal circumstances 
a high proportion of the cells are dividing.
4.8.2 Migration of the stratified squamous progenitor ceils
An alternative possibility to the direct conversion of columnar to basal stratified 
cells is that the squamous epithelium cells arise from progenitors outside of the
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oesophagus. The best potential site is the oral cavity that is derived from the 
ectoderm and endoderm, and forms stratified squamous epithelium earlier 
than the oesophagus (Waterman and Balian, 1980). My results show that if 
there is any migration from another site, the cells would have to migrate into 
the oesophagus before E11.5d since in the cultures the tissue is isolated 
around this time. It would also be a prerequisite that the progenitor cells do not 
express the stratified squamous markers at the time of migration, as we do not 
see them in either tissue from embryos or in the cultures system until after 
E15.5.1 cannot exclude the possibility that some cells do migrate in at an early 
stage, or that the cells that make the transition from columnar to squamous are 
a separate population that migrated in before E11.5, although there is no 
evidence for either of these possibilities.
4.8.3 Significance of columnar ceil loss
Simple columnar cells die by apoptosis if they are detached from the 
extracellular matrix (Gilmore et al., 2000). This is different from stratified 
squamous epithelia where the cells remain metabolically active for several 
days after they detach from the basal lamina (Fuchs and Raghavan, 2002). 
Generation of a single cell suspension using our method may result in a high 
proportion of dead cells in the K14 or K8 positive fractions and may lead to an 
over representation of the true death rate of the cells in culture. However, the 
same manipulation on these two populations of cells after four repetitions 
should make them still comparable. From the results comparing the dead cells 
treated with the caspase inhibitor and the DMSO controls (Fig 4.6) show that 
some of the cells are lost by apoptosis. However, the loss of columnar cells in 
the oesophageal epithelium is at least not dependent on the
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caspase-mediated programmed cell death; this would suggest that loss of the 
columnar phenotype is through columnar gene regulation. I will try and identify 
the molecular controls for regulating columnar gene expression in the next 
chapter.
4.8.4 Columnar cells and apoptosis
One important function of the simple columnar keratins is that they are both 
targets and modulators of apoptosis (Caulin et al., 1997; Caulin et al., 2000). 
K18 is one of the earliest targets of caspase 3 and caspase 7 (these caspases 
are enzymes that cleave substrates and lead to apoptosis). After the activation 
of caspase 3, apoptosis will progress and reach a point of no return 
(Hengartner, 2000). It is likely that the fragmentation of K18 filaments by 
caspases may help apoptotic cells be cleared from the epithelial sheet by 
allowing the keratin network to be dismantled. It has also been reported that 
K8 and K18 are involved in attenuating and desensitising the apoptotic stimuli 
mediated by tumour necrosis factor-a by binding to the downstream TNFR 
effector-TRADD (Inada et al., 2001). K8 and K18 also modulate the Fas 
receptor mediated apoptosis involved in hepatotoxin induced apoptosis by 
acting as the substrate for c-Jun N-terminal Kinase. K8 and K18 acting as the 
substrates for JNK has the affect of sequestrating JNK and prevents it from 
phosphorylating c-jun, thereby interferes the Fas receptor signalling (He et al., 
2002). This evidence shows that the simple columnar intermediate filaments 
have a role in both regulating and being regulated by programmed cell death.




Previous work has attempted to locate the stem cell compartment in the 
epithelium of the adult human oesophagus. Seery and Watt described the 
papillary and interpapillary architecture of the mature human oesophageal 
epithelium (Seery and Watt, 2000). They demonstrated Ki67 expression in few 
papillary basal cells (45 out of 10,865) and even fewer in the interpapillary 
basal layer (9 out of 8,811). Not surprisingly, this compartmentation is not seen 
in the embryonic cultures, as the papillary structure is yet to develop. In the 
later cultures with fully stratified epithelium we find that all of the dividing cells 
are in the basal layer (Fig 4.7), whereas Seery and Watt found some dividing 
cells in the epilayers 2-3 cells above the basal layer in the mature human 
tissue.
4.8.6 Is it transdifferentiation?
In our case, the conversion of simple columnar to a stratified squamous tissue 
in the oesophagus probably does not require cell division as some K14 positive 
cells are Ki67 negative. However, in the current understanding of the stem cell 
population in the oesophagus / stratified squamous tissue, it is unlikely that all 
cells that have changed to stratified squamous phenotype in Fig 4.8 L are stem 
cells. This presumably means the non-progenitor (or at least, the partly 
differentiated) cell types will undergo transdifferentiation into the stratified 
squamous basal layer phenotype. Therefore from the results I have gathered, 
that cell division and cell death are not essential for our case of the conversion 
to occur, we would rather think this is more like a true transdifferentiation 
event -  which is from a relatively differentiated phenotype (not the progenitor / 
stem cell population) directly changing to another differentiated phenotype.
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4.8.7 Conclusions and the way forward
From the results of the current study, we may analyze the strength of each 
experiment to support the following two hypotheses: (a) whether the 
oesophageal epithelia developed is by a direct cell type change from columnar 
to stratified squamous or (b) are there two types of progenitor cells co-existed 
in the embryonic epithelium.
Table 4.1 Experimental evidence to support the two hypotheses of the origin of 
the stratified squamous epithelial cells.
Experiments direct transdifferentiation 2 progenitor cells
Co-incidental staining +++ + (there might still be adult K14 
cells not originally from the 
co-stained cells)
K14-GFP electroporation ++++ + (there might still be adult K14 




++++ + (cannot completely rule out the 
possibility of other outcome of the 
columnar cells fate, e.g. they 
might migrate out)
Growth inhibition study ++++ - (ruled out the hypothesis of cell 
replacement by another source of 
stratified squamous stem cell)
DNA methylation result 
(Fig 5.3 F and H)
++++ (by inhibiting DNA 
methylation which causes 
the natural loss of K8 , we
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see large scale K14 and K8 
co-expression at the basal 
layer)
From the results in the present chapter, I have shown using an oesophageal 
culture model that of the columnar cells convert to a stratified squamous 
phenotype probably through direct transdifferentiation. The next question in 




Chapter 5 Signalling and the conversion of oesophageal columnar to 
stratified squamous epithelium
5.1 Introduction
In the earlier chapters, I described the phenotypic changes from simple 
columnar to stratified squamous in the developing oesophageal epithelium. I 
demonstrated that the full differentiation program of a stratified squamous 
epithelium becomes established and showed that the stratified squamous 
epithelium comes directly from the simple columnar cells rather than via 
outgrowth of another cell population. Furthermore, inhibition of cell death or 
cell proliferation does not affect the transition from a columnar to stratified 
squamous phenotype.
In this chapter, I will focus on the following questions:
(a) Is the mesenchyme required for the transition?
(b) Do Wnt and Shh signalling regulate this process?
(c) Is there epigenetic regulation of columnar genes?
The aim of the experiments described in the present chapter is to determine 
the possible signalling mechanisms that control down-regulation of columnar 
genes and the up-regulation of stratified squamous genes.
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5.2 Role of mesenchyme and Wnt I Shh signalling in the conversion
5.2.1 Overview
5.2.1.1 Epithelial-mesenchymal interaction
It is generally thought that the dermal region is important for instructing the 
ectodermal layers immediately above to gain the stratified squamous tissue 
identity (Byrne et al., 1994). For example, at E9.5, dermomyotome derived 
from the somite region provides signals to the ectodermal cells lying just above 
it to express K5 (Byrne et al., 1994). I wanted to test the idea that the 
mesenchymal region surrounding the oesophagus epithelium affects the 
differentiation of the stratified squamous epithelium. It has recently been found 
that the thickness of mesenchymal layers in embryonic liver cultures is 
reduced when cultured with Keratinocyte-serum free medium (KSFM) 
(Wan-Chun Li, personal communication). I tried culturing embryonic oesophagi 
in KSFM to see if I could reduce the mesenchymal layers and therefore the 
columnar to stratified squamous transition.
5.2.1.2 Morphogen signalling
To further address which signals might be emanating from the mesenchyme to 
the epithelia, and the effects they might have on the formation of the stratified 
squamous epithelium, I tried inhibitors and activators of two important 
signalling pathways - the Wnt pathway and the Shh pathway, (these were 




5.2.2.1 Keratinocyte Serum-Free Medium (KSFM) and mesenchymal layers 
The simplest approach to understanding whether the mesenchyme 
surrounding the epithelium controls the switch from simple columnar to 
stratified squamous epithelium is to mechanically remove the mesenchyme at 
the outer layers of the oesophageal epithelium. However, mechanically 
removing the mesenchymal layers at the E11.5 stage proved very difficult 
without damaging the epithelium. This is partly because there is only 1 layer of 
epithelial cells and the mesenchymal and pre-muscular layers are very thin. An 
alternative approach is to use a defined medium to suppress mesenchymal 
growth. The culture medium keratinocyte serum free medium (KSFM), when 
supplemented with epidermal growth factor (EGF) and bovine pituitary extract 
(BPE) (here named as KSFM+EGF+BPE), is suitable for keratinocyte 
(epidermal epithelium) outgrowth but does not support growth of mesenchymal 
cells (dermal cells) and is usually used for long term primary keratinocyte 
culture (Ura et al., 2004). Culture of E11.5d oesophagus for 7 days with KSFM 
plus 25 ng/ml recombinant human EGF and 25 pg/ml BPE (see section 2.2), 
reduced the thickness of the mesenchymal layers (Fig 5.1 A-F). Whether this 
was the result of loss of specific mesenchymal layer(s), or the result of specific 
mesenchymal cell types migrating out of the culture, or by a change to a 
smaller cell size in these layers, needs to be further investigated. Mesenchyme 
cells were stained with smooth muscle actin antibody (SMA, shown here in red, 
Fig 5.1 B-F). Morphologically, the treated oesophageal cultures appeared 
longer in length than the untreated cultures (Fig 5.1 A, G, I). This was probably 
due to less mechanical constraint of the mesenchymal and muscular layers on 
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Fig 5.1 Effect of KSFM on oesophageal mesenchymal layers and epithelial 
differentiation.
Oesophagi were cultured in KSFM supplemented with EGF and bovine 
pituitary gland extract for 7 days. Morphologically, the oesophagus cultured in 
KSFM elongated and did not contain many mesenchymal layers (A, I). Dual 
immunostaining of E-cadherin (FITC, green) and SMA(TRITC, red) (B-F) were 
performed to demonstrate the relative location and morphology of the 
oesophageal epithelium and mesenchymal layers on different levels of the 
oesophagus. p63 (FITC, green) and K10 (TRITC, red) were co-stained (G, H) 
to show the basal layer and suprabasal differentiation of the stratified 
squamous epithelium. K14 (FITC, green) and K8 (TRITC, red) were stained 
(J-L) to show the formation of the basal layer of the stratified squamous 




To examine whether reduced thickness of mesenchymal layers influenced the 
switch from K8 to K14 expression at the basal layers, and whether a further 
differentiation process of a stratified squamous epithelium is affected, I stained 
p63 and K10 (Fig 5.1 G, H) or K8 and K14 (Fig 5.1 l-L) in control and 
KSFM+EGF+BPE treated oesophageal cultures. p63 expression remains the 
same as control (compare Fig 5.1 H with Fig 6.5 P), while the other markers 
such as K14 and K10 were expressed slightly earlier than normal control (for 
example, compare Fig 5.6 J-L with Fig 3.6 D for K14 and K8 expression, and 
compare Fig 5.6 H with Fig 3.7 D, E for K10 expression). No spatial 
discrepancy is found between normal serum-containing medium and in KSFM 
culture medium. At day 7 of KSFM culture, K14 is expressed in all basal cells 
(Fig 5.1 K, L), K8 cells disappeared at the basal layer, and K10 cells expressed 
at suprabasal layers (Fig 5.1 H). Remarkably, almost all K8 positive cells at the 
suprabasal layers have disappeared as early as day 7 of KSFM culture (Fig
5.1 K, L), K8 usually disappears after 15 day culture under normal 
serum-containing medium (Fig 3.6 G, H), suggesting the reduction in 
mesenchyme thickness has changed the microenvironment and accelerates 
differentiation of the epithelium.
In conclusion, the mesenchymal thickness of the oesophageal culture is 
reduced after 7 days in KSFM and the formation of a stratified squamous is 
accelerated. The question then, is what signals from the mesenchyme are 
important for oesophagus epithelial development?
5.2.2.2 Wnt signalling in the developing oesophagus
I tested the effects of two important signalling pathways, the Wnt and Shh
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pathways, in the epithelial development of the oesophagus.
To investigate the function of Wnt signalling in the oesophageal epithelium, I 
first examined the expression of E-cadherin and P-catenin both in vivo (Fig 5.2 
A, D) and in vitro (Fig 5.2 B, C, E-G). I compared E-cadherin (Fig 5.2 A) and 
p-catenin (Fig 5.2 D) staining in adult mouse oesophagus. In the adult mouse 
oesophagus, E-cadherin localised to the epithelial membrane, while p-catenin 
was present in the epithelial and the muscle region but not clearly expressed in 
the submucosal layers immediately below the epithelium. The staining also 
showed the same distribution of E-cadherin in the epithelial region, and 
P-catenin in both the epithelial and mesenchymal region of the E11.5 
oesophageal 7d culture (Fig 5.2 B,C vs Fig 5.2 E,F). Immunostaining in the 
oesophagus showed that P-catenin localises mostly with the structural 
E-cadherin protein near the cell surface. However, p-catenin could not be 
found in the nucleus even under extensive examination at higher 
magnification.
Lithium is known to inhibit GSK3p (Klein and Melton, 1996; Doble and 
Woodgett, 2003). GSK3P is the main kinase in the degradation complex to 
phosphorylate p-catenin and ensure its degradation. Addition of LiCI to the 
oesophageal culture was performed to investigate the involvement of the 
canonical Wnt pathway in the conversion of oesophageal epithelium from 
simple columnar to stratified squamous (see section 2.2). To my surprise, I still 
did not find any evidence of nuclear p-catenin in the treated culture (Fig 5.2 G), 
even when I looked at different layers of the culture using z-stack imaging on 
the confocal microscope. This may be because the antibody is not sensitive 
enough to detect the nuclear signal in the organ culture system. The normal 
distribution of the basal K14 cells and suprabasal cells (shown as K8 positive
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cells) in the oesophagus culture is affected by 6 days of treatment with 20 mM 
LiCI (Fig 5.2 I) compared to control treatment of 20 mM of NaCI (Fig 5.2 H). 
Under these conditions, K14 no longer labels the entire basal layer but was 
found expressed sporadically in basal cells and is reminiscent of disorganised 
foci of a glandular structure (e.g. salivary gland). In contrast, K8 expression 
and distribution in the LiCl-treated cultures was no different compared to the 20 
mM NaCI culture (Fig 5.2 H). These results suggest canonical Wnt signalling 
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Fig 5.2 Activation of canonical Wnt signalling and inhibition of Shh signalling in 
E11.5 cultured oesophagus.
Immunostaining of E-cadherin (A-C) and p-catenin (D-F) on adult mouse 
oesophagus (Fig 5.2 A, D) or 7 day cultures of E11.5 oesophagi (B, C, E-G). 20 
mM LiCI was added for 6 days to the 7 day E11.5 oesophageal culture, and 
then stained for p-catenin (G, FITC, green), or K8 (TRITC, red) and K14 (FITC, 
green) (I). 20 mM NaCI was added 6 days to the 7 day E11.5 oesophageal 
culture as control and stained for K8 and K14 (H). Note the E-cadherin only 
stains the membrane of the epithelial cells, while p-catenin is expressed in the 
mesenchymal as well as in the epithelium, but is not detected in the nucleus. 
The normal distribution of the basal K14 and the suprabasal K8 in the 7 day 
cultured oesophagus is disorganised. 0.6% DMSO (J) or 1 pM cyclopamine (K, 
L) was added for 6 days to the 7 day E11.5 oesophagus culture. K8 (TRITC, 
red) and K14 (FITC, green) were stained. The transition of the oesophageal 
epithelium from simple columnar to stratified squamous was not affected.
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5.2.2.3 Shh signalling in the developing oesophagus
As previously mentioned (section 1.2.4), Shh is important in the bifurcation of 
the oesophagus and the trachea and lung. To investigate whether Shh still has 
a function after the separation of the oesophagus and trachea, and to 
determine whether it is the signal that induces the switch from simple columnar 
to stratified squamous epithelium, I added the Shh inhibitor-cyclopamine to 
E11.5 oesophageal cultures for 6 days. Cyclopamine is a steroidal alkaloid that 
blocks the hedgehog pathway by directly binding to Smoothened (Chen et al., 
2002). Compared to the DMSO control, inhibiting the hedgehog pathway with 
cyclopamine did not affect the expression of stratified squamous markers and 
the relative structure of the oesophageal culture seems unchanged (Fig 5.2 J 
cf. K, L), the basal marker of the stratified squamous - K14 is expressed at the 




5.2.3.1 The role of mesenchymal cells in the differentiation of the stratified 
squamous epithelium
In the current chapter, I tried to establish the influence of the mesenchymal 
cells on the development of the oesopageal epithelium. By reducing the 
mesenchymal layers of the oesophagus cultured in a non-serum medium, 
there is an acceleration of the differentiation rate in the oesophagus culture. By 
adding LiCI to perturb the Wnt signalling important in both the epithelium and 
mesenchyme of the gut, I find phenotypic changes of the epithelial morphology. 
Both lines of evidence demonstrate that the mesenchyme play an important 
role in the maturation of the oesophagus epithelium.
From the results shown in Fig 5.1, it is possible there are inhibitory signal(s) 
emanating from the mesenchyme that delay the differentiation of the 
epithelium. After 7 days of culture in KSFM, there are fewer (or smaller) 
mesenchymal cells and this is accompanied by premature expression of K10 
and early loss of K8 (Fig 3.6 D, H and Fig 3.7 D-F). These results demonstrate 
that there is premature differentiation of the oesophageal stratified squamous 
epithelium when the mesenchymal thickness is reduced. One possible 
explanation is that some of the components of the KSFM medium and/or the 
supplements (i.e. EGF and pituitary extract) directly stimulate and accelerate 
the epithelial differentiation. This could be further examined by adding EGF or 
the pituitary extract into the normal culturing medium - BME with 20% of fetal 
calf serum or try the KSFM without supplement and examine the differentiation 
markers during different time points. However, I did not proceed further with 
this investigation as we do not have the composition of KSFM medium and 




Addition of LiCI seems to have an effect on cellular composition in the 
oesophageal bud culture. LiCI is an inhibitor of GSK3 (Klein and Melton, 1996; 
Doble and Woodgett, 2003), and probably acts through competition of Mg2+ 
ions that are normally required for the enzyme. GSK3 is involved in many 
different signalling pathways, such as the Wnt / p-catenin and the hedgehog 
pathway. It has many substrates and is known to phosphorylate p-catenin, Axin 
and APC in degrading the cytoplasmic p-catenin in the Wnt signalling pathway. 
GSK3 in concert with casein kinase 1 (CK 1) and protein kinase A (PKA), 
phosphorylates Ci leading to cleaving Ci into its inactive form.
LiCI is also known to inhibit the function of inositol monophosphatase and 
inositol polyphosphatase, thereby leading to a decreased 
inositol-1,4,5-trisphosphate response (Berridge et al., 1989). This inhibition 
prevents both recycling of inositol from inositol phosphates and de novo 
inositol synthesis, and can be overcome by extracellular inositol. While 
production of inositol and function of GSK3 are both inhibited by LiCI at the 
concentration of milli-molar range, I did not examine further on the production 
of inositol-1,4,5-triphosphate. To address how the cellular composition is 
altered by the addition of LiCI, further work should be done to first rule out the 
involvement of the inositols, then address which signalling pathway(s) (such as 
Wnt or Hh, or probably other signalling pathways) that involves GSK3P is the 
main cause of this change. However, from the preliminary results of blocking 
the Hh pathway by cyclopamine, inhibiting Shh does not seem to affect the 
transition and cellular composition during embryonic oesophagus development. 
Without the evidence for nuclear Gli staining (negative data, not shown), the
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Epigenetics, in contrast to genetics, is defined as meiotically and mitotically 
heritable changes in gene expression that are not coded in the DNA sequence 
itself. DNA methylation, RNA-associated silencing and histone modification, 
are used to initiate and sustain epigenetic silencing (Egger et al., 2004). The 
role of epigenetic influences in embryonic development and organogenesis 
has been under intensive investigation (Li, 2002). Epigenetic mechanisms 
regulate many stages during development including correct gene expression in 
the embryonic stem cells, extra-embryonic tissue, pre-implanting and 
gastrulating embryos and during spermatogenesis. DNA methylation is also 
found to be responsible for the maintenance of genomic imprinting, and other 
aspects of development including gut organogenesis. Inhibitors of DNA 
methylation such as 5-aza-cytidine and 5-aza-deoxycytidine bind to DNA 
methyltransferases (Dnmt) and inhibit their function. Inhibitors of histone 
deacetylase (HDAC) are such as phenylbutyric acid. These are powerful 
chemicals affecting normal epigenetic process and are now being explored for 
clinical applications to suppress abnormal gene repression (Egger et al., 2004). 
Knockout mice for genes required for de novo methylation of DNA (Dnmt3a, 
Dnmt3b) are either embryonic lethal or the embryo dies soon after birth (Okano 
et al., 1999). Another DNA methyltransferase, Dnmtl, is responsible for the 
maintenance of the methylated status of the DNA (Lei et al., 1996), the 
homozygous knockout of Dnmtl causes developmental arrest and the 
embryos die at around E8.5. There is also evidence showing the Dnmts
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co-operate in the maintenance of DNA methylation (Liang et al., 2002).
5.3.1.2 DNA methylation and changes in cell fate
Misexpression of genes could result after treatment of the DNA methylation 
inhibitor-5-Aza-2 deoxycytidine (5-Aza2C). This would imply undoing the 
inhibition of gene expression by DNA methylation will cause unexpected genes 
to be expressed. This might, on occasion, cause a metaplasia. For example, 
adding 5-AzaC to fibroblast cell lines such as C3H 10T1/2 or NIH3T3 causes 
them to differentiate into a variety of cells including skeletal muscle cells, 
adipocytes or chondrocytes (Taylor and Jones, 1979; Konieczny and Emerson, 
1984; Boukamp, 1995). There are cases when a teratocarcinoma-derived 
fibroblast expressed K14, and sometimes EndoA (also known as Keratin 8, 
TROMA-I), or even markers of corneocytes after the addition of 5-AzaC 
(Darmon et al., 1984), presumably as a consequence of a 
mesenchymal-epithelium conversion induced by 5-azacytidine. This is 
probably caused by inhibiting the effect of DNA methylation and re-activating 
specific epithelial differentiation genes (or their inducers) in fibroblasts (Semat 
et al., 1986).
The first intron of the K18 gene is found to be one of the regulatory regions that 
transcription factors bind to and exerts its activating or repressive activities 
(Neznanov and Oshima, 1993). An unmethylated CpG island was found at the 
first exon where other heavily methylated CpG surrounds and there is a 
binding site for the transcription factor Ets at the 1st intron where the boundary 
lies. The Ets element was found differentially methylated in tissues that 
normally do not express K18 such as spleen. Transgenic mouse with 2 bp 
mutation at the Ets binding site enhances the mis-expression of K18 in spleen
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and heart probably by disrupting the methylated sequence (Umezawa et al.,
1997).
Since the mechanism for loss of columnar cells in the oesophagus does not 
seem to be attributable to cell death (Fig 4.6), it presumably requires a 
repression of columnar gene activity. I tested the hypothesis that de novo DNA 
methylation is the major cause for the columnar genes to be silenced in both 
the basal layer and the suprabasal layers during the transition process by 




5.3.2.1 Basal and suprabasal K8 gene silencing
I began by asking if inhibition of DNA methylation altered the loss of the basal 
K8 expression in E11.5d oesophagus cultures (Fig 5.3 E-H). The basal layer of 
E11.5d oesophagus treated with 5-azacytidine (5-AzaC) for 6 days expressed 
the stratified squamous marker K14 as normal (Fig 5.3 A, B, D, E, F, H). 
However, compared with the loss of K8 marker at the basal layer in the normal 
oesophageal cultures (Fig 5.3 C), the treated oesophagus retained the basal 
K8 expression (Fig 5.3 G). This result was reproduced by treatment of 
oesophageal cultures with the more stable compound 5 -aza-2 -deoxycytidine 
(5-Aza-2C). 5-Aza-2C is dissolved in DMSO and I used that as control. 6 days 
of treatment with 5-Aza-2C results in the retention of the K8 expression at the 
basal layer (Fig 5.3 J), and K14 expression was not affected by inhibition of 
DNA methylation.
I extended the study to later stages of the culture period to see whether the 
suprabasal layer K8 expression is also regulated by DNA methylation. 
5-Aza-2C was added on day 8 of culture and continued for 12 days, this is after 
the transition from K8 to K14 at the basal layer, but before the columnar K8 
disappears at the suprabasal layers. Surprisingly, 5-Aza-2C had a dramatic 
effect on the suprabasal expression of K8. At the end of the 12 days treatment, 
when normally none or very few K8 cells were left at the suprabasal layers (Fig
5.12 K), I find most cells including some basal cells strongly expressed K8 (Fig
5.12 L), This result suggests DNA methylation is the mechanism for the 





Fig 5.3 The K8 gene is silenced in oesophageal cultures via de novo DNA 
methylation.
E11.5 oesophagi were cultured for 24 hrs and then treated for 6 days with 
5 -aza-cytidine (5-AzaC) (E-H) or 5 -aza-2 -deoxycytidine (5-Aza-2C) (J, L). Or 
cultured for 12 days and treated from day 12 to 20 with 5-Aza-2C (K, L). PBS 
was used as control for 5-AzaC (A-D) and 1% DMSO was used as control for 
5-Aza-2C (I, K). Fig 5.3 C, D and Fig 5.3 G, H are magnified from the same 
area shown by the boxes in Fig 5.3 B and F, respectively. Normally, K8 
expression in the basal layer of oesophageal epithelium is reduced and few K8 
positive cells are found. After adding DNA methylation inhibitors, the K8 cells 
are retained in the basal layer at day 7 and K14 expression is not inhibited 
(compare arrows in C-G and l-J). The DNA methylation inhibitors also prevent 
silencing of the suprabasal K8 genes when added to the cultures at the time 
after the basal layer has switched to stratified squamous tissue and cultured 





In this part, I wished to address whether the loss of columnar K8-positive cells 
was due to the suppression of K8 expression. Since it is known that DNA 
methylation is involved (at least in some cases) for the loss of K18 gene 
expression (see below), I tried adding the DNA methylation inhibitors to the 
cultures to see whether the columnar gene K8 is also silenced in the process 
of the oesophagus epithelial columnar to stratified squamous switch. I found 
that DNA methylation does control the loss of K8 but not the gain of K14 in the 
basal oesophageal epithelium (Fig 5.3 C cf G). It is somewhat surprising, 
however, that the silencing mechanism also acts on the suprabasal layers (Fig
5.3 K cf. L).
5.3.3.2 DNA methylation of columnar genes
DNA methylation had already been implicated in the regulation of the mouse 
K18 gene (Darmon, 1985). A cultured myoblast cell line treated with 
5-azacytidine results in the induction of K18 gene. It would be of interest to 
understand how de novo DNA methyl-transferases (DNMT3a and 3b) were 
induced in the cultured oesophagus model, it is also of interest to determine 
whether they act directly on the enhancer/promoter region of K8 or do they act 
upon some other upstream mechanism to control columnar gene silencing? 
This would mean searching the controlling elements (CpGs) in K8 regulatory 
regions (Tamai et al., 1991) that has similar functional mode of Ets elements 
controlling K18 repression in the spleen and muscle. So far, we cannot rule out 
that there are still major changes in the context of nuclear factors during the 
switch and it may be a combined effect of genetics and epigenetics on the
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repression of columnar genes. There are other transcription factors such as 
Ets members important in regulating K8 and K18 expression. These are Ets-1, 
Ets-2 and ESE-1 which are activators enhancing the expression of K8 
(Hamazato et al., 1993; Umezawa et al., 1997), and Elk-3 which acts as an 
repressor for the expression of K8 (Nozaki et al., 1996). The oesophageal 
culture system provides a good model for study DNA methylation and its 
impact on animal development.
5.3.3.3 Is the columnar to stratified squamous a single process?
From our understanding of the initiation of the oesophageal stratification 
process, there is a down-regulation of the simple columnar genes (note that 
the two columnar markers K8 and K18 were shown in Fig 3.4) at the basal 
layer followed by up-regulation of stratified squamous genes, which leads to 
the cascade of events of epithelial differentiation and stratification. Whether the 
two actions are co-ordinately regulated is not known. However, the DNA 
methylation inhibition study showed that at least in the down regulation of the 
columnar genes in vitro, this process can be separated from the induction of 
stratified squamous genes (Fig 5.3 F, H, J). The preservation of the K8 
expression in cells over the entire basal layer following inhibition of DNA 
methylation (inhibition of columnar gene silencing) also proves that the K14 
cells are derived from K8-positive cells. These results also suggest that all 
K14-specific progenitor cells probably originate from cells expressing the K8 
gene (Fig 5.3 G, H). Combined with the results of KSFM treatment (section 
5.2.2), there is a remote suggestion that the silencing mechanism might be 
controlled by secreted factor(s) originating from the mesenchyme, i.e. when 
there are less mesenchymal cells, the conversion process accelerates and the
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columnar genes are silenced earlier (Fig 5.1 J-L).
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Chapter 6 Molecular basis of the conversion of columnar to stratified 
squamous epithelium in the developing oesophagus
6.1 Expression profile of candidate transcription factors
6.1.1 Introduction
6.1.1.1 Candidate transcription factors
In order to identify candidate transcription factors that might be responsible for 
the switch from columnar to stratified squamous epithelium, I examined a 
number of examples from the literature. Unfortunately, molecules and 
signalling pathways extensively examined for stratified squamous 
differentiation (the most common one is the epidermis) are mostly responsible 
for the process after initiation of a stratified squamous epithelium formation, 
which is further down the progression along the induction of a multi-layered 
stratified squamous tissue (reviewed in Fuchs and Raghavan, 2002). However, 
recent evidence showed there might be transcription factors responsible for 
the columnar to stratified squamous switch (reviewed in Fuchs and Raghavan, 
2002). The candidates include AP-2a, C/EBPa, C/EBPp and p63. I 
investigated the expression of transcription factors at the time when the 
transition begins and determined their location in layers of stratified squamous 
epithelium. I used a combination of RT-PCR and immunostaining to 
characterise the spatial and temporal expression of these transcription factors 
in the oesophagus. This allows us to gain more detailed information on the 
molecular basis of the switch from columnar to stratified squamous tissue.
6.1.1.2 AP-2
Currently, there are 5 members in the mammalian AP-2 transcription factor
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family: AP-2a, AP-2p, AP-2y, AP-25 and AP-2e. AP-2 has a basic 
helix-turn-helix domain at its C-terminal involved in dimerization and 
sequence-specific DNA binding (see Fig 6.1 (A)) (Tummala et alM 2003). AP-2 
transcription factors play an important role in regulating gene expression 
during development and differentiation of multiple organs (Hilger-Eversheim et 
al., 2000). Known target genes of AP-2 include the SV40 enhancer region 
(Mitchell et al., 1987), c-myc (Gaubatz et al., 1995), p21 WAF/CIP (Zeng et al., 
1997), c-kit (Huang et al., 1998) and HER-2/neu (Bosher et al., 1995; Bosher 
et al., 1996). AP-2 is abundantly expressed in the skin and regulates the 
expression of many epidermal keratin genes (Leask et al., 1990; Leask et al., 
1991) In Xenopus, a transcription factor found in nuclear extracts from 
embryos called KTF-1 activates the epidermal keratin gene XK81A1 (Snape et 
al., 1990). Later proven by Leask et al., KTF-1 in Xenopus (or KER-1 in 
humans) is actually the same AP-2 (Leask et al., 1990; Leask et al., 1991). 
AP-2a is important in the expression of K14 in the basal layer of stratified 
squamous epithelium (Leask et al., 1991), and functionally active binding sites 
of AP-2 exist in many epidermal genes (Byrne et al., 1994; Luo et al., 2002). 
AP-2 can act as an activator or a repressor depending on the target gene. For 
example, AP-2 acts as activator for genes such as p21 WAF/CIP (Zeng et al.,
1997), HER2/neu (Bosher et al., 1995; Bosher et al., 1996), c-kit (Huang et al.,
1998) and many of the keratinocyte-specific genes, but down regulates the 
expression of c-myc (Gaubatz et al., 1995), keratin 3 (Chen et al., 1997) and 
MCAM/MUC18 (Bar-Eli, 2001).
AP-2 is probably best known as a tumour suppressor gene. In melanoma cells, 
AP-2 up-regulates p21, c-kit and E-cadherin expression (Bar-Eli, 2001). These 
genes are important in controlling cell cycle progression, mediating cellular
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differentiation, maintaining the epithelial integrity and inhibiting metastasis 
(Bar-Eli, 2001). AP-2 also down-regulates the expression of MCAM/MUC18, a 
surface marker for melanoma, and the proto-oncogene - c-myc.
The repression of c-myc is probably because AP-2 directly inhibits the DNA 
binding activity of c-myc. AP-2 competes with an overlapping DNA binding site 
next to E box elements (the usual c-myc DNA binding site) (Gaubatz et al., 
1995). Also, the C-terminus of AP-2 interacts with the dimerization domain of 
c-myc and impairs c-myc DNA binding activity. A similar mechanism was found 
where the AP-2 binding site is next to and overlaps with other transcription 
factor binding sites, such as neighbouring SP1 elements in the regulation of 
the corneal keratinocyte specific gene-keratin 3 (Chen et al., 1997).
AP-2 can also be activated by oncogenes, as well as activating oncogenes. 
AP-2 is found in breast tumour cells to activate the c-erbB-2, HER2/neu 
receptor, which is seen as an oncogene and is related to breast cancer. 
Although AP-2 RNA is induced by the oncogene n-ras in teratocarcinoma cells 
(Kannan et al., 1994), however the transactivation activity of AP-2 is inhibited 
(Kannan et al., 1994; Kannan and Tainsky, 1999). In short, the AP-2 family is 
closely linked to activities of controlling cell cycle and regulation of apoptosis 
(Hilger-Eversheim et al., 2000).
It is not entirely understood whether different AP-2 isoforms are redundant or 
have specific functions in tissues where their expression overlaps. From the 
study of knockout mice of individual isoforms of AP-2, it was found that AP-2a 
knockout mice showed defects in craniofacial skeletal formation, cranial neural 
tube closure, failure in body wall closure, defective formation in organs such as 
lens and die perinatally (Schorle et al., 1996; Zhang et al., 1996). However, the 
AP-2p knockout mice were found to have rather different defects specifically in
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the kidneys, and they are probably due to apoptotic cell death of the renal 
epithelium rather than failure of kidney cell differentiation (Moser et al., 1995; 
Moser et al., 1997). The AP-2& knockout mice die of polycystic kidney disease 
shortly after birth.
In stratified squamous epithelium, AP-2 isoforms are found in different cell 
types. AP-2a is found predominantly in the basal layer. AP-2B, an alternative 
spliced inhibitory form of AP-2a is found expressed in the mesenchyme 
underneath the basal layer (Byrne et al., 1994). AP-2y is expressed in all 
layers of the epidermis, and can activate a cystein proteinase inhibitor-cystatin 
A expressed in the cornified layers (Takahashi et al., 2000). Recently, AP-2e 
was also found to be highly expressed in the skin, and binds to the AP-2 
binding sites of the keratin genes in keratinocytes (Tummala et al., 2003).
It is assumed that the molecules involved in regulating differentiation of the 
epidermis will most likely do the same job in the oesophagus. AP-2a may 
induce differentiation of the epidermis and induction for K5 and K14 production. 
In vitro results have shown that AP-2a is necessary but not sufficient to induce 
K14 gene expression (Byrne et al., 1994). However, AP-2a knockout mice 
showed no apparent defect in the skin, and the keratin gene expression was 
unaffected (Talbot et al., 1999). The results suggest other members of the 
AP-2 family compensate for the loss of AP-2a. This in turn, makes it more 
difficult to decipher the function of AP-2 in the skin. AP-2a is an important 
factor in mediating and maintaining the expression of cytoskeleton of stratified 
squamous epithelium, I used AP-2a both as a positive control for testing 
induction of the K14 promoter and also examined whether it will repress K18 
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Fig 6.1 Diagrams showing the gene structure of AP-2 and p63 isoforms.
(A) Transcription factors of the AP-2 family have a common transactivation 
domain at the N-terminus, and a basic helix-span-heiix DNA binding and 
dimerization domain at the C-terminus. Adapted from Gene, Vol. 260, p1-12 
(Hilger-Eversheim et al., 2000). (B) p63 transcription factor has a similar 
transactivation domain, DNA binding domain and oligomerization domain as 
the transcription factor, p53. However, the many isoforms of p63 includes 
alternative transcription start site at the N-terminus giving rise to 
transactivating (TA) isoforms, transactivating star (TA*) and delta-N (AN) 
isoforms; and alternative splicing to either include the sterile-alpha motif (SAM) 
and the post-SAM (PS) domain or just the shorter C-terminus domains give 
rise to a, (3 and y isoforms. There are at least 6  different possible isoforms for 
the transcription factor p63. Adapted from Trends in Genetics, Vol. 18, p90-5 




AP-2 and members of the CCAAT/ enhacer binding protein (C/EBP) family of 
transcription factors co-ordinately control the expression of K1 and K10 
(Maytin and Habener, 1998; Oh and Smart, 1998; Zhu et al., 1999). C/EBPs 
are members of the leucine zipper family (bZIP) of transcription factors and are 
important in cellular differentiation. The C/EBP transcription factors are 
expressed in hepatocytes, keratinocytes, adipocytes and haematopoietic cells 
(Lekstrom-Himes and Xanthopoulos, 1998). In the epidermis, for example, 
C/EBP is expressed at the epithelium and was proved to be inhibitory to the 
basal layer specific a2 -integrin (a collagen receptor) (Corbi et al., 2 0 0 0 ).
Maytin et al. (1999) found that K10 is upregulated in suprabasal layers upon 
loss of AP-2a. The loss of AP-2 might be due to cells receiving differentiation 
signals as they migrate upward (Maytin et al., 1999). Additionally, Maytin et al 
(1998) found that AP-2a and C/EBPp are expressed at the basal layer of 
stratified squamous tissue, and C/EBPa and K10 are expressed in the 
suprabasal layers (Maytin and Habener, 1998). In adipocytes, AP-2 is known 
to repress C/EBPa, which is an important regulatory gene for adipogenesis 
(Jiang et al., 1998). Maytin et al. thus hypothesised that C/EBPp controls the 
expression of AP-2a which in turn represses the expression of C/EBPa at the 
basal layer. When the cells of the basal layer move upward, C/EBPp is no 
longer expressed and neither is the C/EBPa repressor-AP-2a. C/EBPa is 
activated and subsequently controls the expression of the differentiation 
marker K10. Furthermore, biochemical analysis demonstrates that C/EBP 
protein interacts with the K10 promoter (Maytin and Habener, 1998). However, 
there is contradictory evidence on the location of different members of the 
C/EBP family. Smart and colleagues also found that C/EBPs regulate
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expression of the early differentiation stratified squamous differentiation 
markers - K1 and K10 (Oh and Smart, 1998; Zhu et al., 1999). The main 
difference between the observations from the two groups is the location of 
C/EBPa and C/EBPp. Smart et al found that C/EBPa is expressed in the basal 
layer and C/EBPp is expressed in the suprabasal layers. They showed that it is 
the C/EBPp that inhibits the basal cell growth and induces early differentiation 
(activation of the K1 and K10 genes). But C/EBPp has no effect on other ‘late’ 
differentiation markers including involucrin and loricrin. A different source of 
C/EBPp knockout mice was used by Smart’s group compared to Haebner’s 
group. Morphologically, the skin of Smart’s knockout mice does show a 
thickened epithelia, mainly at the nucleated layers (basal, spinous, granular 
layers). More proliferating cells at the basal layer in the skin of C/EBPp 
knockout mice than the wildtype suggests C/EBPp's nature in promoting 
epidermal cell’s early differentiation and inhibit its proliferation. Based on these 
results, I wanted to investigate if any of the C/EBP transcription factors have a 
role in regulating expression of K18 and K14 genes during oesophagus 
development.
6.1.1.4 p63
p63 is a candidate for the master switch gene in the conversion of 
oesophageal columnar to stratified squamous epithelium. As a newly found 
member to the p53 family, p63 is ancestral in evolutionarily terms to the 
previously found p53 (Yang et al., 2002). Structurally, like p53, p63 has an 
acidic N-terminal transactivating domain, a highly conserved core DNA-binding 
domain, and a C-terminal oligomerization domain (see Fig 6.1 (B)) (Yang et al.,
1998). However, studying p63 is complicated because there are at least 6
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isoforms where there is only one single type of p53. The use of alternative 
promoters and transcriptional start sites, gives rise to an N-terminal 
transactivating (TAp63) and a non-transactivating (ANp63) isoform. In addition, 
alternative splicing creates three different C-terminal isoforms, designated a, (3 
and y (see Fig 6.1 (B)). p53 is an essential gene for cell cycle and apoptosis 
control, and mainly functions as a tumour suppressor gene but is not lethal 
when knocked out (Hall and Lane, 1999). Because of the essential need for 
p63’s functions established in knockout studies, scientists speculate p53 
evolved later than p63. Further evolutionary studies have confirmed this idea 
(Yang and McKeon, 2000; Yang et al., 2002).
p63 is normally expressed at the basal layer of epithelia that form stratified 
squamous tissue (Mills et al., 1999), e.g., epidermis, oesophagus and cornea 
(Yang et al., 1999). p63 is also expressed during the limb bud stage especially 
at the apical ectodermal ridge (AER). p63 is found in the epithelium of the 
urothelium and prostate, in the epithelium of secretory glands such as 
mammary, lacrymal and salivary glands and at the branchial arch during 
embryonic development. The p63 knockout mouse has no stratified squamous 
epithelia and the mice die soon after birth probably due to dehydration. There 
are no hind limbs and truncated forelimbs in the knockout mice and the teeth, 
hair follicles and mammary glands are missing (Yang et al., 1999; Mills et al.,
1999).
There is a debate about the function of p63 in the basal layer of the stratified 
squamous epithelium (McKeon, 2004). Is p63 crucial for the maintenance of 
the stem cell population in the basal layer, or does it determine the fate of 
stratified squamous cells? From the two groups that performed the knockout 
studies in mice, the exons containing the main DNA binding domain were
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either deleted or frame-shifted in the knockout mice (Yang et al., 1999; Mills et 
al., 1999). The results of these two groups are quite similar, with defects in limb, 
tooth and craniofacial formation, and apparent malformation of all stratified 
squamous tissue. However, there were some differences between the two 
models. First, terminal differentiation markers at the site of stratified squamous 
epithelium were detected by McKeon’s group but not Bradley’s group. Yang et 
al (1999) detected loricrin in the knockout mice and suspects that the function 
of p63 is in maintaining the stem cell population at the basal stratified 
squamous layer (Yang et al., 1999). Mills et al (1999) did not find any 
differentiated stratified squamous markers in the skin and naturally concluded 
that p63 is the epithelial master regulatory gene in the commitment to stratified 
squamous tissue (Mills et al., 1999).
The subtle phenotypic differences in the knockout mice could at least be partly 
explained by different functions of the p63 isoforms (Koster et al., 2004). The 
TAp63 isoform is first to be expressed during embryogenesis and is required 
for stratified squamous cell fate commitment. Misexpression of TAp63 in some 
columnar cell lines such as Ptk2 (kangaroo kidney cells) or in the lung of the 
transgenic mice under the control of the Surfactant Protein-C (SP-C) promoter, 
induces the epithelia to express K14, and inhibits terminal differentiation of the 
skin. In contrast, ANp63 is expressed later than TAp63 and is responsible for 
maturation of the stratified squamous tissue and maintenance of the 
proliferative potential of mature epidermis. The possibility of different functions 
of the p63 isoforms (to facilitate either the initiation or maintenance of the 
stratified squamous) allows compatible interpretations for the discrepancies of 
the two knockout models to be made.
Many people use p63 as a stratified squamous stem cell marker (Pellegrini et
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al., 2001; Moore et al., 2002; Green et al., 2003; Chen et al., 2004; McKeon, 
2004). This might be due to the ability of p63 (as a member of the p53 family) 
to regulate cell cycle and apoptosis (Yang et al., 1998; Yang and McKeon, 
2000; Yang et al., 2002; Flores et al., 2002). The transcription factor p53 is 
generally seen as a tumour suppressor gene and can promote cell death in 
certain conditions. p53 is structurally similar to p63, but there is no sterile alpha 
motif domain (SAM) and no post SAM domain in the C-terminal of p53 (see Fig
6.1 (B)). p63 and p73 (another member of the p53 family), can bind directly to 
p53 binding sites, and act as an inhibitor of p53 function because of either 
competition for binding sites or the inability to transactivate p53 target genes 
(Yang et al., 1998; Yang et al., 2002; Flores et al., 2002). For example, a recent 
finding suggests that ANp63 might directly regulate a proapoptotic gene -  
IGFBP-3 in stratified squamous tissue (Barbieri et al., 2005).
A description of p63 expression in the developing mouse oesophageal and 
tracheobronchial epithelium has been published (Daniely et al., 2004). There is 
also a study on the expression of p63 in human oesophageal biopsy samples 
from both normal oesophagus and from patients with Barrett’s oesophagus 
(Glickman et al., 2001). Expression of keratin 14 and p63 was demonstrated in 
both studies, and p63 disappears once the metaplastic phenotype commenced. 
In normal human oesophagus epithelium, p63 is expressed mostly in the basal 
layer but can also be found in suprabasal cells of the oesophageal epithelium. 
To date, the target genes of p63 in the stratified squamous tissue are not fully 
understood. The most recent results show that p63 can activate a desmosomal 
protein - Perp at the adheren junction in the basal layer cells of stratified 
squamous tissue (Ihrie et al., 2005). Oddly enough, no one has determined 
whether p63 directly activates K14, which seems logical for a direct target of
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p63. In this study I used cell lines and investigated (using luciferase reporter 




6.1.2.1 RT-PCR and immunostaining
I determined the change in expression of the transcription factors (AP-2a, 
C/EBPa, C/EBPp and p63) during the conversion from columnar to stratified 
squamous epithelium. These changes should correlate with alteration in the 
time of appearance of K8  and K14. I used two approaches to address this 
problem. First, I examined by RT-PCR the temporal profile of the transcription 
factors’ RNA expression during oesophagus development. Second I performed 
antibody immunostaining to detect the protein expression and cellular location 
in the tissue. RT-PCR and immunostaining of the transcription factors were 
carried out at least twice.
I isolated whole oesophagus (which included epithelium, mesenchymal and 
muscular layers) from E11.5, E13.5, E15.5, E17.5 embryos, postnatal day 1 
newborn mice and from adult mice. Total RNA was extracted and reverse 
transcription polymerase chain reaction (RT-PCR) was used to analyse the 
expression of the candidate transcription factors and stratified 
squamous-specific markers (Fig 6.2). As indicated in chapter 2 (see section
2.7), I used 35 cycles for the PCR reaction of transcription factors and 28 
cycles for the keratins and the loading control GAPDH.
First I determined the expression profile of K14 and K18. The RT-PCR time 
course confirmed our results from the immunostaining of the two keratin 
markers in vivo (Fig 3.4). K18 was expressed from E11.5 until P1, but was not 
present in the adult oesophagus. However, K14 RNA is detected earlier (E13.5) 
compared to the protein (E15.5 to E17.5). Whether this is because the protein 
detection by immunostaining is less sensitive, or that translation starts about 3
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Fig 6.2 The time course of embryonic oesophagus epithelium gene expression 
by Reverse Transcription - Polymerase Chain Reaction assay.
Analysis of the expression of transcription factors and columnar and stratified 
squamous markers during development and in adult tissues. The results 
shown are representative of 2  separate experiments.
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days after the transcripts are produced is currently not known. The K14 
expression persists until adult stage. Next, I determined the expression of the 
homeobox gene - HoxC4, known to be expressed only in the oesophageal 
region of the gut (Boulet and Capecchi, 1996). HoxC4 is expressed at all the 
time points I examined, showing that I indeed have isolated the oesophageal 
tissue (see Table 1.1).
6.1.2.2 AP-2
AP-2a, was detected by RT-PCR from E11.5 (Fig 6.2), although expression 
appeared to drop after E15.5, or just before the oesophagus starts to express 
the K14 protein (Fig 3.5 K, L). However, the strong expression of AP2a is 
found again at the adult stage both by RT-PCR (Fig 6.2) and immunostaining 
(Fig 6.3 L). The monoclonal antibody to AP-2a did not detect oesophageal 
expression at stages E11.5 to P1 (Fig 6.3 A, C, E, G, I, K and L). AP-2a is 
expressed in the epidermal epithelium from E11.5 (Fig 6.3 B, D, F, H and J) 
and in the edge of the limb bud which includes the apical epidermal ridge (AER) 
(E11.5 limb Fig 6.3 B). The location of AP-2a expression in both the epidermis 
and the adult oesophageal epithelium is the same, which is in most basal 
epithelial cells and some of the suprabasal layers. As found previously, there 
are alternative spliced forms of AP-2 (Buettner et al., 1993; Huang et al., 1998). 
AP-2B (or called AP-2a2 (Meier et al., 1995)) is an inhibitory form of AP-2A 
that lacks the DNA binding domain, and there might be a regulatory function of 
this inhibitory form to AP-2a. Our primers could not differentiate between the 
AP-2a and AP-2a2. From the results obtained by the two methods, I suspected 
the AP-2a I detected in the oesophagus by RT-PCR at the early embryonic 











Fig 6.3 Expression of AP-2a in the oesophagus and skin during development. 
Immunostaining of AP-2a on cross sections of embryos from E11.5 to adult (2 
months old) mice, either on oesophageal epithelium (A, C, E, G, I, K, L) or skin 
epithelium region (B, D, F, H, J). AP-2a marks many of the cells on the apical 
ectodermal ridge region of the forming limb bud (B). The basal layer of the skin 
showed strong expression of AP-2a from E11.5, but the basal epithelium of the 




detected by antibody staining. However, this needs further confirmation and I 
still cannot exclude the possibility that other AP-2 isoforms could initiate K14 
expression in the oesophagus.
6.1.2.3 C/EBP
The RT-PCR results show that C/EBPp was expressed from E11.5 until the 
adult stage. However, I failed to detect C/EBPa in the oesophagus by RT-PCR 
methods (although it was detected in the adult liver, which is known to express 
this gene, data not shown). Immunostaining of the adult oesophagus (Fig 6.4) 
showed an expression pattern similar to the findings of Smart et al. in the skin 
(Oh and Smart, 1998; Zhu et al., 1999). C/EBPa is expressed in the cytoplasm 
or perinuclear region in most cells of the basal layer, and in the nucleus of 
some suprabasal cells (arrows in Fig 6.4 B). C/EBPp is expressed in very few 
cells in the basal layer, and in more cells of the suprabasal layers (all in the 
nucleus) (Fig 6.4 D).
Although there are some discrepancies as to the role of C/EBPs in the 
regulation of keratin genes in stratified squamous, there is no doubt C/EBPs 
are important for keratin gene expression and stratified squamous 
differentiation. It is possible that the basal C/EBPa and the suprabasal C/EBPp 
have a role controlling the simple columnar to stratified squamous conversion, 
perhaps in the down-regulation of K8 and K18 columnar genes. I will 
investigate this possibility using the luciferase assay (see section 6 .2 ).
6.1.2.4 p63
Koster et al. (2004) showed that TAp63 is expressed earlier than A Np63 in 
tissues of the embryos that later become stratified squamous epithelium. Using
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Fig 6.4 Expression of C/EBPa and C/EBPp in the oesophagus epithelium.
In the adult oesophagus, C/EBPa is mainly expressed in the basal layer, and to 
a lesser extent in the suprabasal layers (A, B). The basal cells showed 
perinuclear expression of C/EBPa, while some of the suprabasal cells showed 
expression of C/EBPa in the nucleus (arrows in B). C/EBPp is found 
expressed in the nucleus of cells at the suprabasal layers of oesophageal 
stratified squamous (Fig 5.4 C, D).
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RT-PCR, the transactivating isoforms were shown to be expressed from E7.5, 
and the AN isoforms, expressed from E9.5 are the dominant form around birth 
(Koster et al., 2004). It is worth noting that there is another additional 39-amino 
acid stretch at the N-terminal of p63 (Yang et al., 1998), named TA* isoform, 
the function of which is unknown. I specifically designed PCR primers to detect 
the TA* isoform (but not the TA or AN isoforms), while another set of primers 
detected all the TA isoforms (including the TA* isoform). A third set of primers 
were designed to specifically detect only the AN isoforms since there is a 
region present in the ANp63 N-terminal that is not present in any of the other 
TA isoforms (because of alternative selection and splicing of the 3rd exon). 
Using RT-PCR, the results for the different p63 isoforms were rather surprising.
I find no significant quantity of any of the p63 TA isoforms (the design of the 
primers will not distinguish between a, p and y isoform) until after P1 (Fig 6.2). 
However, the TA* specific isoform was detected at the same time points as the 
general TAp63 isoforms were detected (P1 and the adult stage oesophagus). 
On the other hand, the AN isoforms are strongly expressed at all the time 
points examined. This suggests that in the oesophagus, the AN isoforms are 
already dominantly expressed from the start of the observation period, i.e. 
E11.5. In contrast, the TA isoforms of p63 are hardly detectable before birth, 
and the major p63 isoform with the transactivation domain is the TA* isoform.
I next examined the spatial location of p63 by immunohistochemistry and 
immunofluorescence detection methods (Fig 6.5). The antibody I used detects 
all the p63 isoforms. Immunostaining was performed on sections of mouse 
E11.5, E13.5, E15.5, E17.5, P1 and adult oesophagus. p63 was strongly 
expressed at the basal layer and in a few cells of the suprabasal epithelium. 
While the expression of p63 by RT-PCR and immunohistochemistry shows p63
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protein expressed at the basal layer from E11.5, there might be changes of 
different p63 isoforms expressed. So far, I do not have a method to distinguish 
between a, p and y isoforms. We will need a better understanding of the 
interaction of the different p63 isoforms and the whole p63 story may be more 




























Fig 6.5 Expression of p63 in the oesophagus in vivo and in vitro.
The p63 antibody stains the nucleus of nearly all basal layer cells of the 
oesophageal epithelium from E11.5 to the adult stage (A-L). Note nuclear p63 
is also stained in the trachea and bronchial regions at E13.5 (C). Embryonic 
oesophagi isolated from E11.5 mouse were cultured in vitro for 1 day (M, N), 7 
days (O, P) and 9 days (Q, R). K8  (red) and p63 (green) were co-stained at 1 
day (M, N) and 7 days culture (O, P) to show the co-expression of both 
markers at the beginning of the culture, but do not co-exist in the same cells 
after the stratified squamous programme has started. K14 and p63 were 
co-stained at 9 days culture (Q, R) showing co-expressing of both markers at 





I used two methods: RT-PCR and immunohistochemistry to determine the time 
course of expression of the candidate transcription factors: AP-2a, C/EBPa, 
C/EBPp and p63s. Information on the spatial and temporal expression profile 
of these genes was obtained. However, some questions are raised after 
comparing the results of the two methods. Based on immunostaining, I showed 
that all the transcription factors are expressed in either the basal layer (AP-2a, 
C/EBPa and p63), or the suprabasal layers (C/EBPp). However, studying the 
time course of expression of different isoforms of each transcription factors is 
much more complicated.
The results from RT-PCR and immunostaining studies suggest the AP-2a 
isoform is not expressed in the oesophagus until postnatal stages. This 
suggests the mRNA signal detected at earlier stages may be the inhibitory 
isoform of AP-2cr - AP-2a2 (AP-2B). I could not detect C/EBPa by RT-PCR, but 
C/EBPa is found in the basal layer of the adult oesophagus by immunostaining. 
The RT-PCR results for the time course of C/EBPP expression showed the 
transcription factor is present from E11.5 to the adult stage. I cannot rule out 
the possibility that the C/EBP signals from RT-PCR were amplified from the 
vascular smooth muscle and the stromal layers of the oesophagus during 
sample collection (Kousteni et al., 1998; Sekine et al., 2002). Here follows a 
brief discussion of implications we can make of for each transcription factor.
6.1.3.2 AP-2a
Although AP-2a could not be detected by immunostaining, it was present 
based on RT-PCR results. There is evidence of the inhibitory AP-2a2 found in
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the dermis of the skin at E13.5 (Byrne et al., 1994). If the form of AP-2a 
detected by RT-PCR is the inhibitory form - AP-2a2, it is probable that other 
AP-2 isoforms are involved in the formation of the oesophageal epithelium. 
Recently, a new AP-2 isoform (called AP-2e) is expressed in all layers of the 
epidermis (Tummala et al., 2003). Whether AP-2z is involved in the expression 
of the stratified squamous specific keratin genes remains to be determined.
6.1.3.3 C/EBP
From the results of C/EBP expression profile in my study, I found C/EBPa 
expressed at the basal layer and C/EBPp at the suprabasal layers. This is 
similar to the results by Smart’s group but not Haebner’s group (Oh and Smart, 
1998; Maytin and Habener, 1998; Zhu et al., 1999; Maytin et al., 1999). In this 
case, the role of the basal C/EBPa could be either activating or suppressing 
the basal proteins of a stratified squamous tissue. Surprisingly, I find that there 
is perinuclear or cytoplasmic staining of C/EBPa in cells of the basal layer. A 
similar staining pattern was also found by Smart’s group (Oh and Smart, 1998). 
However, there is also some nuclear staining of C/EBPa in cells at the 
suprabasal layers (arrows in Fig 6.4 B). Therefore I postulate there might be an 
unknown post-transcriptional regulatory mechanism to prevent C/EBPa from 
entering the nucleus, probably exerting an inhibitory effect to its normal 
function at the basal stratified squamous gene expression.
According to the expression profile I find, C/EBPp is more likely to activate the 
suprabasal differentiation genes in the oesophageal epithelium, such as K1 
and K10. Whether the transcription factor AP-2 is still involved in the regulation 




p63 is present from E11.5 in the basal layer of the oesophagus epithelium. The 
timing of expression is much earlier than K14 (which starts to be expressed 
around E15.5-E17.5 in vivo or 5-7 days of culture based on immunostaining). 
This means p63 is expressed at least 5-7 days before the stratified squamous 
basal cell fate is committed. It is unlikely that a transcription factor involved in 
directly regulating gene expression will take this amount of time to activate an 
immediate early gene. Either there are specific isoform(s) of p63 that are 
responsible for inducing K14 at the right time but which cannot be 
distinguished by RT-PCR or immunostaining methods; or, of course, K14 might 
not be the immediate early target genes of p63.
One of the postulated functions of p63 is to commit epithelial cell fate to a 
stratified squamous tissue. Recently, two groups (using zebrafish as a model 
system) found that p63 is responsible for the initiation of stratified squamous 
tissues (including the formation of the epidermis and fin bud (equivalent to the 
limb in mammals)) (Bakkers et al., 2002; Lee and Kimelman, 2002). 
Interestingly, zebrafish only possesses the ANp63 isoforms but not the TAp63 
isoforms. Using a luciferase assay, BMP2b has been demonstrated to be an 
upstream signal that induces ANp63 expression in zebrafish. Downstream 
effectors of BMP signals including SMAD4 and SMAD5 can directly bind to the 
ANp63 promoter and activate the expression of the gene. BMP signalling is 
important in determining the ectodermal cell fate to become epidermis instead 
of neural cells in early development (Wilson and Hemmati-Brivanlou, 1995; 
Suzuki et al., 1997a; Suzuki et al., 1997b), and this mechanism might be 
mediated through activation of ANp63 to suppress the neuronal program when 
determining the cell fate of the ectoderm to become epidermis.
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In conclusion, I need more evidence to clarify the roles of these transcription 
factors in the induction and maintenance of the oesophageal stratified 
squamous tissue. In the next section, I will extend the study by assaying the 
activity of the K14 and K18 promoters in different cell lines when candidate 
transcription factors are introduced. Columnar epithelial cell lines will also be 
transfected with some of the candidate transcription factors and 
immunostained for ectopic K14 expression.
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6.2 Analysis of candidate transcription factors on cell lines - Luciferase 
assay and stratified squamous metaplasia
6.2.1 Introduction
In order to determine the molecular mechanisms that control the change from 
a simple columnar to stratified squamous tissue, I used two approaches. The 
first was based on a reporter assay to quantify the changes in gene expression 
of columnar and stratified squamous genes in an in vitro cellular system. The 
second approach was to directly induce the transdifferentiation of columnar 
epithelia to a stratified squamous phenotype by the introduction of candidate 
transcription factor(s). Ideally, there might be a master switch gene that will 
simultaneously control down-regulation of the columnar genes, i.e. K8  and K18 
at the basal layer and at the same time causes the up-regulation of the basal 
markers of a stratified squamous tissue (expression of K5 and K14).
6.2.1.1 Specificity ofK18 and K14 promoters
In order to investigate how genes of the simple columnar and stratified 
squamous basal layer cells are regulated, I needed to establish biochemical 
evidence that the transcription factors can activate the stratified squamous 
specific K14 gene and repress the simple columnar K18 gene. To address this 
problem, I used a luciferase assay based on co-transfection of the transcription 
factor and the reporter gene (K14 and K18 promoter linked to an enhanced 
luciferase reporter, GL3 plasmid from Promega). The human K14 cassette 
promoter construct for making the luciferase reporter was the same as the 
K14-nucGFP used in Fig 4.3. Vasioukhin et al. showed that the K14 promoter 
was able to drive expression of lacZ in stratified squamous tissue such as skin, 
tongue, and the oesophagus (Vasioukhin et al., 1999). However, it is also
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possible that there might be promiscuity of the promoter when it is transfected 
into cell lines in vitro (Vassar et al., 1989). To address this possibility, I have 
also carried out control electroporation experiments. The K14 promoter 
construct driving nuclear GFP was electroporated into organs expressing a 
columnar phenotype such as embryonic stomach, intestine and lung cultures. I 
saw no cells expressing GFP (Fig 4.4 B-D). In contrast, GFP under the control 
of the CMV promoter was expressed in the tissues under the same 
experimental conditions, demonstrating that the electroporation is working (Fig
4.4 F, G). It appears that the K14 promoter I use is faithfully expressed in the 
tested stratified squamous embryonic oesophagus after electroporation.
To study the down regulation of the columnar genes, I also used a K18 
promoter for luciferase reporter assay. The K18 promoter construct has been 
engineered to contain the following elements: the 2.5 kb 5 upstream enhancer 
and promoter region of the human K18 gene (which includes the minimal 
promoter region), the 1st intron of the K18 gene which has strong enhancer 
activity, plus a translation enhancer element (TE) inserted immediately 5 end 
of the start codon, the whole length of the K18 promoter / enhancer regulatory 
construct consists about 3.2 kb in total (Koehler et al, 2001). The TE element 
was derived from the alphalfa mosaic virus to enhance translation of the 
mRNA (Chow et al., 1997). The K18 promoter is shown to consist of elements 
specific to the columnar specific tissue, in the K18-LacZ transgenic mouse, the 
promoter controls expression in places such as the airway epithelium of the 
bronchiole and lung (Chow et al., 1997; Koehler et al., 2001). The promoter will 
therefore be useful for the present study since the origin of oesophagus and 
trachea / bronchiole / lung are closely related during foregut development.
I have assayed for promoter activity using a luciferase assay. The assay is
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based on the promoter activating or repressing the downstream reporter (in 
this case luciferase GL3). When an activator or repressor transcription factor 
binds to the promoter region, the change in fluorescence produced by the 
luciferase-substrate reaction can be quantified in the transfected cells. The 
luciferase vectors (under the control of the K18 or K14 promoter elements) are 
co-transfected with candidate transcription factors (AP-2a, C/EBPa, C/EBPp, 
TAp63a, TA*p63a or ANp63a) into oesophageal or non-oesophageal cell lines. 
The experiments should provide evidence if any of the transcription factors are 
responsible for suppression of K18 or induction of K14 genes. In order to 
mimic the in vivo situation it is important to use oesophageal cell lines that 
recapitulate the normal expression pattern of keratin genes. I chose four cell 
lines representative of columnar, stratified squamous or mesenchymal cell 
types to investigate how the transcription factors act on the promoters in 
different cellular contexts (See Table 6.1 for experimental design).
6.2.1.2 Cell lines
The four cell lines I utilized to test the effect of candidate transcription factors 
on the promoters activities were (a) OE33, a human oesophageal carcinoma 
cell line, derived from a Barrett’s patient (Jones et al., 2003), and express 
columnar cell markers, (b) KYSE30 is an oesophageal stratified squamous 
carcinoma cell line (Rigberg et al., 1998; Shimada et al., 1992). (c) NIH3T3 4.2, 
is a mouse fibroblast cell line (null control for columnar and stratified squamous 
keratin markers). However during the progress of the work I found that NIH3T3 
cells express K14. (d) CaC02, a human colon adenocarcinoma, is thought to 
be strictly columnar with no stratified squamous marker expression (Baricault 
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Table 6.1 Luciferase assay.
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assay on these different cell lines testing transcription factors -  AP-2a, 
C/EBPa, C/EBP/3, TAp63a, TA*p63a and ANp63a. For analysis of the stratified 
squamous inducing function of the transcription factors - AP-2 and p63s, I 
used Caco-2 and HepG2, a human hepatoma cell line that does not normally 
express stratified squamous markers (Morris et al., 1982).
From Chapter section 6.1, I learned which transcription factors express in the 
epithelium of the oesophagus during development. In the present chapter I 
used a luciferase assay to test the transcription factors and assay their effect 
on K14 and K18 promoters. I also directly transfected some of the transcription 





6.2.2.1 Transcription factors detection after transfection
Before I could begin asking about the relationship between the transcription 
factors and the K18 and K14 promoters, I first needed to verify that the 
transcription factor constructs were being expressed and whether the proteins 
could be detected by the antibodies available in the lab. I therefore transiently 
transfected cells with plasmids expressing the transcription factors and then 
immunostained for the transcription factors. The transcription factor constructs 
were under the control of the ubiquitously expressed Cytomegalovirus (CMV) 
promoter. I transfected the following transcription factors: mouse AP-2a, rat 
C/EBPa, rat C/EBPp, human TAp63a, human TA*p63a and human ANp63a 
into the K14-negative colonic cell line - Caco-2. The cells were cultured for two 
days after transfection. All the transcription factors were detected (Fig 6 .6 ). 
However, the detection sensitivity for TA*p63 isoform (Fig 6 . 6  D, E cf. Fig 6 . 6  
F), was not as great as the other transcription factors probably because the 
conformation is different with the additional N-terminal 39 amino acids.
6.2.2.2 Characterisation of cell lines and the luciferase promoter constructs 
Before I quantified the K14 and K18 promoter activity by luciferase activation, I 
characterised the cell lines. I immunostained for K14 or K8  on each cell line to 
verify expression of the two keratin markers and compared with the detection 
of the K14-GFP and K18-LacZ after 2 days of transfection in each cell line (Fig
6.7).
K14 was found expressed in the oesophageal cell lines OE33 and KYSE30 
(Fig 6.7 B, C), but not in the Caco-2 colonic cell line (Fig 6.7 A). This result 
showed that in the transformed adenocarcinoma cell line OE33, there are still
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Fig 6 . 6  Ectopic expression of transcription factors in CaC02 cells.
CaC02 cells do not normally express stratified squamous transcription factors. 
Cells were transfected for 24 hrs with 1 pg transcription factors (AP-2a (A), 
C/EBPa (B), C/EBPp (C), TAp63a (D), ANp63a (E) and TAp63a (F) and 
cultured for a further 48 hrs before fixation and immunostaining for AP-2a (A), 
C/EBPa (B), C/EBPP (C) and pan-p63 (D-F). Transfection of transcription 















Fig 6.7 K8  and K14 expression.
Four cell lines were tested for expression of K14 and K8  by antibody staining 
alongside reporter gene expression driven by K14 or K18 promoters. The K14 
promoter driving GFP (A-D) and the K18 promoter driving LacZ (E-H) were 
transfected into cell lines: CaC02 (A, E), KYSE30 (B, F), OE33 (C, G) and 
NIH3T3 4.2 (D, H). Arrows show co-expression of the keratin protein 
expression with the GFP or p-gal reporters in the same cells (B, D, E, G). 
Arrowheads show the reporter expressed alone without the related keratin 
gene expression (Fig 5.8 B, C and F). Inset in B showing many KYSE30 cells 
expressing K14. Arrow in C shows K14 expression in one OE33 cell.
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K14-positive cells although they appear less frequently than in the KYSE30 
stratified squamous carcinoma line (Fig 6.7 B cf. arrow in C). I also found 
abundant expression of K14 in NIH3T3 cells (Fig 6.7 D). The expression of 
epithelial keratins in cultured fibroblastic cell lines was also observed by other 
groups (Katagata et al., 2002).
In K14-nucGFP transfected cell lines, GFP was expressed in OE33, KYSE30 
and NIH3T3, but not in Caco-2 cell lines, consistent with the results of K14 
protein expression. I found examples of cells co-expressing nuclear GFP 
(green) with keratin 14 (red) (arrows in Fig 6.7 B and D). However, on more 
frequent occasions, I found nuclear GFP in cells that do not express K14 
(arrow heads in Fig 6.7 B, C). These results suggest that the promoter activity 
is not totally equivalent to the endogenous keratin expression in the cell lines. 
K8  was detected in Caco-2 cells (Fig 6.7 E), in oesophageal adenocarcinoma 
OE33 (Fig 6.7 G) and in the stratified squamous carcinoma KYSE30 cell lines 
(Fig 6.7 F), but not in NIH3T3 fibroblasts (Fig 6.7 H). The K18 promoter driving 
nuclear LacZ showed a stronger correlation to the protein expression 
compared to the K14 promoter. The nuclear lacZ expression was found in 
Caco-2 (Fig 6.7 E) and OE33 cells (Fig 6.7 G) co-expressing K8  protein, but 
there were also KYSE30 cells in which the K8  proteins expression is absent in 
cells expressing nuclear LacZ (arrowheads in Fig 6.7 F). It therefore seems 
that the promoters I use behave differently in different cellular contexts. A 
combined analysis of results obtained in these diverse conditions will likely 
yield more clues on the regulation of keratin promoters.
6.2.2.3 Luciferase assays
I examined the effect of individual transcription factors (AP-2a, C/EBPa,
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C/EBP(3 and TA, AN and TA* p63a isoforms alone and in combination) on the 
columnar K18 promoter-K18mTELucE (Fig 6 .8 ) and the stratified squamous 
promoter pK14-Luc (Fig 6.9) (Maps of the constructs can be found in Appendix 
A-1). The idea of testing the combined effect of transcription factors arises 
from the observation that different p63 isoforms could differentially affect the 
initiation of stratified squamous epithelium (Koster et al., 2004). There might 
also be a different effect to the tested promoters when the TA isoform and the 
AN isoform are present together, e.g. they might be antagonistic.
For each assay I transfected 1 pg of the promoter luciferase reporter 
constructs along with 1 pg of a pCMV-nucLacZ plasmid and 1 pg of each 
transcription factor (see Table 6.1 for details). Whenever a single transcription 
factor was being tested, I added 1 pg of empty pcDNA3 plasmid. The results 
shown were from transfections carried out three times and each transfection 
sample was assayed four times. The relative luciferase unit (RLU) is 
normalized by the total protein loaded, and the transfection efficiency is 
normalized by a colorimetric measurement of the p-Gal activity from the 
pCMV-nucLacZ plasmid.
In terms of the effect of AP-2a or C/EBPa on the K18 promoter-K18mTELucE, 
my results showed no significant difference in the promoter activity of the two 
transcription factors compared to the pcDNA3 control in all four cell lines (Fig
6 . 8  A, B). C/EBPp in KYSE30 was the most promising candidate as a 
repressor of the K18 promoter (0.39±0.05 of the K18 promoter activity of the 
control pcDNA3) (Fig 6 . 8  C). However, C/EBPp had a tendency to act as an 
activator instead of a repressor in other cell lines tested (Fig 6 . 8  C), although 
the activator activity in compared to the control is not statistically significant. 







Fig 6 . 8  K18 promoter activity in cell lines.
Luciferase under the control of the K18 promoter (Koehler et al., 2001) was 
assayed in four different cell lines (Caco-2, KYSE30, OE33 and NIH3T3), by 
co-transfection with 1 pg of transcription factor and 1 pg of control pcDNA3 
plasmid or a combination of 2 transcription factors (2 pg in total). 1 pg of |3-Gal 
was transfected along with the transcription factors and the luciferase 
expressing plasmids for transfection control, and total protein assay was used 
as a loading control. The experiments were repeated 3 times.
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repression in all the cell lines examined (Fig 6 . 8  D, E), and the effect of 
TA*p63a is similar, except in the OE33 cell line (Fig 6 . 8  F).
TAp63a and ANp63a in combination activates K18 in Caco-2 or KYSE30 cell 
lines but represses K18 in OE33 or NIH3T3 cells (Fig 6 . 8  G). TA*p63a and 
ANp63a in combination had the same effect on the K18 promoter as alone (Fig
6 . 8  H).
For K14 promoter luciferase assay, AP-2a mildly enhanced the promoter 
activity of K14 in all cell lines (Fig 6.9 A), although this was less than reported 
previously (Byrne et al., 1994), the quantitative difference may be due to 
differences in the promoter length (I used 2,000 bp vs the published 2,300 bp). 
C/EBPa is slightly repressive on K14 promoter activity except on NIH3T3 cells 
(Fig 6.9 B) whereas C/EBP(S activates K14 promoter in Caco-2 or NIH3T3, but 
represses K14 activity in KYSE30 or OE33 cell lines (Fig 6.9 C). TAp63a and 
ANp63a can activate the K14 promoter activity in Caco-2 cell line, and the AN 
isoform has more K14 promoter activating potential than TA isoform (Fig 6 . 8  D, 
E), although the AN isoform is repressive of K14 activity in OE33 (Fig 6.9 E). 
TA*p63a isoform also activated K14 in Caco-2 cells, but not significantly, and 
was repressive in the OE33 cell line (Fig 6.9 F). The combination of the TA and 
AN p63a or TA* and AN isoform activated K14 promoter (4.2x and 3.8x, 
respectively compared to the pcDNA3 control) in Caco-2 cells (Fig 6.9 G, H), 
although there is some variations in the results. The effect of combined 
transcription factors (TA or TA* isoform with AN isoform) is repressive to the 
K14 promoter activity in other cell lines (Fig 6.9 G, H).
In conclusion, the relative luciferase (RLU) results of the luciferase assay 
showed wide variations. The variation may arise from the amount of DNA used 
(4 pg in total including 1 pg of (3-Gal construct, 1 pg of luciferase reporter and
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Fig 6.9 K14 promoter activity in different cell lines.
K14 promoter (Vasioukhin et al., 1999) activity was assayed in four different 
cell lines (Caco-2, KYSE30, OE33 and NIH3T3), after co-transfection with 1 pg 
of transcription factor (and 1 pg of control pcDNA3 plasmid) or combination of 
2 transcription factors (2 pg in total). 1 pg of (3-Gal plasmid was transfected 
along with the transcription factors and the luciferase expressing plasmids for 
transfection control, and total protein assay were used as a loading control. 
The experiments were repeated 3 times.
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2 pg of transcription factors). It is possible I saturated the cell transcription and 
translation machinery. There might also be a difference in the luciferase assay 
results on the effect of different molar ratio of transcription factor vs luciferase 
reporter (TF: Luc) (see Fig 6.10) Therefore, I set out to perform a control 
transfection experiment using less DNA and also to test the effect of different 
molar ratios of transcription factor vs luciferase reporter.
Instead of using 1 pg of transcription factor or luciferase construct, I used 0.5 
pg of the luciferase reporter and either 0.5 or 1.5 pg of the transcription factor. 
The (5-Gal transfection control was still 1pg. I decided to test AP-2cr on both 
K18 and K14 promoters in KYSE30 cells since it was already known that 
AP-2a can directly bind to and activate the K14 promoter (Sinha et al., 2000). 
The AP-2a effect on the K14 promoter is 2.1 fold more active than the pcDNA3 
control when the TF:Luc is 3:1, but there is no difference when the TF:Luc is 
1:1 (Fig 6.10). The effect on K18 is 2.6 fold more active than the pcDNA3 
control when the TF:Luc is 3:1, and also no difference when the TF:Luc is 1:1. 
The results in Fig 6.10 have a much smaller standard error bar comparing to 
Fig 6 . 8  and Fig 6.9. Using less DNA provides a more consistent result 
indicating the importance to titrate the DNA amount before commencing the 
experiments.
6.2.2.4 Ectopic expression of the candidate transcription factors in Caco-2 and 
HepG2
In order to test the idea that some of the candidate transcription factors might 
induce the expression of stratified squamous markers in cell lines that are not 
stratified squamous epithelia in origin, I transfected AP-2a, TAp63a, ANp63a 
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Fig 6.10 The ratio of transcription factors to luciferase reporter influences the 
promoter luciferase assay.
1.5 pg of the transcription factor AP-2a transfected with 0.5 pg of the K14 or 
K18 promoter controlled luciferase give different luciferase results to 0.5 pg of 
the AP-2a transfected with 0.5 pg of the reporters.
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cannot induce the ectopic expression of K14 in Caco-2 or HepG2 cells (results 
not shown). This result confirmed the observation by Fuchs group who also 
transfected AP-2 into HepG2 and did not find K5 or K14 expression (Leask et 
al., 1991).
When p63 was transfected into Caco-2 (Fig 6.11 A-D) or HepG2 (Fig 6.11 F-l) 
cells for 5 days, K14 became expressed. Interestingly, both the AN (Fig 6.11 A, 
B, F, G) and the TA (Fig 6.11 C, D, H, I) isoforms showed ectopic K14 
expression but the TA* isoform did not (results not shown). When examined 
under lower magnification, transfection of the AN isoform actually gave rise to 
more K14 positive cells compared to the TA isoform (Fig 6.11 K cf Fig 6.11 L). 
In HepG2 cells, I observed seven K14 positive cells in a single field where 
there are six cells in the same field showing p63 expression after the AN 
isoform transfection (Fig 6.11 K). While there is only one K14 positive cell in a 
similar field of HepG2 cells which showed nine p63 expressing cells under the 
same condition of TA isoform transfection (Fig 6.11 L). Similar differences are 
found for the AN and TA isoforms in Caco-2 cells (results not shown). I also 
observed K14 positive cells where no p63 is detectable (arrows in Fig 6.11 C, 
K, L). This is found in both AN and TA isoform transfection, but no K14 positive 
cells are found when the columnar cell lines were transfected with a GFP 















Fig 6.11 p63 induces expression of K14 in columnar cell lines.
1 pg of transcription factor ANp63a (A-D, I) or TAp63a (E-H, J) was transfected 
into two columnar cell lines -  Caco-2 (A, B, E, F) and HepG2 (C, D, G, H, I, J). 
K14 positives cells are found 5 days after transfection of both p63 isoforms and 
in both cell lines. However, lower magnification of HepG2 transfected with the 
two isoforms showed that there are more K14 positive cells in the ANp63a 
than the TAp63a transfected cells. Some cells express K14 without p63 





From the results of the luciferase assay, it is not easy to draw any substantive 
conclusions on the role of transcription factors either as activators or 
repressors for the same promoter in different cell lines. Similar results were 
also found for C/EBPa or C/EBPp. These transcription factors act as 
repressors of cr2 and a5-integrin promoter constructs in primary human 
keratinocytes, but act as activators of a2 and a5-integrin promoter in the 
human hepatoma cell line-HepG2 (Corbi et al., 2000). Until now, no one has 
examined the effect of C/EBPa and C/EBPP on the keratin 14 and keratin 18 
promoters, although they were found to regulate the K1 and K10 (suprabasal) 
genes (Maytin et al., 1999). However, in light of the results from the experiment 
using different amounts of DNA and different TF to Luc ratio, future work might 
start by optimizing the assay before I can interpret the promoter activities (Oh 
and Smart, 1998).
It is surprising that the p63 isoforms do not have more of an impact on K14 
activity on OE33 and KYSE30 oesophageal cell lines. From the p63 knockout 
studies and the observation that the TAp63 isoform initiates epidermal 
stratified squamous tissue (Yang et al., 1999; Mills et al., 1999; Koster et al., 
2004), it would be expected that the TAp63 isoform should activate K14 
promoters. In this context, it would be of interest to determine the relationship 
between K14 expression and p63. It is surprising as to why no-one has studied 
the K14 promoter activity and p63 or direct binding analysis of p63 and K14 
promoter. One possibility that I do not find significant activation of K14 by p63 
is that the p63 binding element is not on the K14 and K18 promoter constructs 
used in the present study. This would mean the enhancer element responsible
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for p63 binding is not located in the 2.0 kb bp or 3.2 kb regulatory sequence in 
the K14 and K18 promoter constructs, respectively. Another possibility is that 
p63 does not directly bind to K14 and/or K18 promoter enhancer region at all, 
but is acting through other upstream factor(s) regulating initiation of the 
stratified squamous programme. This would mean I might observe significant 
activation of the K14 promoter if I leave the transfected cells cultured for longer 
periods of time. There are currently no consensus p63 binding sites known, 
however, there are studies showing p63 might bind to p53 binding elements 
(Yang et al., 2002). From my preliminary results using bioinformatics for 
consensus binding elements for transcription factors, both human K14 and 
K18 promoter/enhancer regions contain p53-like binding sites (data not 
shown), but unless I perform an electromobility shift assay (EMSA) or 
chromatin immunoprecipitation (CHIP) with antibodies specific to the p63 
transcription factor, there is still no way to tell whether the p63 isoforms bind 
directly to the K14 promoter.
6.2.3.2 Ectopic expression of the candidate transcription factors in columnar 
cell lines
ANp63a and TAp63a but not AP-2 or TA*p63a have the ability to activate K14 
expression in Caco-2 and HepG2 columnar cell lines. This result suggests that 
members of the p63 family may act as master switch gene(s) inducing the 
formation of stratified squamous epithelium. In addition, knowing that ANp63a 
and TAp63a as potential master switch genes, they might have therapeutic 
potential to reverse stratified squamous abnormalities such as Barrett’s 
metaplasia.
Three lines of evidence obtained in the present study suggest that ANp63
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isoform is important in the initial formation of stratified squamous epithelium 
instead of TAp63 isoform as previously suggested (Koster et al., 2004). This 
includes (a) expression analysis by RT-PCR (Fig 6.2), which demonstrates that 
the ANp63 isoform is expressed earlier than both the TAp63 and TA* isoform, 
(b) luciferase analysis in Caco-2 cells shows that the AN isoform induces 
stronger K14 promoter activity than the TA isoform, and (c) by transfection 
studies, the AN isoform induces more K14 positive cells than the TA isoform. 
However, both AN and TA isoforms can induce K14 expression in the 
luciferase assay and the transfection study, suggesting there might be a 
positive (auto-)regulatory feedback loop of each of the isoforms to induce one 
another. Evidence for this hypothesis is that putative p63 binding elements 
were also found in the enhancer region of the AN p63 gene (Yang et al., 2002). 
One curious observation is some of the cells were found expressing K14 but 
not p63 after p63 transfection. There are at least two possibilities: (1) the need 
for p63 to induce K14 is temporary. Therefore, there might be cells that had 
lost p63 expression, but the K14 gene is already activated and (2) there might 
be paracrine signalling from p63 positive cells to p63 negative cells instructing 
them to start expressing K14. There are of course possibilities other than these 
two explanations such as the existence of a p63-independent pathway for K14 
expression, but I currently have no means of testing.
Future work for understanding p63 function is to test other stratified squamous 
differentiation markers such as K10 and involucrin in p63-transfected cells. I 
would hope to find the full repertoire of stratified squamous genes expressed in 
the transfected columnar cells if p63 is truly a master switch gene for stratified 
squamous transdifferentiation. In addition, other nuclear factors such as AP-2 




Chapter 7 Conclusions, Discussions and Future Work
7.1 Summary
The development of the oesophagus has not received much academic 
attention. The reason is not clear but in part may be the fact that it appears 
relatively simple with no intricate cellular and functional complexity. Moreover, 
up until now, there has been no suitable in vitro system for studying its 
development and function. The oesophagus is unique in the sense that it is the 
only endodermally-derived organ that contains stratified squamous epithelium 
(Wells and Melton, 1999). In the current thesis, I have examined the 
development of the oesophagus and in particular, focused on the formation of 
the stratified squamous epithelium.
There are three types of cell type conversions that arise either during 
development of the oesophagus or in certain human oesophageal pathologies. 
These conversion are (a) the change from simple columnar to stratified 
squamous epithelium (at around embryonic day 15.5 to 17.5 in mice), (b) a 
change from the smooth muscle to skeletal muscle during the perinatal period 
and (c) conversions of stratified squamous to columnar epithelium in the 
clinical condition - Barrett’s metaplasia. Barrett’s metaplasia predisposes to 
development of adenocarcinoma (Paulson and Reid, 2004). The rising 
incidence of Barrett’s metaplasia and oesophageal adenocarcinoma in 
Western countries has led researchers to search for the underlying 
mechanism(s) as well as a cure for the disease. Based on the clinical 
importance of Barrett’s metaplasia, researchers have also come to realise the 
importance in understanding how endodermal organs are formed during 
development, and to identify the molecular and cellular differences between
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organs such as the oesophagus and intestine.
In Chapter 3, I studied the normal development of the mouse embryonic 
oesophagus from stage E11.5. After E10, the foregut has separated into two 
lumen structures, the oesophagus and the trachea / lung buds (Motoyama et 
al., 1998). My study is the first to systemically characterise in detail the 
morphological appearance of the oesophagus as well as the muscular and 
epithelial markers of the developing mouse oesophagus throughout 
developmental stages from E11.5 to postnatal 2 months. I found that the cell 
type changes from smooth to skeletal muscle tissue (in agreement with a 
number of published studies) and also characterised in detail the conversion 
from columnar to stratified squamous epithelium in the oesophagus.
In addition to characterising the switch of epithelial phenotype in vivo, I also 
established an in vitro culture model for the oesophagus, which was based on 
isolation of mouse oesophagi from E11.5 embryos and cultured on 
fibronectin-coated dishes. The in vitro model recapitulated the in vivo switch 
from smooth to skeletal muscle and from columnar to stratified squamous 
epithelium. By using the oesophagus culture model, I could monitor the 
phenotypic changes more closely, and in addition, the model provides us with 
a means to manipulate the normal development of the oesophagus and to 
address a number of specific questions. I first compared the cultured 
oesophagi to in vivo oesophagus development, in which I used cytoskeletal 
and epithelial markers - K14, K8 , K18, K4, K13, K10, involucrin and E-cadherin 
for characterising the epithelial tissue. I used markers such as desmin, smooth 
muscle actin, myoglobin and skeletal myosin for characterising muscle. The 
cell types for stratified squamous epithelium and oesophageal muscle cells 
were found in a similar spatial relation in culture compared to in vivo. From the
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outer to the inner layers, there were fibroblastic cells, muscle layers, 
mesenchymal submucosal layers, basement membrane, basal layer and the 
suprabasal layers of stratified squamous epithelium (illustrated in Fig 1.4).
We were interested to know if the cells of the basal stratified squamous 
epithelium come directly from the simple columnar cells lining the embryonic 
oesophagus. I tried several methods and confirmed the idea that the stratified 
squamous tissue arise from the simple columnar epithelium. It is also 
interesting to examine if there is a requirement of cell division during the switch. 
I found that inhibition of cell proliferation, however, does not affect the 
transition from simple columnar to stratified squamous.
It is evident that the oesophagus does not need to interact with cells from other 
organs in controlling the epithelium to undergo a phenotypic change from 
columnar to stratified squamous in my culture system. Furthermore, reducing 
the thickness of mesenchymal layers accelerates this switch, suggesting there 
might be a repressive signal coming from the mesenchyme to suppress the 
switch, and the signals were gradually nullified during development. We 
hypothesised that either the switch is caused by (a) the columnar cells 
disappearing by apoptosis and there is an outgrowth of the stratified squamous 
epithelial progenitor cells, or (b) it is simply shutting off of the columnar genes. 
From the results in Chapter 4, we favour the second model. There is no 
significant difference between the number of dead columnar cells and dead 
stratified squamous cells in vitro, and inhibition of programmed cell death does 
not have any effect on the switch. Interestingly, inhibition studies with 
5-aza-2-deoxycytidine found that DNA methylation might be responsible for 
silencing of the columnar genes.
A number of transcription factors have been previously identified that might be
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important for initiation of stratified squamous epithelium development. For 
example, different p63 isoforms are thought to control the induction of stratified 
squamous epithelium (Koster et al., 2004). In Chapters 6  I found that the AN 
isoform is expressed from E11.5 and the transcription factor was still 
expressed in the adult oesophagus. p63 (probably the AN isoform) might act 
as a master switch gene to transdifferentiate colonic and hepatic cell lines to 
express stratified squamous (K14) markers. The cell transfection results also 
confirmed the results of the K14 promoter/enhancer activity activated in the 
columnar cell line by ANp63a (Fig 6.9 E and F).
In conclusion, the work of this thesis provides a detailed description of the 
normal development of the mammalian oesophagus. Specifically, I described 
the morphological, cellular and molecular basis of oesophageal epithelial 







in vivo: E11.5 
in vitro: E11.5+1d
in vivo: E15.5-17.5 
in vitro:E11.5+ 5-7d
Involucrin starts to 
express
in vivo: E13.5-15.5 
in vitro£11.5+3-5d






g  : K8/K18 positive cells 
Q] : K8/K18 negative cells (Dnmt3 
; Converting cells (ANp63 
Q  : K14 positive cells
vivo: P1 - P5 
in vitro:E11.5+ 7-1 id
suprabasal differentiation 
markers: K10 starts to 
express
- >15d
vivo: > P5 - adult 
in vitro:E11.5 + 11d
Wei-Yuan Yu
Fig 7.1 A model for the conversion of oesophageal epithelium from 
simple columnar to stratified squamous tissue.
Summary for the development of stratified squamous in the oesophageal 
tissue. Comparative results are shown for both normal development and in 
vitro culture. At E11.5d or 1 day of culture, the oesophageal epithelium is only 
1-2 cell layers thick and consists only of K8 positive cells. At E13.5-E15.5 
(approximately 3-5 days of culture), the epithelium of the oesophagus 
becomes thicker, the submucosal and muscle layers are more defined, and 
keratin 4 is expressed (not shown). At E15.5-E17.5 (5-7 days of culture), the 
columnar K8 expression is lost at the basal layer and some basal cells start to 
express K14. In addition, involucrin starts to be expressed. In some segments 
of the oesophagus, we see epithelium that is characteristic of a granular layer 
near the lumen appear. At P1-P5 (7-11 days of culture), the basal layer of the 
epithelium is mostly K14 positive, but K8 positive cells are still retained in the 
suprabasal layers. We also see stratified squamous suprabasal differentiated 
marker K10 expression and very thin cornified layers. At adult (> 2 months old) 
(11 - >15 days of culture), K8 cannot be found in both the basal and 
suprabasal layers of the epithelium, and the oesophagus is fully differentiated 
as a stratified squamous tissue. Dnmt3 may be responsible for the K8 
silencing and ANp63 may be involved in K14 induction.
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7.2 Discussions and Future work
7.2.1 Oesophageal and foregut specific markers
My intention was to investigate development of the oesophageal epithelium. 
However, the lack of oesophageal specific markers somewhat hindered the 
study. We looked for stratified squamous markers in the epidermis to help 
characterise the oesophageal epithelium. The keratins K4 or K13 were used 
as regional markers for the oesophagus, since other organs that express these 
markers are tongue and cornea. We can distinguish the oesophagus from the 
neighbouring trachea/lung, stomach and intestine by using K4 and K13 
antibodies (Moll et al., 1982). One question arising from this work is: are there 
known foregut markers expressed in the early oesophagus? HNF3/forkhead 
genes are members of the winged helix DNA binding domain family of 
transcription factors. GATA4 and GATA6 transcription factors contain distinct 
zinc finger DNA binding domains and are expressed in and are important for 
both the specification and maintenance of foregut identity (Zaret, 1999). To 
date, we have not looked closely at the expression of these transcription 
factors but in the future some attempt should be made to identify novel foregut 
and early oesophageal transcription factors. By conducting studies such as 
microarray analysis of the genes expressed during oesophageal 
developmental should facilitate (i) the identification of oesophagus-specific 
genes and (ii) the essential steps in organogenesis of the oesophagus.
7.2.2 Bifurcation and stratification
There are a number of interesting questions on oesophagus development that 
remain unanswered. For example, which factor(s) control the identity of the 
neighboring dorsal oesophagus and ventral trachea and lung? It is known from
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knockout studies that Shh and the transcription factors Nkx2.1 and Foxfl are 
important in bifurcation process of the foregut (Litingtung et al., 1998; 
Motoyama et al., 1998; Minoo et al., 1999; Mahlapuu et al., 2001). How does 
Shh actually regulate the bifurcation process is not clear? Since Shh is 
expressed in the gut endoderm (except in the pancreas (Roberts, 2000)), there 
must be other factors controlling invagination and closure of the foregut into 
two tube-like structures. However, bifurcation and stratification do not seem to 
be related, as an immature stratified squamous epithelium is still found on the 
dorsal side of the oesophageal-trachea fistula in the Shh'A knockout mice 
(Litingtung et al., 1998). Inhibiting Shh with cyclopamine (Chapter 5, Fig 5.2), 
after bifurcation of the oesophagus and trachea/lung does not affect the 
induction of stratified squamous epithelium. This result confirms the notion that 
Shh might only be important for bifurcation but not related to the formation of 
stratified squamous epithelium in the oesophagus.
7.2.3 Signalling pathways involved in stratified squamous epithelium initiation 
There are probably a number of signalling pathways essential in the 
maintenance of the adult oesophageal stratified squamous epithelium. For 
example, Ca2+ signalling has been shown to be important in controlling 
differentiation of stratified squamous epithelium (Green and Watt, 1982; Ma 
and Sun, 1986). We were interested in the early induction of the stratified 
squamous epithelial marker K14. I tried perturbing Wnt and Shh signalling, 
both signalling pathways were found to function in early foregut and 
oesophagus formation (Litingtung et al., 1998; Motoyama et al., 1998; Lickert 
et al., 2001; Theodosiou and Tabin, 2003). However, no suppression of K14 
expression was found either following activation of the Wnt / p-catenin pathway
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by adding LiCI or suppression of Shh signalling by adding cyclopamine to the 
oesophagus culture.
Induction of ectoderm to either a neural or epidermal cell fate is determined by 
Bmp signalling (Hemmati-Brivanlou and Melton, 1997). During early 
gastrulation, Bmp is expressed along the primitive ectoderm. Noggin, a 
secreted inhibitor of Bmp, is found expressed where neurons are later formed. 
The ectodermal region where Bmp signalling is not inhibited, is induced to form 
epidermis (Wilson and Hemmati-Brivanlou, 1995; Suzuki et al., 1997a). 
Recently, a zebrafish study of ANp63 (the only form of p63 in zebrafish), 
showed a requirement for p63 in the formation of the dermis and pectoral fin 
(equivalent to limbs in mice) (Bakkers et al., 2002; Lee and Kimelman, 2002). 
What is particularly exciting about this study was that Smad binding sites were 
found in the promoter/enhancer region of ANp63. Smad is presumably directly 
activating ANp63 expression (Bakkers et al., 2002). ANp63, (like Bmp) is also 
suppressing the ventral neural fate in the zebrafish. These observations 
suggest that one of the upstream signals controlling p63 is Bmp. It would be 
interesting to determine if Bmp or other TGFp family members are involved in 
the up-regulation of ANp63 in the oesophagus as well as the induction of K14 
and the programme of epithelial stratification in the oesophagus.
Other genes involved in the epidermis forming pathway are also worth 
investigating. These include downstream targets of Bmp such as Msx1 (Suzuki 
et al., 1997b) and Dlx (Park and Morasso, 2002; Rouzankina et al., 2004). It 
should be noted that ANp63a could also be up-regulated by phosphoinositide 
3-kinase pathway (PI3K) through the signal from epidermal growth factor 
receptor (EGFR) (Barbieri et al., 2003).
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7.2.4 p53, p63 and Dnmts
It has been known for some time that p53 can directly regulate the epigenetic 
function of DNA methyltransferases (Dnmts) as well as acting in concert with 
Dnmts (Peterson et al., 2003; Roos et al., 2004; Esteve et al., 2005). It would 
also be interesting to see if p63 with the p53 homologous DNA binding domain 
have similar functional properties as to interfere or regulate the Dnmts. If this is 
the case, there might be a link between p63, Dnmt and down-regulation of the 
columnar genes in the oesophagus epithelium.
7.2.5 Transdilferentiation argument
Is the transition from columnar to stratified squamous epithelium in the 
oesophagus an example of “transdifferentiation”? It does satisfy the criteria of 
Eguchi since the starting and finishing phenotypes are well characterised and 
we have two lines of evidence for a direct conversion of one to the other. 
Moreover it can occur in the absence of any cell division. However it could also 
be argued that this is not true transdifferentiation between differentiated tissue 
types because the columnar cells are simply the normal precursors of the 
squamous cells and the process is more properly described as a maturation or 
differentiation event. However, the columnar epithelium can persist, if initiation 
of the straitified squamous epithelium is blocked. In the p63 knockout mouse, 
squamous epithelia cannot be formed and instead the columnar epithelium 
persists in the oesophagus (and elsewhere) until at least the time of death in 
the perinatal period (Yang et al., 1999; Mills et al., 1999). For this reason, we 




In addition to the data presented in the current thesis, I had also tried to set up 
in vitro model for Barrett's metaplasia and the establishment of a model for the 
development of the small intestine. This part of work is still ongoing in our lab 
and the details will not be included.
From the work presented in this thesis, we hope to gain more understanding of 
the molecular and cellular basis of how the mammalian oesphogeal epithelium 
develops; the understanding of this process might help us find the molecular or 
cellular means to stop Barrett’s metaplasia from occurring. Consequently, the 
present study might prove useful for people working in the fields of 
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A.2 Raw data of FACS analysis
FACS Raw data
Date: 12-04-04 Date: 16-04-04 Date: 14-04-04
76 K14 11 d K14 15d K14
All Live percentage 30.24 All Live percentage 35.7 All Live percentage 18.4
All Dead percentage 69.76 All Dead percentage 64.3 All Dead percentage 81.6
All K14+ percentage 31.12 All K14+ percentage 37.39 All K14+ percentage 28.17
K14+ Dead 23.96 K14+ Dead 20.96 K14+ Dead 19.58
K14+ Live 7.16 K14+ Live 16.43 K14+ Live 8.59
K14+ Dead/All 76.99 K14+ Dead/All 56.06 K14+ Dead/All 69.51
K8 K8 K8
All Live percentage 15.76 All Live percentage 26.76 All Live percentage 20.46
All Dead percentage 84.24 All Dead percentage 73.24 All Dead percentage 79.53
All K8+ percentage 50.41 All K8+ percentage 55.12 All K8+ percentage 43.4
K8+ Dead 37.53 K8+ Dead 32.06 K8+ Dead 36.69
K8+ Live 12.88 K8+ Live 23.06 K8+ Live 16.71
K8+ Dead / All 74.45 K8+ Dead / All 58.16 K8+ Dead / All 61.56
Date: 06-04-04 Date: 28-03-04 Date: 01-04-04
7d K14 11 d K14 15d K14
All Live percentage 18.51 All Live percentage 21.06 All Live percentage 16.55
All Dead percentage 81.49 All Dead percentage 78.95 All Dead percentage 83.45
All K14+ percentage 43.13 All K14+ percentage 18.26 All K14+ percentage 29.12
K14+ Dead 29.73 K14+ Dead 12.05 K14+ Dead 18.87
K14+ Live 13.4 K14+ Live 6.21 K14+ Live 10.25
K14+ Dead/All 68.93 K14+ Dead/All 66 K14+ Dead/All 64.8
K8 K8 K8
All Live percentage 23.45 All Live percentage 46.37 All Live percentage 15.4
All Dead percentage 76.56 All Dead percentage 53.63 All Dead percentage 84.59
All K8+ percentage 40.96 All K8+ percentage 54.16 All K8+ percentage 42.43
K8+ Dead 24.01 K8+ Dead 10.4 K8+ Dead 30.32
K8+ Live 16.95 K8+ Live 43.76 K8+ Live 12.11
K8+ Dead / All 58.62 K8+ Dead/All 19.2 K8+ Dead / All 71.46
Date: 31-03-04 Date: 19-03-04 |0ate: 19-04-04
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7d K14 11 d K14 15d K14
All Live percentage 48.75 All Live percentage 9.51 All Live percentage 21.4
All Dead percentage 51.25 All Dead percentage 90.49 All Dead percentage 78.6
All K14+ percentage 26.27 All K14+ percentage 19.34 All K14+ percentage 12.44
K14+ Dead 7.02 K14+ Dead 11.48 K14+ Dead 10.96
K14+ Live 19.25 K14+ Live 7.86 K14+ Live 1.48
K14+ Dead/All 26.72 K14+ Dead/All 59.36 K14+ Dead/All 88.1
K8 K8 K8
All Live percentage 53.83 All Live percentage 18.07 All Live percentage 17.74
All Dead percentage 46.17 All Dead percentage 81.92 All Dead percentage 82.26
All K8+ percentage 53.32 All K8+ percentage 25.9 All K8+ percentage 23.18
K8+ Dead 2.38 K8+ Dead 12.34 K8+ Dead 12.94
K8+ Live 50.94 K8+ Live 13.56 K8+ Live 10.24
K8+ Dead / All 4.67 K8+ Dead / All 47.64 K8+ Dead / All 55.82
Date: 02-02-04 Date: 28-02-04 Date: 03-03-04
7d K14 11 d K14 15d K14
All Live percentage 63.85 All Live percentage 73.69 All Live percentage 89.7
All Dead percentage 36.16 All Dead percentage 26.31 All Dead percentage 10.3
All K14+ percentage 22.21 All K14+ percentage 58.67 All K14+ percentage 92.67
K14+ Dead 4.79 K14+ Dead 4.57 K14+ Dead 5.68
K14+ Live 17.42 K14+ Live 54.1 K14+ Live 86.99
K14+ Dead/All 21.57 K14+ Dead/All 7.79 K14+ Dead/All 6.13
K8 K8 K8
All Live percentage 32.78 All Live percentage 75.05 All Live percentage 85.12
All Dead percentage 67.21 All Dead percentage 24.95 All Dead percentage 14.88
All K8+ percentage 36.33 All K8+ percentage 81.82 All K8+ percentage 91.61
K8+ Dead 16.05 K8+ Dead 13.5 K8+ Dead 9.46
K8+ Live 20.28 K8+ Live 68.32 K8+ Live 82.15
K8+ Dead / All 44.18 K8+ Dead / All 16.5 K8+ Dead / All 10.33
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Average for Proportion of Dead Cells
4x
7d 
1 1  d 
15d
K14 K14SE K14SE K8 K8 SD
40.34 2 0 1 0 . 0 1 31.46 16
34.99 28 13.97 41.56 25







A.3 Raw data of Luciferase assay
Luciferase assay in Caco-2 and KYSE30 cell line
Cell Line Reporter 
CaC02 pK18mTELucE
Cell Line Reporter 
CaC02 pK14-LucE
Cell Line Reporter 
KYSE30 pK18mTELucE
KYSE30 pK14-LucE
TFs (1 ug each) Average SD SEM
pcDNA3 (2ug) 1 . 0 0 0 . 0 0 0 . 0 0
(pcDNA3)+pAP-2a 1.39 0.89 0.52
(pcDNA3)+pC/EBPa 0.93 0.31 0.18
(pcDNA3)+pC/EBPb 2.53 2.76 1.59
(pcDNA3)+pTAp63a 0.76 0.25 0.14
(pcDNA3)+pDNp63a 0.76 0.55 0.27
(pcDNA3)+pTA*p63a 0.65 0 . 1 0 0.06
pTAp63a+pDNp63a 2.37 3.98 1.99
pTA*p63a+pDNp63a 0.25 0.06 0.03
TFs (1 ug each) Average SD SEM
pcDNA3 (2mg) 1 . 0 0 0 . 0 0 0 . 0 0
(pcDNA3)+pAP-2a 1.41 1 . 0 0 0.58
(pcDNA3)+pC/EBPa 0 . 8 6 0.62 0.36
(pcDNA3)+pC/EBPb 1.58 1.08 0.62
(pcDNA3)+pTAp63a 1.45 0.71 0.41
(pcDNA3)+pDNp63a 1.93 0.62 0.36
(pcDNA3)+pTA*p63a 2.19 2.36 1.36
pTAp63a+pDNp63a 4.32 6.37 3.19
pTA*p63a+pDNp63a 3.79 4.21 2.43
TFs (1 ug each) Average SD SEM
pcDNA3 (2 ug) 1 . 0 0 0 . 0 0 0 . 0 0
(pcDNA3)+pAP-2a 0.87 0.36 0 . 2 1
(pcDNA3)+pC/EBPa 0.81 0.58 0.33
(pcDNA3)+pC/EBPb 0.39 0.09 0.05
(pcDNA3)+pTAp63a 0.80 0.62 0.36
(pcDNA3)+pDNp63a 0.82 0.50 0.29
(pcDNA3)+pTA*p63a 0.55 0.30 0.18
pTAp63a+pDNp63a 1.85 3.16 1.58
pTA*p63a+p D N p63a 0.57 0.50 0.29
pcDNA3 (2ug) 1 . 0 0 0 . 0 0 0 . 0 0
(pcDNA3)+pAP-2a 1.64 0.47 0.27
(pcDNA3)+pC/EBPa 0 . 6 6 0.51 0.30
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(pcDNA3)+pC/EBPb 0.47 0.31 0.18
(pcDNA3)+pTAp63a 1.50 1.38 0.80
(pcDNA3)+pDNp63a 1.09 0.46 0.27
(pcDNA3)+pTA*p63a 0.91 0.67 0.39
pTAp63a+pDNp63a 1.81 2.75 1.38
pTA*p63a+pDNp63a 0.51 0.30 0.17
Luciferase assay in OE33 and NIH3T3 cell line




TFs (1 ug each) Average SD SEM
pcDNA3 (2 ug) 1 . 0 0 0 . 0 0 0 . 0 0
(pcDNA3)+pAP-2a 1.33 0.41 0.29
(pcDNA3)+pC/EBPa 1.24 0.69 0.40
(pcDNA3)+pC/EBPb 1.40 0.99 0.57
(pcD N A3)+pT Ap63a 0.82 0.16 0 . 1 1
(pcDNA3)+pDNp63a 0.79 0.83 0.41
(pcDNA3)+pTA*p63a 1 . 0 2 0.46 0.27
pTAp63a+pDNp63a 0.36 0.26 0.13
pTA*p63a+pDNp63a 0.41 0.23 0.13
pcDNA3 (2ug) 1 . 0 0 0 . 0 0 0 . 0 0
(pcDNA3)+pAP-2a 1.30 0.72 0.51
(pcDNA3)+pC/EBPa 0.53 0.23 0.13
(pcDNA3)+pC/EBPb 0.61 0.38 0 . 2 2
(pcDNA3)+pTAp63a 0 . 8 6 0.37 0.26
(pcDNA3)+pDNp63a 0.44 0.42 0.30
(pcDNA3)+pTA*p63a 0.53 0.26 0.15
pTAp63a+pDNp63a 0.42 0.43 0 . 2 2
pTA*p63a+pDNp63a 0 . 2 1 0.24 0.14
TFs (1 ug each) Average SD SEM
pcDNA3 (2ug) 1 . 0 0 0 . 0 0 0 . 0 0
(pcDNA3)+pAP-2a 2 . 0 2 2.50 1.77
(pcDNA3)+pC/EBPa 1.60 1.03 0.60
(pcDNA3)+pC/EBPb 1.92 1.81 1.04
(pcDNA3)+pTAp63a 0.52 0.29 0 . 2 1
(pcDNA3)+pDNp63a 0.51 0.23 0 . 1 1
(pcDNA3)+pTA*p63a 0.58 0 . 2 2 0.13














1 . 1 2 0.36 0 . 2 1




0.91 0 . 0 1 0 . 0 1
0.92 0.16 0 . 1 1
0.81 0.33 0.19







Luciferase assay-TFs on K18 promoters
Average SEM



















1.00 0.00 pK18mTELucE pcDNA3 (2ug)
2.53 1.59 (pcDNA3)+pTAp63a CaC02
0.39 0.05 KYSE30
1.40 0.57 OE33
1.92 1.04 NIH3T3 4.2
Average SEM 
1 . 0 0  0 . 0 0  
0.76 0.14 
0.80 0.36 








1.00 0.00 pK18mTELucE pcDNA3 (2ug)
0.76 0.27 (pcDNA3)+pTA*p63a CaC02
0.82 0.29 KYSE30
0.79 0.41 OE33















1.00 0.00 pK18mTELucE pcDNA3 (2ug) 1.00 0.00
2.37 1.99 pTA*p63a+pDNp63a CaC02 0.25 0.03
1.85 1.58 KYSE30 0.57 0.29
0.36 0.13 OE33 0.41 0.13
0.65 0.09 NIH3T3 4.2 1.12 0.21
































1.00 0.00 pK14-LucE 
1.58 0.62 
0.47 0.18 
0.61 0 . 2 2
2.40 0.45









0 . 8 6  0.26 
0.91 0.01
Average SEM Average SEM
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pcDNA3 (2ug) 1.00 0.00 pK14-LucE pcDNA3 (2ug) 1.00 0.00
(pcDNA3)+pDNp63a CaC02 1.93 0.36 (pcDNA3)+pTA*p63a CaC02 2.19 1.36
KYSE30 1.09 0.27 KYSE30 0.91 0.39
OE33 0.44 0.30 OE33 0.53 0.15
NIH3T3 4.2 0.92 0.11 NIH3T3 4.2 0.81 0.19
Average SEM Average SEM
pcDNA3 (2ug) 1.00 0.00 pK14-LucE pcDNA3 (2ug) 1.00 0.00
pTAp63a+pDNp63a CaC02 4.32 3.19 pTA*p63a+pDNp63a CaC02 3.79 2.43
KYSE30 1.81 1.38 KYSE30 0.51 0.17
OE33 0.42 0.22 OE33 0.21 0.14




T F : Luc ratio
luc/prot/beta-gal SEM Normalised Luciferase Activity
pK14-LucE pcDNA3 1.5 ug (3:1) 0.37 0.07 1.00
pAP-2a 1.5 ug (3:1) 0.78 0.03 2.13
pcDNA3 0.5 ug (1:1) 1.04 0.03 1.00
pAP-2a 0.5 ug (1:1) 1.08 0.08 1.04
pK18mTELucE pcDNA3 1.5 ug (3:1) 0.23 0.06 1.00
pAP-2a 1.5 ug (3:1) 0.62 0.05 2.67
pcDNA3 0.5 ug (1:1) 0.47 0.07 1.00
pAP-2a 0.5 ug (1:1) 0.51 0.01 1.08
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A.4 List of Materials
A. 4.1 Culture Medium
Basal Medium Eagles (BME) with Earle’s salts (Sigma)
Minimum Essential Medium with Hank’s salts (MEM/Hank’s) (Sigma) 
Dulbecco minimum essential medium (DMEM) (Sigma)
RPMI-1640 (Sigma)
F-12 HAM Nutrient medium (Sigma)
Hank’s Balanced Salt Solution (HBSS) (Sigma)
Foetal Bovine Serum (FBS) (Life Technologies)
Phosphate Buffer Saline (PBSA)
Trypsin / EDTA (Gibco/lnvitrogen)
Gentamycin (Gibco/lnvitrogen)
Penicillin / streptomycin (Gibco/lnvitrogen)
L-Glutamine (Life Technologies)
3 -aminopropyltriethoxysilane (APTES) (Sigma)
Fibronectin (Life Technologies)
1% Non-essential amino acids (NEAA) (Life Technologies) 
Keratinocyte serum-free medium (KSFM) (Gibco/lnvitrogen) 
Supplements for KSFM -
Pituitary gland extract and Epidermal Growth Factor (Gibco/lnvitrogen)
A.4.2 Transfection and chemicals 
GeneJuice (Novagen)
5-Azacytidine (5-Aza-C) (Sigma)




z-VAD-fmk (Caspase Inhibitor VI) (Calbiochem)
I.I'-dioctadecyl-S.S.S'.S'-tetramethylindocarbocyanine perchlorate (Vybrant Dil 
solution) (Molecular Probes)
Cyclopamine (Toronto Research Chemicals)
Ethidium Homodimer (Molecular Probes)
A.4.3 Immunohistochemical and immunostaining reagents 
Triton X-100 (Sigma)
Roche Blocking Reagent (Roche)




ABC detection kit (DAKO)
3,3 -Diaminobenzidine (DAB) (Sigma)
Alkaline phosphatase substrate kit (Black) (Vector labs) 
5-bromo-4-chloroindol-3-yl p-D-fucopyranoside (X-Fux) (Sigma)
Periodic Acid Solution (50%) (BDH)
Schiff reagent (Sigma)
A. 4.4 Luciferase assay 
Luciferase Assay Reagent (Promega)
Microplate Luminometer (Berthold LB96V) with Wing low software 
Microplate Colorimeter (Anthos AN2001) with Stingray v1.5 software 
ONPG (2-nitrophenyl-p-D-galactopyranoside) (Sigma N1127)
Protein Reagent (Biorad 500-0006)
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A.4.5 FACS analysis 
Cell strainer (40 pm) (Falcon)
Propidium iodide with RNaseA (BD Pharmingen)
Fluorescent activated cell sorting (FACS) machine (BD Coulter flow cytometer)
A.4.6 Electroporation 
Micropipette Puller (Sutter, P-97)
Thin wall borosilicate glass capillaries (Clark Electromedical Instrument, 
GC100-15)
Electrosquareporator (BTX, ECM830)
A. 4.7 Microscopes and software programs 
Dissecting microscope (Leica Mz12)
Compound microscope (Leica DMRB)
SPOT camera (IMAGE SOLUTIONS) with software
Zeiss LSM 510 confocal microscope (Carl Zeiss) with LSM 5 Image browser 
program




Murine Maloney Leukaemia Virus (MMLV) reverse transcriptase (Invitrogen) 
DNA thermal cycler (MJ Research Peltier Thermal Cycler-200)
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A.4.9 Cell lines and culture conditions
Cell lines (source) Culture condition
Caco-2 (ECACC) MEM medium supplemented with 10% FBS, 1% 
Non-essential amino acids, 2 mM L-Glu and 0.5 
U/ml penicillin / 500 ng/ml streptomycin
KYSE30 (ECACC) 50% RPMI-1640 and 50% F-12 HAM Nutrient 
medium supplemented with 2% FBS, 2 mM 
L-Glutamine and 0.5 U/ml penicillin / 500 ng/ml 
streptomycin
OE33 (ECACC) RPMI-1640 medium supplemented with 10% FBS, 2 
mM L-Glu and 0.5 U/ml penicillin / 500 ng/ml 
streptomycin
NIH3T3 4.2 (ECACC) DMEM medium supplemented with 10% FBS, 2 mM 
L-Glu and 0.5 U/ml penicillin / 500 ng/ml 
streptomycin
HepG2 (ECACC) DMEM medium supplemented with 10% FBS, 1% 
Non-essential amino acids, 2 mM L-Glu and 0.5 
U/ml penicillin / 500 ng/ml streptomycin
A. 4.10 Primary antibodies list
Primary antibody Species Dilution Company
AP-2a mouse 1:10 DSHB (3B5)
(3-catenin mouse 1:100 Transduction Laboratory 
(610153)
C/EBPa rabbit 1:100 Santa Cruz (sc-61)
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C/EBPp mouse 1:100 Santa Cruz (sc-7962)
Desmin mouse 1:100 DAKO (D33)
E-cad herin mouse 1:100 Transduction Laboratory 
(C20820)
Filagrin rabbit 1:100 Covance (PRB-417P)
GFP mouse 1:100 Clontech (8362-1)
GFP rabbit 1:500 Abeam (ab290)
Involucrin mouse 1:100 Neomarkers (SY5)
K4 mouse 1:100 Sigma (6B10)
K8 rat 1:200 DSHB (TROMA I)
K10 mouse 1:100 DAKO (DE-K10)
K13 mouse 1:100 Sigma (KS-1A3)
K14 mouse 1:100 NeoMarkers (MS-115)
K14 rabbit 1:100 Covance (PRB-155P)
K18 mouse neat Prof. B Lane (LE61)
Ki67 mouse 1:100 BD Pharmingen (556003)
Loricrin rabbit 1:100 Covance (PRB145P)
Myoglobin rabbit 1:100 DAKO (A0324)
pan p63 mouse 1:100 Santa Cruz (4A4)
Skeletal myosin (Fast) mouse 1:100 Sigma (MY-32)
a-smooth muscle actin mouse 1:100 Sigma (1A4)
Smooth muscle myosin 
kinase
mouse 1:100 Sigma (K36)
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A.4.11 Secondary antibodies list
Secondary antibody Dilution Company
FITC anti-mouse IgG 1:100 Vector (FI-2000)
FITC anti-rat IgG 1:100 Vector (FI-4000)
FITC anti-rabbit IgG 1:100 Vector (F-0382)
Texas Red anti-rat IgG 1:100 Vector (TI-9400)
Tetramethylrhodamine 
Isothiocyanate (TRITC) swine 
anti-rabbit IgG
1:100 DAKO (R0156)
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